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P.aeruginosa is one of the most important pathogens in nosocomial infections and 
fails to respond to standard treatment, particularly in the case of patients subjected to 
prolong antibiotic treatment. To generate a more comprehensive understanding of the 
failure of antimicrobial treatment, focusing especially on the adaptive resistance 
could be the key area that the bacterium develops in this phenomenon. Most studies 
on antibiotic resistance in P.aeruginosa have focused upon genotypic studies. This 
study set out to develop an in vitro model to examine the effect of continual exposure 
of P.aeruginosa PA01 to the antibiotics studied. Experiments were initially 
conducted to consider the factors that having a significant influence on antibiotic 
susceptibility using a novel fluorescence based assay (OxoPlate® system). 
P.aeruginosa was subjected to the action of tobramycin, amikacin and colistin under 
various environmental factors. The results of the in vitro analysis showed that, from 
among the three antibiotics used, amikacin was the antibiotic where resistance was 
most readily developed. From these results, chemostat studies were designed to 
examine prolonged exposure of the antibiotic to planktonic cells.  Chemostat cultures 
were exposed to amikacin at sub-inhibitory concentrations using Evans defined 
synthetic medium at different dilution rates (D) under glucose limitation. Both 
cultures grown at 0.025h-1 and 0.06h-1 developed the following characteristics i. low-
level amikacin resistance, which exhibited an increase in the MIC 4-fold.  ii. a clear 
development of phenotypic resistance and this resistance was not acquired as 
evidenced by the loss of resistance on culture into fresh medium lacking antibiotic. 
iii. adaptive resistance to amikacin conferred low-level resistance to other 
aminoglycosides such as tobramycin and antibiotics with different modes of action 
such as colistin. Low oxygen availability was seen in the cultures grown at 0.099 h-1 
and 0.125 h-1, which lead to i.  the appearance of the so called “persister” phenotype. 
These persisters are sub populations of cells that showed a reduction in bacterial cell 
size as evidenced from the flow cytometry output as well as being slow growing and 
resistant ii. extracellular polymeric fibrils were produced in the cells derived after 
72h incubation time. In all cases, continual exposure resulted in phenotypically 
distinct mucoid and non- mucoid colony morphotypes, which were clearly observed 
on amikacin-free nutrient agar. Some of these selected morphotypes showed from the 
MIC and MBC data a high-level resistance to the antibiotic when left without 
iv 
 
antibiotics. The biological responses resulting from these studies offer valuable clues 
underlying unsuccessful treatment. Conducting experiments using robust systems 
renders this project extremely novel in the field of microbiology and this will 
contribute to the development of viable treatment options and ultimately the 
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It was only by chance that, in 1928, whilst studying bacteria in his laboratory at St 
Mary’s Hospital in London Alexander Fleming discovered that bacteria could be 
destroyed by the mould-produced substance penicillin, due to the accidental 
contamination of his petri dish with mould. In a little over a decade after this 
discovery, drugs containing penicillin were prepared by Fleming and other 
researchers for administration in the treatment of bacterial infections. Subsequently, 
other antibiotics were created, paving the way for the unprecedented advancements 
made in healthcare and medicine during the 20th century. The discovery of 
antibiotics improved the efficiency of treatment of diseases associated with a high 
prevalence and high mortality rate, including pneumonia and tuberculosis (Cars et 
al., 2011, Stover et al., 2000).  Recently, however, many strains of bacterial 
pathogens which could previously be killed with effective antibiotics have become 
resistant to these drugs (Canton and Morosini, 2011). In fact, the problem with 
antibiotic resistance has globally increased since the 1940s (Partridge, 2011). 
However, the widespread use of antibiotics led to the appearance of bacterial strains 
that could resist the drug effects. Therefore, antibiotic resistance is considered to be 
the greatest problem faced by the healthcare sector in the present modern era (Cars et 
al., 2011).  From a microbiological point of view, this resistance refers to bacterial 
pathogens which have a resistance mechanism, making them less susceptible to 
antibiotics. Clinically, resistance is viewed as a clinical criterion of treatment in 
patients who are infected by specific bacterial pathogens which are difficult to treat 
(Turnidge and Paterson, 2007).  
 
In more recent times, antibiotic resistance has become more extensive, and is now 
considered to be among the gravest threats to healthcare in communities as well as in 
hospitals (Rice, 2009, Witte, 1998, Aarestrup, 2005). Human activities, such as 
agricultural practice and frequent use and abuse of antibiotics in the treatment of 
                                                                                    




human and animal conditions, are deemed to be the main cause for the development 
of antibiotic resistance at a global level (Witte, 1998, Aarestrup, 2005, Ferber, 2000, 
McManus et al., 2002, Cabello, 2006). The selection of resistant mutants in bacterial 
strains is a logical consequence of the use of antibiotics at high concentrations. 
However, it is not clear to what extent mutant selection in a polluting environment is 
fostered by low antibiotics concentrations. Such antibiotics are naturally produced by 
microorganisms or introduced by human or animals during use of antibiotics for 
therapeutic or growth stimulation purposes (Kummerer, 2009, Thiele-Bruhn, 2003, 
Chander et al., 2005). 
 
Due to its complexity, the issue of antibiotic resistance must be addressed from 
different angles (Levy and Marshall, 2004). The increase in emergence of antibiotic 
resistance is believed to be promoted first and foremost by exposure to antibiotics. 
Thus, there are major concerns regarding the dangers of microbes being ‘trained’ to 
become highly resistant to drugs (Singer et al., 2003).  It has been argued that the 
extensive presence of antibiotics in the environment enables bacteria to acquire 
antibiotic resistance (Guilfoile, 2007). This issue has been particularly observed in 
animal husbandry, where antibiotics are routinely used for promoting growth.  In a 
review by Phillips in 2007 it was reported that in Denmark the resistance to the 
antibiotic streptogramin had dropped from 40–60% in the late 1990s to 16% in pigs 
and 13% in chickens after antibiotic growth promoters had discontinued in this 
country. A considerable quantity of antibiotics are naturally eliminated by humans 
and animals after ingestion, ending up in the sewage treatment centres and finally in 
rivers or lakes (Guilfoile, 2007). There is important evidence that support prolonged 
drug exposure may lead to the development of antibiotic resistance in bacteria 
present in the environment. The US geological survey revealed that antibiotics were 
found in 22% of the rivers that were analysed (Kolpin et al., 2002). What is more, 
alarming is that bacteria can develop resistance even when exposed to low 
concentrations of antibiotics. The subpopulations of cells that survive under these 
conditions are selected for because they have mutations that give the cells an 
advantage over the general population. Because of this advantage they dominate and 
essentially become selected (Canton and Morosini, 2011). This process facilitates the 
exposure of an immense number of bacteria to the variety of different types of 
antibiotics (Guilfoile, 2007). Thus, resistant bacteria may arise and find themselves 
                                                                                    




in a human clinical setting as a result of using antibiotics in this way, leading to 
antibiotics being banned in some countries for use in animal husbandry (Singer et al., 
2003). The resolution of the European Union to forgo the practice of accelerating the 
growth of food animals with the use of antimicrobials was revised in May 2010 by 
the Alliance for the Prudent Use of Antibiotics (APUA). This committee was 
composed of 16 representatives from 10 European Union nations and overseen by 
Herman Goossens from the University of Antwerp, Belgium and by Christian Greko 
from the National Veterinary Institute in Uppsala, Sweden. A number of European 
Union (EU) member nations have interdicted the use of antibiotic growth promoters 
(AGPs) in food animals, including Sweden, Denmark and Great Britain (Cogliani et 
al., 2011). In a review by Phillips in 2007 it was reported that since 1986, antibiotic 
growth promoters had been withdrawn from Sweden. In 1995, the rest of the EU 
banned the use of growth promoting antibiotics. Based on the Precautionary 
Principle basis, other growth promoters such as bacitracin, spiramycin, tylosin and 
virginiamycin were also discontinued from the middle of 1999 in the whole of the  
E U. The frequency of antibiotic resistance among bacterial pathogens is high, and is 
on the increase due to the reportedly intensive use of antibiotics (Partridge, 2011). 
Considering the connection between the use of antibiotics and acquisition of 
resistance, bacteria can prove to be seriously dangerous to human life. The results of 
two European studies proved particularly enlightening with regards to the link 
between the exposure of bacteria to antibiotics and the development of resistance. 
The first study, conducted on wild mice, discovered that a large number of antibiotic 
resistant bacteria could be isolated from these rodents living in wooded areas in 
England (Gilliver et al. 1999 cited in Guilfoile, 2007).  The second study, carried out 
in Finland, examined the bacteria found in the intestines of a number of species of 
mammals and revealed that the level of antibiotic resistance of the bacteria was low 
(Osterblad et al. 2001 cited in Guilfoile, 2007). It was concluded that the factor 
which determines the level of antibiotic resistance of bacteria is related to the 
proximity to people (Guilfoile, 2007). Undoubtedly, there is a strong relationship 
between the emergence of resistance and antibiotic use, as observed in community 
environments and hospitals (Canton and Morosini, 2011).  
The global spread of antimicrobial resistance has resulted from the use of several 
million tons of antibiotics in both clinical and agriculture sectors (Chait et al., 2012). 
                                                                                    




Nearly twelve tons of antibiotics are globally used every hour, with many being 
administrated without proper regulations or prescriptions (Harbarth et al., 2015). The 
rapid speed of resistance evolving throughout the bacterial population is the greatest 
risk to effective bacterial infection treatment (Cars et al., 2011). In fact, an increase 
in antimicrobial resistance worldwide is a significant source of global health 
concern. Antibiotic resistant microorganisms are considered to be one of the most 
significant life-threatening issues for public health, which must be experimentally 
addressed (Chait et al., 2012). Many of these links between antibiotic use and 
resistance have been deduced from in vivo studies. What is lacking is an in vitro 
approach to link the overuse of drugs to resistance. In addition, a robust model 
system would allow us to investigate other contributory factors resulting in 
resistance. 
1.2. An overview of antibiotic resistance 
For all of scientists, antibiotic resistance has been an essential issue of concern since 
the very beginning of antibiotic use. Around 162512 publish papers were listed by 
PubMed in June 2016, those which had the expression “antibiotic resistance” iterated 
under “any field”. Genetic elements and/or chromosomal genes were the focus of 
concern in the majority of these publications. A number of viable reasons are present 
to justify the considerable amount of attention that has been devoted to inherited 
antibiotic resistance. Alongside being a significant health issue, it has shown no 
signs of improving with the passage of time (Rubin et al., 1999, Lipsitch, 2001, Levy 
and Marshall, 2004, Fuller and Low, 2005, Cosgrove, 2006). Researchers find 
inherited antibiotic resistance to be particularly interesting as it has a number of 
special characteristics. Various studies such as those regarding mathematical 
modelling, biochemistry, physiology, molecular biology, and bacterial genetics have 
been conducted. The hereditary resistance, which resist the action of the most of 
antibiotics, has proved to be an important influence of motivation for the 
pharmaceutical industry to discover and develop enhanced and advanced medicines 
(Andriole, 2005), that have the characteristics for defeating the resistance 
mechanisms (Lomovskaya et al., 2001, Lomovskaya and Bostian, 2006).   
                                                                                    




In spite of significant progress being made in term of treatment options and the 
improvement of available antibiotics, it has shown no long term solution to this issue 
(Sandoval-Motta and Aldana, 2016).  
Even though such inherited resistance is particularly important for clinical 
reductionism, it is not considered to be the only route to resistance. This is supported 
by the recent study by Feng et al. (2016), who showed that a minimal fitness cost 
was associated when P.aeruginosa cultures were subjected to a week-long course of 
high-dose ceftazidime and meropenem using chemostat cultures. The study 
suggested that resistance in patient treatment is not necessarily linked to genetic 
resistance. In the case of P.aeruginosa, reports by Lee et al. (2016) have pointed to 
the phenomenon of phenotypic resistance where cells do not inherit resistance rather 
they become ‘fitter’ due to exposure to colistin resulting from altered gene 
expression. The susceptibility of the bacterial population to colistin returned to its 
previous levels when the antibiotic was removed. 
The effectiveness of antibiotic treatment is related to host factors (Sorensen et al., 
1988). Factors such as the health condition, age, and genetics are the major factors 
upon which the path of an infection directly depends. In some cases the infection 
may appear to be cleared but following the removal of chemotherapy the infection 
may re-appear. Such manifestations can arise due to subpopulations that have the 
ability to survive. Their survival may not be simply explained by mutations in these 
populations. Their survival could be due to their physiological state at the point of 
antibiotic treatment (Janeway and Travers, 1996). Such survival can be attributed to 
non-inherited resistance. Non-inherited resistance is often classified as were being 
phenotypic which is in contract to inherited resistance. The hereditary susceptibility 
remains unchanged when the population is being treated with the antibiotics (Levin 
and Rozen, 2006).  
Thus, there are two types of antibiotic resistance – inherited and phenotypic 
resistance. The former arises from genetic transformations and has received the most 
attention from researchers. The latter refers to the expression of a phenotype of a 
bacterium those results in it being less susceptible to an antibiotic with no resistant 
underlying genetic change. In all phenotypic resistance situations, considerable 
attention has been devoted to drug indifference as well as bacteria grown in biofilms. 
                                                                                    




Bacterial permeability changes are also researched thoroughly alongside working on 
persistence and its entire construction. Nevertheless, there are still situations in 
which the vulnerability to antibiotics depends on the state of metabolism. While in 
certain occasions, resistance phenotype to antibiotics is involved to a condition of 
growth arrest that inhibits the action of certain bactericidal antibiotics such as β-
lactams. There are a number of researches that have highlighted how a prominent 
connection is apparent between the susceptibility phenotype and the bacterial 
population’s metabolic state. This has proven to be rather complex (Corona and 
Martinez, 2013).  This section was conducted of numerous scenarios where non-
inherited and transient antibiotic resistance states are formed.  
1.3. Non-inherited antibiotic resistance (phenotypic variation) 
In 1985, the first phenotypic resistance switch was characterised in the fungal 
pathogen Candida albicans. In the case of the pathogenic C. albicans reports by 
Slutsky et al. (1985) have pointed to seven general phenotypes recognized by variant 
colony morphology on agar Fig.1. Other fungi for instance Crytococcus neoformans 
were introduced later. These increments also incorporated other Candida species 
(Fries et al., 2002). Afterwards, it was further identified in the microorganisms as 
Neisseria spp, Salmonella spp, Escherichia coli, Staphylococcus aureus, and 
Pseudomonas aeruginosa. In a review by Proctor et al. (2006), it was reported that 
the first phenotypic switch termed bacterial small colony variants (SCVs) was 
identified in 1910 in Salmonella enterica and has since been observed in a wide 
range of microorganisms. Thus, for both non-pathogenic as well as pathogenic 










                                                                                    



















Figure 1: Colony morphology switch in the fungal pathogen C. albicans 3153A. (A) Original 
smooth; (B) star; (C) ring; (D) irregular, wrinkle; (E) stippled; (F) hat; (G) fuzzy (note aerial mycelia 
on colony dome); (H) revertant smooth (Slutsky et al., 1985). 
 
1.3.1. Bacterial persistence 
Since the antibiotics were developed, it was well understood that antibiotics that 
possess bactericidal activity are ineffective in killing all the bacterial population 
(Bigger, 1944). With the passage of time, the killing rate significantly decreases and 
certain bacterial population fractions survive as a result of being less susceptible to 
the action of antibiotics. This phenomenon was first documented in 1942, in cases of 
Staphyloccocal infections which reappeared even after intensive administration of 
penicillin. Despite the ability of penicillin to destroy bacteria, it was found that it 
was difficult to carry out complete eradication of the bacterial population. This 
particular aspect is referred to by a number of names, for instance ‘bacterial 
persistence’ (Bigger, 1944, Balaban et al., 2004), ‘adaptive resistance’ (Barclay et 
al., 1992), and ‘phenotypic tolerance’ (Wiuff, 2005, Levin, 2004). Persistent cells 
refer to the fact that the same cultures of bacteria react in different ways when 
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which manifests when a bacterial culture is subjected to the action of antimicrobial 
agents and the number of surviving bacteria is recorded. The surviving bacteria do 
not possess intrinsic resistance mechanisms and they regenerate a culture that is 
susceptible to the effects of antibiotics. Microbial persisters are produced by 
bacterial populations to ensure population survival, and can be viewed as an 
important example of a high tolerance to antibiotics (Keren et al., 2004a). A small 
fraction of the population is made up of microbial persisters. One of the most 
common characteristics is that microbial persisters have the ability to survive 
antimicrobial treatment with a high concentration of bactericidal antibiotics, because 
these cells are in an inactive state. By removing the antimicrobial agent and culturing 
persister cells in fresh media, not only will the sensitivity to antibiotics be acquired 
again by the progeny of “persister cells”, but microbial persisters will also resume 
growth (Dawson et al., 2011). It is easy to repopulate the majority of bacterial 
infections after finishing off a course of antibiotics, because bacterial persisters are 
present in a dormant state in a bacterial population, which means that there has been 
no growth or death. These cells are highly resistant to antibiotics, because antibiotics 
are unable to destroy non-growing bacterial cells such as “persister cells” (Martínez 
and Rojo, 2011). The reason why the persistent subpopulation is in a non-dividing is 
that the production of toxins is responsible for stopping essential cellular functions 
which put bacteria in a dormant stat (Lewis, 2005). Thus, “persister cells” are 
considered to be the best example for studying phenotypic change among bacterial 
pathogens. Experimentally however, it has been quite difficult to study persistence as 
a phenotype. This is because the fraction is comparatively small in contrast to the 
overall bacteria population: only 1 in 105–106  cells of the wild-type E.coli are 
classified as persister cells (Moyed and Bertrand, 1983). E.coli has so far been 
utilized for characterizing the persister formation, (Lewis, 2007), and considerably 
less is known in regard to better understanding such cells of P. aeruginosa. 
No explanations were provided for this phenomenon and the aspect was 
comparatively ignored until such persistent cells were extensively studied by Harris 
and Moyed in the 1980s ( Moyed and Bertrand, 1983, Moyed and Broderick, 1989).  
There are currently a number of hypotheses that have been formulated to provide an 
explanation for the differences in reaction to the effects of antibiotics that have been 
observed in the same bacterial culture (Gefen and Balaban, 2009). The reason why 
                                                                                    




this aspect was disregarded for a long time is due to the fact that the immune system 
disposes of surviving bacteria in cases of bacterial infections. Nevertheless, 
pathological conditions such as tuberculosis has made it clear that persistence 
represents the principal issue, a single surviving bacterial organisms being enough to 
trigger the infection, thus rendering the immune system powerless. 
1.3.1.1.Persistent cells type 
Persistent cells can be classified into two types. Starvation is the major factor 
resulting in generating the Type I persistence. This phenomenon is not directly a 
result of bacterial cells that are not growing rather it is thought to be linked to a 
metabolic shift that is present once the end of stationary phase is reached. The cells 
eventually become fully sensitive to antibiotic after the whole population is re-grown 
in replete media (Gefen et al., 2008). The stringent responses is considered to be 
crucial in Type I persistence development. This particularly pertains to E. coli 
persistence (Korch et al., 2003).  
On the other hand, Type II persister cells are created as a result of a phenotype-
switching mechanism in which normal cells eventually evolve to become such 
persister cells type II. The type II also possesses the ability to return back to normal 
phenotype. However, there seems to be no apparent relationship between the 
stationary phase, stringent response and the switch (Kussell et al., 2005).  
1.3.1.2.Mechanisms of persistence  
All bacterial species appear to have persistence as one of their primary 
characteristics (Cohen et al., 2013). A number of biological mechanisms have been 
put forward over the years for highlighting how certain sets of dividing bacterial 
population can stop replicating and thus end up adopting the persistent phenotype. 
The reason behind this is that  a number of a subset of cells that have not started the 
replication procedure would  be included in growing populations that exists during 
the exponential phase (Balaban et al., 2004, Metris et al., 2005). Cells currently 
conducting DNA repair would also be present during the growth phase. Such cells 
would have stopped division while the repair is being carried out (Debbia et al., 
2001). Certainly, the SOS system is induced by various antibiotics that lead to a halt 
in the division of cells (Pérez-Capilla et al., 2004). Lastly, based on the study of 
molecular genetics and genome-wide mutant screening, there are two major classes 
                                                                                    




of genes which contribute to the development of persister cells. The expression of 
toxin or antitoxin (TA) genes lead to a direct generation of persistent populations 
(Cohen et al., 2013, Gerdes and Maisonneuve, 2012). The initial linking of 
persistence and TA systems was conducted in the 1980s, (Moyed and Bertrand, 
1983) via ethylmethane sulfate mutagenesis of E. coli. Such factors helped to 
identify  high persistence (hip) mutants in E. coli  (Korch et al., 2003). Bertrand and 
Moyed were the first to identify the hipA mutants of E. coli, and how these were 
able to result in considerably higher persistent cell frequencies pertaining to this 
mechanism (Moyed and Bertrand, 1983, Lewis, 2005). However, a significant 
number of persister cells in E. coli were derived due to over expression of the toxin 
element present in the TA systems called ReIE, which leads to bacterial growth 
arrest (Keren et al., 2004b). These modules are considered to be comparatively 
common in microbial genomes and thus could be seen to be representing general 
mechanisms that allow persistent population to be generated (Levin and Rozen, 
2006). This mechanism is affected by changes or modifications in the concentration 
of the proteins (Cohen et al., 2013, Gerdes and Maisonneuve, 2012).  
The knowledge regarding persistence mechanisms has been significantly increased 
over the years leading to various approaches to eliminate the subpopulations of such 
bacteria that are rather resisting to the action of drugs. The response of Quorum 
Sensing (QS) in P. aeruginosa can be related to persister cells (Moker et al., 2010). 
Moreover, infection caused by P.aeruginosa could be tackled as a result of inhibition 
of QS, which constitutes an anti-virulence approach (Hentzer et al., 2003, Wu et al., 
2004). This type of inhibitors lead to reduce the proportion of persistent cells or on 
the other hand, increase how susceptible they are to such drugs, which is 
considerably crucial for treating infections pertaining to P. aeruginosa. Various 
recent studies have highlighted how the QS inhibitor (Z)-4-bromo-5-
(bromomethylene)-3-methylfuran-2 (5H)-one revives the susceptibility of persister 
cells in P. aeruginosa PAO1. Still, such results cannot be solely attributed to QS 
inhibition and the various mechanisms involved in determination of such activities 
(Pan et al., 2012). Some studies conducted in this regard have indicated knockout of 
such genes coding for metabolic enzymes, for instance yigB, which encodes a flavin 
mononucleotide phosphatase or ygfA, also encoding enzymes that are utilized in 
folate biosynthesis which decreases the level of persistence (Hansen et al., 2008), 
                                                                                    




while over expression of these genes lead to enhance the tolerance levels. Shifting of 
the microbial metabolism is a rather unique approach for the eradication of such 
persistent cells. Various articles published recently have showed the feasibility and 
viability of using such an approach. For instance, a researcher indicated how 
persister cells were killed used aminoglycoside antibiotics as a result of simply 
adding various specific metabolic substrates, which permit recoveries of the bacterial 
proton motive force alongside ensuring that growth is not resumed (Allison et al., 
2011). In line with the same procedure, it was also subsequently discovered that 
adding 3-[4-piperazin-1-yl]piperidin-4-yl biphenyl-4-carboxylate to the bacterial 
cultures results in reversing the persistent cells to become sensitive to the action of 
antibiotics (Kim et al., 2011).  
1.3.2. Biofilms 
Another common type of phenotypic change is the bacterial biofilm. Communities of 
microorganisms binding to the surface are called biofilms. Every year, millions of 
lives are being threatened by persistent bacterial infections caused by cells living in 
biofilms. Developing a biofilm is a phenotypic strategy employed by microbes, so 
that they are able to survive in the host (Chen and Wen, 2011). Anaerobic growth 
takes place in the centre of biofilms, exhibiting a slow growth rate and little 
metabolic activity when compared with bacteria living on the surface of biofilms 
which grow aerobically, allowing a faster growth rate and high metabolic activity 
(Høiby et al., 2011). It is important to note that resistance mechanisms in planktonic 
bacteria seem to be different to those of bacteria in a biofilm, mainly due to the fact 
that bacteria in biofilms are highly resistant to antimicrobial agents compared with 
stationary phase planktonic bacteria (Drenkard, 2003). One of the most important 
properties affecting bacteria living in biofilms is a slow growth rate in the centre of 
biofilms, which enhances the resistance to antimicrobial agents. Gene expression in 
biofilms is another property which gives bacteria the opportunity to become more 
adaptive to physiological and biochemical conditions. Up-regulation of specific gene 
expression occurs in the bacteria living in the centre of biofilms, making them able 
to adapt to anaerobic growth (Høiby et al., 2011). A host of genes are up-regulated 
and downregulated during in response to a biofilm lifestyle and a study by Hentzer et 
al. (2003) have characterised the response at the level of the transcriptome. In 
addition, the factor which plays the most significant role in restricting the diffusion 
                                                                                    




of chemical components of antibiotics is the physical and chemical structure of the 
exopolysaccharide matrix, which surrounds the bacterial population in biofilms. A 
biopolymeric matrix consists of proteins, polysaccharides and extracellular DNA. 
This factor has a serious impact on chronically ill patients infected by bacterial 
biofilms, as it is extremely difficult to eradicate from the host. Bacterial growing in 
biofilms exhibit higher Minimal Inhibitory Concentrations (MIC) and Minimal 
Bactericidal Concentrations (MBC) when compared with planktonic bacteria. 
Indeed, biofilms have a high resistance both to host immune system components and 
to antimicrobial agents (Drenkard, 2003, Hoiby et al., 2011). A mature biofilm of P. 
aeruginosa can be produced very rapidly, usually in 5 to 7 days (Fig.2) (Høiby et al., 
2011). Planktonic cells (free living) are involved in the first step of biofilm 
formation, when they attach to a surface reversibly. In this stage, such cells are 
sensitive to antibiotics. Irreversible binding to the surface takes place in the next step 
of the formation of biofilm. In this stage bacteria continue growing and form a 
microcolony surrounded by a polymer matrix. The thickness of biofilm is up to 
50µm and it looks like a mushroom. A mature biofilm is the final stage of formation 
which involves focal dissolution to ensure formation of a new biofilm to take place 
in another location caused by spreading of liberated bacterial cells. The conventional 
resistance mechanisms can be clearly studied in P. aeruginosa biofilms which are 
exposed to β- lactam antibiotics and colistin (Høiby et al., 2011). Studies have 
shown that there is a strong relationship between survival strategies, including the 
formation of a biofilm or small-colony variants, and the response of the bacterial 
population of P. aeruginosa to treatment with antibiotics  (Surhone et al., 2010).   
 
                                                                                    





Figure 2: An in vitro experiment of biofilm formation of P. aeruginosa with green fluorescent 
protein-tagged. Cells grown in a flow-cell and confocal scanning laser microscope used to exam the 
structure of biofilm. A cell-to-cell communication results from Quorum Sensing (QS) and 
Extracellular Polymeric Substance (EPS) is hydrated extra-cellular biofilm matrix. The biofilm 
become thick between 25–100 μm. Adapted from Hoiby et al. (2011).  
 
1.3.3. Drug indifference 
Very soon after discovering that penicillin could be utilized for clinical purposes, it 
was also discovered that there was a direct relationship between the growth rate and 
the rate at which these microorganisms are being killed as a result of the action of 
antibiotic (Lee et al., 1944). The antibiotic has no effect on those bacteria, which 
were not dividing. This phenomenon was termed as ‘drug indifference’ by Walsh 
McDermott, when he reviewed the subject. This was also not limited to a particular 
antibiotic class, for instance the β-lactam class (McDermott, 1958, Paramasivan et 
al., 2005, Herbert et al., 1996). Those bacteria that have inadequate nutrients or are 
not dividing appear to be refractory to being killed by the antibiotics.  
 
The bacteria can be effectively killed in the exponential phase of growth by the 
major classes of antibiotics that are available. Persister cells can be found in the 
stationary phase of antibiotic free media. However, if cultures are exposed to 
antibiotics during the growth phase the prevalence of persister cells in the stationary 
phase is much greater. Even though ciprofloxacin and streptomycin contribute 
towards the killing of bacteria in the stationary-phase, death rates are comparatively 
lower in contrast to the incidence of death when the antibiotics are present during the 
                                                                                    




exponential phase. The persister phenomenon is not just found in in vitro situations. 
Using mouse and rabbit models eagle demonstrated that infection became difficult to 
eradicate as the infection progressed and the bacteria became nutrient depleted. 
There was also a clear correlation between the inoculum density and the resistance of 
the population to eradication by antibiotics (Eagle, 1952, Eagle et al., 1950, Eagle, 
1949, Darnell et al., 1955, Wood and Smith, 1956). The results indicated that the 
bacteria tended to become progressively less susceptible to antibiotic treatment as 
the infection period progresses (Bull et al., 2002). This change in susceptibility 
cannot be attributed to heritage and rather are considered to be a result of alternate 
changes that occur in bacterial physiology. Moreover, it was recently indicated that 
drug indifference can be observed when the bacteria are in “resting state”, after the 
infection has taken place (Levin and Rozen, 2006).  
1.3.4. Colony morphology switches 
Various dynamic and different populations result due to phenotypic switching. Such 
populations also possess the capability to tackle different challenges. Colony 
morphology variation is considered to be one of the extremely prominent 
characteristic of phenotypic switching which is also known as “dissociative attitude”. 
This term was first illustrated by Zierdt et al, back in 1964. Changed colony 
manifestations were established for quite a few bacteria such as Streptococcus 
pneumonia (Allegrucci and Sauer, 2007), Haemophilus influenza (Roche and 
Moxon, 1995), Enterococcus faecalis (Wellinghausen et al., 2009), Burkholderia 
pseudomallei (Chantratita et al., 2007) , and P.aeruginosa (Haussler, 2003). 
Any sort of change in colony morphology might be an indicator of transformed 
appearance of the traits of the bacteria. These modifications may be in the form of 
changes in texture, colour, or opacity. A number of hospitals and laboratories are 
actively utilizing colony morphology for identification of microorganisms as well as 
isolation. Less information is available regarding the relationship between colony 
morphologies and bacterial features, irrespective of the importance of this aspect. 
For predicting and identifying the altered bacterial traits, colony visualization might 
be utilized. External factor relationships would also be highlighted. Coupled with it, 
the examination of colonies can play an important role to create connection among 
factors such as virulence, variations in morphological colony, persistence and 
                                                                                    




antimicrobial resistance. The relationships between the above mentioned can prove 
to be tremendously constructive to devise curative and biotechnological techniques 
(Sousa et al., 2011). For many microorganisms, quite a few colony morphotypes are 
recognized and further explained out of which the finest ones are the rugose small 
colony variants (RSCV) (Starkey et al., 2009), the mucoid morphotypes (Kirov et al., 
2007, Govan and Deretic, 1996), and the small colony variants (SCV) (Singh et al., 
2009, Malone et al., 2010). Few of the aforementioned morphotypes can be linked 
with decreased immunogenicity, resistance of antibiotic, and changed metabolism. 
All these factors may result in an augmented ability of an organism to cause disease 
and persistence.   
1.3.5. Bacterial permeability  
A particularly crucial reason that enhances susceptibility of an antibiotic against 
bacteria is that they penetrate inside the targeted cells. This also implies that 
bacterial envelopes are thus the first obstacle encountered by antibiotics.  As a result, 
antibiotic effectiveness may be affected as a result of bacterial permeability changes 
(Fernandez and Hancock, 2012, Pages et al., 2008). Three differing mechanisms can 
be utilized for modulating the permeability of bacteria to antibiotics. Firstly, the 
surface of bacteria might be altered through the change in lipopolysaccharide which 
subsequently decreases the interactions of the antibiotic with this molecule and 
decreasing the penetration of the drug. Secondly, altering the antibiotic transporters 
or the porin type proteins can also have a significantly influence antibiotics 
susceptibility. Thirdly, once the cytosol is reached by the antibiotic, active pumping 
can be carried out by efflux pumps. The outer membrane is considered to be the 
foremost barrier encountered by the antibiotic penetration in gram-negative bacteria. 
This is comprised of lipopolysaccharide (LPS), which indicates particular anionic 
groups in which there is a binding of the cationic antibiotics. This also represents the 
initial step that needs to be taken in adsorbing antibiotics (Peterson et al., 1985). It 
was additionally described in P. aeruginosa that altering the negative charges 
possessed by the lipid A of the LPS through adding 4-aminoarabinose would lead to 
an increase in the resistance against cationic antimicrobial peptides, 
aminoglycosides, and polymyxin. Such responses can be particularly induced 
through concentration limitations of Ca2+ as well as Mg2+. This usually pertains to 
                                                                                    




the antimicrobial peptides and polymyxin. Three particular component systems have 
been identified in P. aeruginosa, these are PhoP-PhoQ (Macfarlane et al., 2000, 
Macfarlane et al., 1999), PmrA-PmrB (McPhee et al., 2003), and ParS-ParR 
(Fernández et al., 2010), which up-regulated the arnBCADTEF operon. The products 
of these systems possessed the capability to modify the LPS. Inducing antibiotic 
resistance to the various cationic antibiotics by the lowering of  concentrations of 
magnesium had been highlighted by work on Salmonella typhimurium (Groisman et 
al., 1997). Stenotrophomonas maltophilia highlighted a much similar phenomenon 
of such LPS alterations that eventually led to aminoglycosides’ transient resistance 
(Rahmati-Bahram et al., 1996).  
A correlation was found to exist between the increase in the resistance of the 
aminoglycosides antibiotics and the composition of LPS. This was particularly 
applicable when the bacteria were incubated at the temperature of 30°C resulting in a 
change in LPS content. Particularly important in this overall phenomenon is 
antibiotic resistance induced by the host-defence peptides that belonged to the innate 
human defence (Gellatly et al., 2012). This is an area that is being exploited to 
develop novel active peptides as new antimicrobials (Hancock and Sahl, 2006).    
1.4.  Selective pressure  
1.4.1.  External factors 
External factors continuously pose a threat to microorganisms in natural 
environments. Adapting to the environment thus becomes essential in order to 
survive. A number of stressful conditions might also be encountered by such 
organisms which include immune host defences, the action of a wide range of 
antimicrobial agents, predation, UV exposure, anoxia or hypoxia conditions, pH 
changes, temperature shocks, and even starvation (Costerton et al., 1987).  Adaptive 
response refers to the capability of bacteria to modify itself based on fluctuations in 
the environment. Various complex and detailed regulatory networks are triggered by 
the microorganisms in response to changes in the external environment. Such actions 
ensure that they survive. The genetic variations along with behavioural changes and 
physiological changes are a part of the process of adaptation of microorganism. This 
adaptation can take place by various mechanisms, including phenotypic switching.  
 
                                                                                    




The reversible switches that are present in states of phenotype are referred to as 
phase variations or phenotypic switching. Phenotypic switching in a population of 
cells is believed to be less prevalent than spontaneous mutations. The result of such 
phenotypic switching is a dual sub populations in which the entire genes profile is 
showed by one, while a certain modified expression of certain variable gene phases 
are expressed by the other  (van der Woude, 2006). The ON/ OFF mechanism is one 
of the most interesting characteristics in the study of phenotypic switching. This 
allows the bacteria to take preference in the process of state interchange. Repetitive 
switching capabilities have been identified in microorganisms that possess a 
particular phenotypic state. This is usually done in response to new environmental 
factors, and switching back to the prior state might also occur as a result of 
conditions returning to normal.  
 
As identified earlier, a population that is hereditarily alike (also referred to as 
isogenic population), usually can contain more than one phenotypes. This may 
happen in an environment that is homogenous. This characteristic is known as the 
inherent phenotype heterogeneity or at times referred as individuality. This particular 
microbial phenotype heterogeneity does not engage variations within the genome, 
and is considered to be a non-genetic disparity. This may occur because of the noise 
factor; that is the result of variations occurring from the stochasticity of responses of 
chemicals at the level of DNA. For example, the casual modifications in the 
degradation rate and the rates of protein synthesis (Veening et al., 2008 & Davidson 
and  Surette, 2008). Different stress responses highlight the inherent phenotype 
diversity that is present in a particular homogenous population (Avery, 2006). This is 
very essential for microbial development and fitness. A number of studies 
highlighted that external factor (responsive switching) influence the switching that is 
carried out, even though random events (stochastic switching) might trigger 
phenotypic switching.  
Phenotypic switching creates microbial heterogeneity which produces variants of 
phenotype. These variants are considered to be “healthier” and “better” , this part of 
the population manages to become accustomed in the new surrounding better than 
the rest of overall population (Bayliss, 2009). Conversely, those parts of the 
population have the capacity to prevail over all possible future and new 
                                                                                    




consequences which may arise. The “insurance hypothesis” of the model of ecology 
suggests that a greater amount of biodiversity makes it more probable that 
ecosystems will be better able to uphold or further develop their performance to deal 
with the fluctuations occurring in the environment (Yachi and Loreau, 1999). This 
supposition is supported by quite a few reports based on microbial diversity (Goerke 
et al., 2007, Boles and Singh, 2008, Boles et al., 2004).  
1.4.2. Antimicrobial agents 
Apart from helping in the avoidance of immune defence, phenotypic switching also 
has a remarkable effect on a number of biological aspects. As mentioned earlier, 
there is already a connection recognized among microbial virulence and phenotypic 
switching for certain bacteria. Nevertheless the reconsideration of the process of 
phenotypic switching holds vital importance considering that it may affect certain 
other biological processes like antimicrobial resistance (Sousa et al., 2011). It has 
been demonstrated that bacterial fitness costs are mainly associated with bacterial 
antibiotic resistance. This correlation, however, has been negated by Massey et al. 
(2001) when he and other researchers examined the resistance mechanism of S. 
aureus. The results revealed that infection caused by S. aureus in both in vivo and in 
vitro models lead to the generation of SCV when the population was treated with 
gentamicin. Phenotypically, SCV possesses important features such as pigmentation, 
high resistance to antibiotics, small size, and slow growth rate compared with the 
normal phenotype. Such SCV can revert to the parental phenotype when grown in 
antibiotic free media. It can be concluded that  SCV established by Staphyloccocal 
infections represents a temporary phenotype which manifests when a bacterial 
culture is subjected to the action of gentamicin but resume growth characteristics as 
a wild-type when selective pressure is being taken off.  
1.5. Background of the genus Pseudomonas 
The group of bacteria known as Pseudomonas is highly adaptable and, as a result, it 
can proliferate and thrive in a great variety of environments, both terrestrial and 
aquatic. In addition, Pseudomonas can attach themselves to plants as well as 
animals. The wide ranging prevalence of this type of bacteria has been attributed to 
genomic heterogeneity and genetic versatility (Rehm, 2008). The description of the 
                                                                                    




genus Pseudomonas was conducted in 1894 by Migula, and then became a part of 
bacteriology history (Peix et al., 2009). This genus can be easily isolated from a wild 
range of natural materials, because members of the genus Pseudomonas have been 
widely observed in all types of environments (Goldman and Green, 2009, Rehm, 
2008).  
1.5.1. Taxonomy 
The class Pseudomonas forms Genus I of the family of bacteria Pseudomonadaceae. 
The common functional characteristics of this family include the 
chemoorganotrophic metabolism which requires oxygen to function, the lack of 
fermentation and photosynthesis, as well as the ability to use a wide range of organic 
substances to develop (Moore et al., 2006). 
1.5.2. Habitat 
These characteristics enable Pseudomonas to adjust to any type of environment, 
from dry and aquatic environments to animal and plant organisms. In addition, it 
uses other types of bacteria, which it lives in conjunction with, as sources of carbon 
for development (Moore et al., 2006). Pseudomonas pose significant problems in the 
food industry as they cause meat, whether kept in refrigerators or not, to decay. What 
is more, the bacteria were discovered even in tap water and saline solutions, which 
are considered to lack the nutrients needed by the bacteria. Oligotrophic mineral 
water sources were also found to contain new types of Pseudomonas. Furthermore, 
the bacteria contribute to the creation of biofilms on the interior surface of pipelines 
(Moore et al., 2006). Cultures of broth media have been commonly used to study 
Pseudomonas species as ‘planktonic forms’. Nevertheless, the types of bacteria 
which proliferate in natural ecosystems have been noticed to live in biofilm 
environments of either small or large dimensions. The system of QS has been shown 
to have a significant influence on the creation of biofilms, due to the fact that it 
enables the detection of culture density and it dictates which genes included in the 
different phases of the creation of biofilm should be manifested (Moore et al., 2006). 
1.5.3. Isolation 
The nutritional preferences of Pseudomonas are not complex and the bacteria can be 
sampled from a wide range of environments without difficulty. In artificial 
                                                                                    




laboratory environments, the bacteria favour solutions which contain organic 
material, have a neutral pH and moderate temperatures of between 28 and 30°C. For 
instance, P. aeruginosa, which is a type of Pseudomonas most frequently used in 
laboratory environments, requires a temperature of 37°C to proliferate. The ideal 
environment for the majority of Pseudomonas is one which contains a substantial 
concentration of peptides, such as Nutrient Broth and Agar or Tryptic Soy Broth and 
Agar (Moore et al., 2006). 
1.5.4. Identification 
Pseudomonas can be identified based on its straight or somewhat curved rod shape. 
The rods are gram-negative and can move with the help of one or more flagella 
situated at the both extremities. Certain types of Pseudomonas also have short lateral 
flagella. In general, the metabolic functions of Pseudomonas require oxygen, but 
sometimes it can be replaced with nitrate, thus enabling development in the absence 
of oxygen. Furthermore, it can only live in an environment with a pH higher than 
4.5, and needs an organic source of carbon and metabolic energy, can be oxidase 
positive or negative, and are catalase positive.  
 
Pseudomonas spp. can cause disease in animal or vegetal organisms. Some types of 
Pseudomonas have been studied more than others and, consequently, the information 
known about them differs. P. aeruginosa is one example of a thoroughly studied 
Pseudomonas, mainly due to the fact that it is an opportunistic pathogen and, thus, is 
of clinical significance. Moreover, unlike other types of Pseudomonas, P. 
aeruginosa is a homogenous taxonomic organism that can be readily distinguished 
(Moore et al., 2006). 
1.5.5. Pigment production 
In order to classify Pseudomonas, preliminary studies of Pseudomonas relied heavily 
on the ability of this type of bacteria to generate pigments. Subsequently, it was 
discovered that there are also types of Pseudomonas which do not produce pigments; 
nevertheless, the feature of pigmentation remained a significant indicator in the 
identification of certain varieties (Goldman and Green, 2009). 
                                                                                    




1.5.6. Nucleotide Base 
The nucleotide base composition of genomic DNA has been the first such genotypic 
examination to be used in studies of bacteria and is designed to measure the 
concentration of guanine and cytosine nucleotides from the overall concentration of 
nucleotide bases. The G+C concentration of Pseudomonas is approximately 59-68 
mol% (Moore et al., 2006). 
1.5.7. Ribosomal RNA Gene Sequences 
According to Moore et al. (2006) and Brogden et al. (1976), in order to determine 
the intergenetic connections between bacteria, a comparison of the rRNA-rDNA 
sequences is necessary. With regard to new species of bacteria, identification of 
sequences and investigation of 16S rRNA are required.  
1.6. General characteristics of P.aeruginosa  
According to Goldman and Green (2009), all types of P.aeruginosa are characterised 
by a motile bacterium with straight rod shape and one or more flagella at the 
extremities. They do not produce spores, nor do they undergo fermentation. The 
ideal temperature for the proliferation of P.aeruginosa is 37°C, but it can withstand a 
large variety of temperatures, from normal environmental temperatures to 42°C. The 
resistant nature of P.aeruginosa is given by its highly adaptable metabolism, which 
enables the bacterium to extract the necessary carbon from both simple as well as 
complex organic composites. In addition, the fact that it can use nitrates and amino-
acids, such as arginine, as respiratory electron receptors, signifies that P.aeruginosa 
can reproduce in environments both with and without oxygen (Rehm, 2008). 
Furthermore, P.aeruginosa is an opportunistic bacterium, which has clinically 
become the most prevalent bacterial pathogen in nosocomial infections, due to the 
fact that it is capable of resisting the effect of a wide range of antimicrobial agents 
(Tenover, 2006, Rehm, 2008). It has the ability to cause diseases in mammals, 
including humans. Patients who suffer from AIDS, cancer, burn injuries and cystic 
fibrosis are particularly prone to becoming infected with P.aeruginosa, due to their 
weak immune system. Once infected with P. aeruginosa, people are likely to carry it 
forever, as an efficient treatment is yet to be developed (Rehm, 2008).  
                                                                                    




The main identification mark of the bacterium P.aeruginosa is the blue water-
soluble phenazine pigment that it produces, known as pyocyanin. The pyocyanin 
generates what is known as ‘blue pus’ in infections with P. aeruginosa. This pigment 
has been the focus of numerous studies, particularly regarding its toxic effect on 
other bacteria and the part that it plays in eukaryotic infection. Nevertheless, the 
physiological effect that pyocyanin has on the bacterium that produces it is yet to be 
fully elucidated (Price-Whelan et al., 2007).   
 
As explained by Lau et al. (2004), the redox-active blue pigment pyocyanin is 
produced by P. aeruginosa, based on two novel phenazine-modifying genes, namely, 
phzM, which encodes phenazine-specific methyltransferase, and phzS, which 
encodes flavin-containing monooxygenase. Phenazines generate significant 
biological activity as they go through redox cycling when exposed to different 
reducing agents as well as molecular oxygen. This causes toxic superoxide (O2
-) and 
hydrogen peroxide (H2O2) to accumulate in the cell, which can die as a result 
(Mavrodi et al., 2001).  
As explained by Goldman and Green (2009), particular culture environments are 
capable of activating or increasing the production of pigments. However, recurrent 
transfers of strains conducted in the laboratory frequently led to the complete loss of 
the ability of P. aeruginosa to generate pigments. Such experiments have indicated 
that, among all the phenotypic characteristics, pigmentation is the most 
unpredictable.  
1.6.1. Genome diversity of P.aeruginosa  
P.aeruginosa PA01 has a high concentration of G+C 66.6% (Stover et al. 2000). The 
genome of P.aeruginosa consists of one chromosome spheroid in shape and an 
irregular number of plasmids. The chromosome is composed of a central core and an 
auxiliary part, which determines fluctuations in the dimensions of the genome of 
between 5.2 and 7 Mbp. The main strain of P.aeruginosa, PA01, is characterised by 
a coding density of 89.35% and contains 5570 protein coding sequences (Cornelis, 
2008). In 2000, a breakthrough was made when a wild-type P.aeruginosa PA01 
strain was completely sequenced (Stover et al., 2000), see Fig.3, enabling the 
creation of a more comprehensive picture not only about its ability to cause disease, 
                                                                                    
































Figure 3: The genome of P. aeruginosa. It has been represented as a circular structure. The 
situation of base pairs of chromosomes is in the outermost circle. Different coloured boxes are used to 
indicate the location of genes of different functions and direction of transcription. The position and 
direction of transcription of ribosomal RNA genes is indicated by the red arrows. The process of 
homologous recombination between rrnA and rrnB generates a reversed area indicated by the green 
arrow. The areas consisting of potential bacteriophages are indicated by the blue arrows. The 
percentage G+C content is represented as a black central plot, the average for non-overlapping 1-kb 
windows covering a single strand of the whole genome. The areas of ≥3.0 kb with G+C content of 
two standard deviations of 58.8% below the average of 66.6% are indicated by the yellow bars 
(Stover et al., 2000) 
 
Prokaryotic genomes of pathogenic bacteria compared with that of P. aeruginosa are 
shown in Fig.4. This genome is composed of an inordinate number of proteins, 
which are in charge of activities of regulation, transport and infectiousness. Given 
the fact that 0.3% of the entire gene code for proteins geared towards withstanding 
the antimicrobial agents, the resiliency and adaptability of the bacterium may be 
attributed to this protein composition. What is more, the genome is characterised by 
a high degree of flexibility, 10% of the genes with coding for virulence factors being 
structured into ‘pathogenicity islands’; such structures are also capable of amassing 
mobile genetic elements of large dimensions known as integrons, which contain 







The image originally presented here cannot be made freely available via LJMU Digital Collections 
because of ‘copyright’. The image was sourced from Stover et al., (2000). 
                                                                                    




variety of different environments, as well as to cause extensive damage to different 
types of tissues and to withstand the action of the majority of available antibiotics, 
can be attributed to its complex genome (Mesaros et al., 2007).   
 
 
Figure 4: Prokaryotic genomes of pathogenic bacteria compared with that of P. aeruginosa 
(PA01) (Stover et al., 2000).  Staphylococcus aureus (N315) (Baba et al., 2008), Neisseria 
gonorrhoeae NCCP11945 (Chung et al., 2008), Streptococcus mutans UA159 (Ajdic et al., 2002),  
Salmonella enterica T000240 (Izumiya et al., 2011), E.coli, Mycobacterium leprae and 
Mycobacterium tuberculosis (Sandy and Primrose, 2003).. 
 
1.6.2. Emergence of antibiotic-resistant of P.aeruginosa 
As antibiotic treatments have become increasingly specialised, bacteria have become 
more and more resistant. P. aeruginosa has joined the level of ‘super-bugs’, having 
developed resistance to multiple antimicrobial agents (Breidenstein et al., 2011). The 
resistance of these super-bugs is the result of its ability to develop an intrinsic and 
acquired resistance mechanism against a wide range of antibiotics, including the fact 
that the outer membrane has low permeability (Tenover, 2006). Mutations in 
chromosomal genes are responsible for regulating resistance genes, such as 
aminoglycoside-modifying enzymes, and other organisms can pass additional 
resistance genes through transposons, plasmids and bacteriophages (Chen and Wen, 
2011). The resistance of bacteria to the effect of antimicrobial agents is enhanced 
























                                                                                    




(Mesaros et al., 2007). Infections caused by P. aeruginosa are becoming increasingly 
difficult to treat as the organism is becoming more resistant to a significant range of 
commonly used antibiotics  (Ding et al., 2016) . 
For a long time, P. aeruginosa was considered to affect tissues in the aftermath of a 
different infection, causing extensive damage. Only recently has it been 
demonstrated that P. aeruginosa develops in people with weak immune systems 
independent of other pathogens that initially affected the health of those people. The 
high resistance of P. aeruginosa to antibiotic treatments is a well-known fact. There 
are a number of internal factors which enhance the resistance of P. aeruginosa to the 
effects of antibiotics, including its almost impermeable external membrane, the 
activity of the efflux pumps, and the generation of enzymes which inhibit the action 
of antibiotics. In addition, P. aeruginosa has the ability to generate new mechanisms 
of withstanding the effect of antimicrobial agents due to the complexity and 
dimensions of its genome, as well as to its proliferation in aquatic environments, 
where it can acquire resistance genes from other bacteria. Resistant strains determine 
infections which are three times more likely to result in death, the patients being nine 
times more likely to develop secondary bacteremia and extend their period of 
hospitalisation, which contributes to a substantial increase in the cost of treatment 
(Mesaros et al., 2007).  
Given their variety, likelihood of generating epidemic isolates and their ability to 
withstand most antibiotics, the treatment of infections with P. aeruginosa should be 
geared towards recognizing the pathogen and determine the extent to which it is 
affected by antimicrobial agents. This can be done by creating microbiological 
growth of cultures of P. aeruginosa and observing their cultural and phenotypic 
features (Mesaros et al., 2007). What makes P. aeruginosa stand out from other 
pathogens is its ability to resist an extensive range of antibiotics, such as 
aminoglycosides, fluoroquinolones, and β-lactams, given by its external membrane 
which is almost impermeable, as well as by its ineffectual porins, thus making it 
difficult for antibiotics to gain access. The development of secondary mechanisms of 
resistance is also favored by these characteristics; among such mechanisms are the 
increased efflux and the enzymatic antibiotic transformations, such as β-lactamase 
activity. Moreover, the resistance mechanisms determine an extremely high minimal 
inhibitory concentration (Høiby et al., 2011), basically suppressing the effect of 
                                                                                    




antibiotics on the bacterium. Genetic mutations balance or increase the efficiency of 
the resistance mechanisms. Furthermore, P. aeruginosa gains additional adaptive 
resistance mechanisms due to its capability of thriving in different environments and 
modified growth conditions, as well as withstanding exposure to the action of 
antimicrobial agents. Despite having been discovered a while ago, research on the 
adaptive resistance mechanisms and their relevance from a clinical point of view, has 
only just begun. It is small wonder that the resistance of P. aeruginosa has been 
recorded with all existing antibiotics that target it, given the numerous ways in which 
the bacterium acquires resistance. There are a number of antibiotics which can be 
used to treat infections with P.aeruginosa; nevertheless, their efficiency is 
diminished due to the constant increase in the resistance exhibited by the bacterium, 
which makes the development of new antibiotics ever more difficult. Hence, it is 
necessary to gain a comprehensive picture of the resistance mechanisms of P. 
aeruginosa (Breidenstein et al., 2011).  
Genetic or phenotypic changes are responsible for the inefficiency of antibiotics. The 
present study will focus particularly on phenotypic modifications.    
1.7.  The mode of antibiotics action 
Antibiotics are organic compounds which form naturally and have bacterial action 
which makes it possible to employ them as chemotherapeutic agents to combat 
infections (Russell and Chopra, 1990). Terms such as ‘bacteriostatic’ or 
‘bactericidal’ are frequently used when referring to antibiotics. Bacteriostatic 
antibiotics momentarily suppress the development of bacteria, which continues after 
the administration of the antibiotics ceases. Bactericidal antibiotics completely 
destroy bacteria; as such, they are frequently used in the treatment of patients with a 
weak immune system or those with bacterial infections which cannot be destroyed 
by the host organism (Schwalbe et al., 2007). Thus, antibiotics aim to suppress the 
development of bacteria by eradicating them or diminishing their proliferation in 
order for the defence systems of the organism to be able to eliminate the infection.  
Antimicrobial agents have been categorized differently, according to the manner in 
which they act, their chemical composition, and targets (Russell and Chopra, 1990). 
More specifically, this entails preventing protein and nucleic acid synthesis, 
                                                                                    




peptidoglycan synthesis, or destroying the cell wall/membrane (Schwalbe et al., 
2007) (Fig. 5) 
 
 
Figure 5:  Schematic diagram of the mode of antibiotics action. Adapted from Essential 
Biochemistry (2004). 
 
1.7.1. Inhibits of protein synthesis 
There are a number of antibiotics which target bacterial protein synthesis by 
employing selective toxicity such as aminoglycosides. Aminoglycoside antibiotics 
are produced from Streptomyces (Brown and Stoudemire, 1998). The first 
aminoglycoside was produced by Selman Waksman in 1944 from Streptomyces 
griseus. Other types of Streptomyces were used to extract neomycin, kanamycin, 
tobramycin, and paromomycin. Gentamicin was first extracted from 
Micromonospora spp. by Weinstein in 1980, amikacin and netilimicin being semi-
synthetic subsidiaries. The names of aminoglycosides are an indication of the 
sources from which they derived. Those which terminate in mycin are sourced from 
Streptomyces, whilst those which terminate in micin are sourced from 
Micromonospora spp (Schwalbe et al., 2007). 
 
Aminoglycosides suppress protein synthesis by attaching themselves to the bacterial 
ribosome. The wall of the bacterial cell must firstly be penetrated, which is achieved 
                                                                                    




through active transport and passive dissemination. When it penetrates the core of 
the cell, the aminoglycoside attaches to the 30S subunit of the ribosome, hinders 
protein synthesis and finally destroys the cell by elimination of its components 
(Schwalbe et al., 2007). 
 
Bacterial resistance to aminoglycosides manifests in three different ways. 
Disruptions to active transport or passive dissemination can render the antibiotic 
incapable of infiltrating the cell wall. The antibiotic may not be able to attach itself 
to the 30S subunit of the ribosome due to chromosomal alterations. Finally, the 
bacterium can generate enzymes which neutralize the effect of the antibiotic 
(Schwalbe et al., 2007). Antibiotics such as gentamicin, tobramycin and amikacin 
target enteric gram-negative bacilli. As such, they are used to treat people with 
febrile neutropenia or nosocomial infections. However, in cases when bacteria 
exhibit high levels of drug resistance, tobramycin or amikacin are administered. In 
the case of severe gram-negative infections, such as those engendered by P. 
aeruginosa, aminoglycosides are usually administered in combination so as to hinder 
the build-up of resistance (Schwalbe et al., 2007). 
1.7.1.1.Tobramycin 
Tobramycin is an aminoglycoside , which can be produced by Streptomyces 
tenebrarius (Funk, A et al. 1959 cited in Neu, 1976). Tobramycin is chemically 
represented as C18H37N5O9 and has a molecular weight of 467.52. As regards its 
structure, tobramycin is similar to the kanamycin aminoglycosides. 
The bacterial actions of tobramycin include suppression of protein synthesis which 
determines increased porosity of the cell membrane and its gradual deterioration, 
finally causing the cell to die. Tobramycin suppresses protein synthesis in a 
bactericidal way by attaching itself to the 30S subunit of the ribosome, which is thus 
displaced from the polysome pool. This is the main in vivo activity not only of 
tobramycin but of other aminoglycosides as well. However, in vitro misconstructions 
of polypeptide synthesis can happen. Tobramycin can act in vitro upon a variety of 
gram-negative bacteria, among them P.aeruginosa. When it has a concentration 
which is equal or higher than the inhibitory concentration, the antibiotic is 
bactericidal in nature. A low concentration of tobramycin is enough to suppress 
                                                                                    




gram-negative bacilli. Similarly, most types of Escherichia coli, Klebsiella, 
Enterobacter, Proteus mirabilis, and P. aeruginosa, are inhibited by a tobramycin 
concentration of < 1.5 µg/ml (Neu 1976).  
1.7.1.2. Amikacin 
Amikacin is a semi-synthetic derivative of kanamycin which has a strong effect 
against the majority of gram-negative bacteria, even against strains which are 
resistant to gentamicin and tobramycin, as numerous studies have revealed. The 
molecular formula of the antibiotic is C22H43N5O13 (Ristuccia and Cunha, 1985). 
 
Amikacin is an aminoglycoside, which means that it has a bactericidal effect on the 
30S and 50S ribosomal subunits of bacteria, preventing protein synthesis. Within the 
cell membrane, amikacin is conveyed in two different transport stages, due to the 
fact that it is extremely polar. Amikacin attaches itself irrevocably to the ribosomes 
of the bacteria, thus disrupting the protein synthesis and the reading of the genetic 
code, which determines the formation of impaired proteins. Subsequently, the 
ribosomes divide from mRNA too early, causing the cell to die (Ristuccia and 
Cunha, 1985).  
 
It has been observed that both in vitro and in vivo, amikacin has an effect on an 
extensive range of gram-negative bacteria, in particular P. aeruginosa, which can 
cause a variety of infections. However, in contrast to other aminoglycosides, such as 
gentamicin or tobramycin, amikacin has a less powerful effect, on a weight basis. 
Nevertheless, the selection of an aminoglycoside should take into consideration the 
attainable concentration and not the weight basis. In spite of this, comparative 
analyses have indicated that amikacin generated higher serum concentrations than 
gentamicin or tobramycin. The extent of the impact that aminoglycosides have on 
strains of Pseudomonas at clinically attainable concentrations is an important 
consideration. In particular, amikacin has a strong effect on certain isolates of 
Enterobacteriaceae and Pseudomonas, which are resistant to the action of 
gentamicin and tobramycin (Ristuccia and Cunha, 1985). 
This represents the main benefit of amikacin and has been demonstrated by the 
successful administration of amikacin to patients with infections caused by resistant 
                                                                                    




bacteria as well as to patients who had received earlier aminoglycoside treatment 
which had been unsuccessful.  
In contrast to gentamicin and tobramycin, which can be inhibited by eight different 
enzymes, there are only two enzymes which can inhibit amikacin. Among these 
enzymes, plasmid-mediated production of enzymes is the most common one, and 
alters tobramycin via acetylation, adenylylation or phosphorylation (Ristuccia and 
Cunha, 1985). Some strains may have common enzymes, like an aminoglycoside 
adenylyltransferase AAD(2”) and AAD(3”), in an inactive state on amikacin 
(Ristuccia and Cunha, 1985). 
This makes amikacin superior to gentamicin and tobramycin, particularly as it 
effectively suppresses the action of bacteria which are resistant to the other two 
aminoglycosides (Ristuccia and Cunha, 1985), due to its chemical structure 
(Chambers and Sande, 1996).  
When penetration of the antibiotic depends upon a transporter protein a lack of this 
protein can result in an increase in resistance to the antibiotic attributed to adaptive 
resistance to aminoglycosides in the case of P. aeruginosa. Such adaptive resistance 
can result in an in vivo in spite of the sensitivity recorded in in vitro appraisals 
(Karlowsky et al., 1997). 
1.7.1.3.Divalent cations affect the activity of aminoglycosides  
Falagas and Kasiakou (2005) have discovered that the use of calcium and 
magnesium determined an increase in the MIC value of P. aeruginosa, which means 
that calcium has the potential to overturn the bactericidal effect of aminoglycosides 
against P. aeruginosa, but not against other types of enteric bacteria. The location of 
interaction between P. aeruginosa and magnesium or calcium, which builds 
resistance to the effect of antibiotics, is not only the cell wall, but also at the 
cytoplasmic membrane (Jorgensen and Ferraro, 2009). In addition, calcium can 
diminish the synergistic activity of aminoglycosides and carbenicillin only to a 
certain extent. According to Brogden et al. (1976), considerable discrepancies in the 
ion concentrations can generate different MIC values, which could determine the use 
of an inadequate antibiotic against infections with Pseudomonas.  
                                                                                    




Divalent cations, particularly Ca2+, in high concentrations inhibit aminoglycoside 
activity and therefore are conducive to bacterial survival. Ca2+ is more efficient than 
Mg2+ in protecting bacterial cells due to often present this element in the structural 
components of bacteria (Verkhovskaya et al., 2011). The outer membrane of P. 
aeruginosa was found to contain an Mg2+ binding site with involvement in cation 
antagonism (Nicas and Hancock, 1980 ). This explains why cations have such a 
marked effect in P. aeruginosa which, by comparison to other gram-negative 
bacteria, has a high concentration of lipopolysaccharide phosphate residues. Hence, 
in P. aeruginosa, MIC is increased by even a small cation concentration (Zimelis 
and Jackson, 1973, Garrod and Waterworth, 1969).  
1.7.2. Inhibits of membrane integrity  
Polymyxins is the collective name for a group of polypeptide antibiotics composed 
of five chemical compounds, first produced in 1947 (Falagas and Kasiakou, 2005). 
As noted by Russell and Chopra (1990), apart from polymyxin B and polymyxin E, 
polymyxins have not received a great amount of medical attention as they act only 
upon mammalian membranes. The most frequently applications of polymyxins have 
been in ear and eye solutions (Falagas and Kasiakou, 2005).  
 
The interaction with the cytoplasmic membrane of the bacterial cell provides 
polymyxins with a bactericidal effect, which generates disruption to the structure of 
the cell membrane. Gram-negative bacteria are more affected by polymyxins than 
gram-positive ones due to the fact that the membranes of the former include 
phospholipid phosphatidylethanolamine, which is highly susceptible to polymyxins 
(Russell and Chopra, 1990). Polymyxins have to penetrate the external membrane of 
the bacterial cell to arrive at the target location within the gram-negative bacteria. As 
explained by Russell and Chopra (1990), in order to do this, a self-promoted uptake 
of polymyxins is undertaken which entails the dislocation of divalent cations which, 
in turn, causes disruptions to the membrane, enabling the infiltration of antibiotic 
molecules. 
                                                                                    





Among the polymyxins, colistin is a cationic cyclic polypeptide extracted from 
Bacillus polymyxa var colistinus. It has the same structure as polymyxin E and a 
similar one to polymyxin B (Falagas and Kasiakou, 2005).  
 
Colistin was first synthesised in 1949 from colistinus Koyama, a subspecies of 
Bacillus polymyxa. During the 1950s, colistin was used in therapeutic treatments in 
Japan and Europe and it began to be used in the United States in 1959 as 
colistimethate sodium. By the early 1980s, the intravenous administration of 
combinations of colistin and polymyxin B ceased due to the high levels of 
nephrotoxicity documented. Since then, colistin was administered intravenously only 
in cases of lung infections with gram-negative resistant bacteria (Falagas and 
Kasiakou, 2005). Polymyxins have received a great amount of attention in the face 
of development of multi-resistant bacteria and scarcity of antibiotics which can 
effectively target gram-negative bacteria. The molecular weight of colistin is 1750 
Da (Falagas and Kasiakou, 2005). 
 
Colistin has a more efficient action than polymyxin B against the majority of gram-
negative aerobic bacilli, including P. aeruginosa, despite the fact that resistance has 
been recorded in the case of the latter. On the other hand, colistin does not have any 
influence on parasites, fungi, gram-positive aerobic bacilli, anaerobic bacteria, gram-
negative and gram-positive aerobic cocci. In vitro susceptibility analyses have to 
take into consideration the concentration of magnesium and calcium in the culture 
environment (Falagas and Kasiakou, 2005).  
 
Colistin targets the cell membrane of the bacteria. This activity entails electrostatic 
interactions between the antibiotic and the anionic lipopolysaccharide (LPS) 
molecules in the bacterial external membrane, colistin removing the magnesium and 
calcium required by the LPS molecules, which causes disruptions to the structure of 
the cell membrane. Consequently, the membrane has increased porosity which 
enables the removal of cell contents, which the cell dies (Falagas and Kasiakou, 
2005). Mechanisms of genetic mutation or adjustment enable gram-negative bacteria 
to become resistant to colistin. Research related to the resistance of P. aeruginosa to 
polymyxin has indicated that the changes that the external cell membrane undergoes, 
                                                                                    




such as decrease in concentrations of LPS, proteins, magnesium, calcium and lipids, 
are the result of the build-up of bacterial resistance (Falagas and Kasiakoul, 2005).  
1.8. Antibiotic Susceptibility testing  
Laboratory tests are mainly focused on observing the reaction of P. aeruginosa to 
antimicrobial agents, as well as on recognizing its resistance mechanisms. In order to 
assess the susceptibility of Pseudomonas to the effects of antibiotics, it is important 
to employ distinct methods at the same time, which should also comprise the 
determination of the minimal inhibitory concentration of the antibiotics. 
Furthermore, it is important to carefully choose the antibiotics to be tested, with 
emphasis on efficient phenotypic indicators of resistance mechanisms. Nevertheless, 
P. aeruginosa poses considerable difficulties with regard to the examination of 
susceptibility tests and identification of resistance mechanisms dependent on 
phenotypic information for a number of reasons: (i) several resistance mechanisms 
often act simultaneously on the same antibiotics (Baba et al.) and Keren et al. 
(2004a); (ii) indicate variations in the efficiency of the resistance mechanisms in 
different strains; (iii) the methods employed to determine low-level resistance are 
inadequate (Mesaros et al., 2007).  
 
Antimicrobial susceptibility tests generate in vitro data, which can be used to ensure 
a suitable and efficient antimicrobial treatment (Goldman and Green, 2009). As 
indicated by Goldman and Green (2009), the empiric therapy can be altered or 
amended based on the results of the antimicrobial susceptibility testing (AST). It can 
employ either qualitative or quantitative methods. The latter generate MICs and 
qualitative method refers to MBCs. MICs represent the smallest dose of antibiotics, 
which can inhibit the growth of bacteria after 24 hours incubation. MICs are 
employed to confirm resistance, as well as to examine the in vitro activity of newly 
developed antibiotics (Andrews, 2001). The main applications of quantitative 
methods are related to the treatment of severe infections, including endocarditis and 
osteomyelitis, or infections associated with a weak immune system, as in the case of 
transplant or gravely ill patients (Goldman and Green, 2009). According to Andrews 
(2001), MICs are the ‘gold standard’ for assessing the extent of the effect of 
antibiotics on bacteria and, as such, the efficiency of all the other methods of 
                                                                                    




sensitivity testing is evaluated against the MICs. The standard doses of antibiotics 
employed in the MIC tests are doubly diluted and lower than 1mg/l. MBCs refer to 
the smallest dose of antibiotics which can kill the microorganism (Andrews, 2001).  
Among the analyses carried out by the medical microbiology laboratory, testing the 
sensitivity of certain bacterial cultures to antibiotics is particularly important. The 
main objectives are identifying potential antimicrobial resistance in ordinary 
pathogens and ensuring the efficacy of antibiotics which target specific infections. 
The testing methods which are frequently employed are broth dilution and rapid 
automated instrument methods which rely on a variety of materials and devices 
available on the market (Jorgensen and Ferraro, 2009). The activity of antibiotics 
was measured by determining MIC and MBC. The determination of the MIC value 
of antibiotics used against human pathogens is a very useful way for identifying the 
lowest concentration of antibiotics, which have the ability to completely inhibit 
growth of the bacteria. The determination of the MBC value is also important to test 
the bactericidal activities of the antibiotics.  
1.8.1. Microtiter plates (OxoPlates). 
The OxoPlates are micro-plates with 96 wells, each equipped with optical oxygen 
sensors. Two types of OxoPlate are available, one called OxoPlate OP96U, which 
has a round bottom, whereas; OxoPlate OP96C has a flat bottom (Precision Sensing 
GmbH, 2012). The OxoPlate OP96U is the most widely used type as the signal it 
generates is extremely powerful.  
 
 
Figure 6: Photograph of the OxoPlate. 
It contains 96 wells with integrated sensors on its bottom. 
 
                                                                                    




It has the ability to determine in near-real time the oxygen concentration in all the 96 
wells of a well plate, due to the its oxygen sensor incorporated at the bottom of the 
plate. Each sensor is composed of a thin polymer film about 10μm consisting of two 
distinct dyes, namely, the indicator dye and the reference dye. Owing to the thin 
sensor polymer film (10μm), the OxoPlate’s response time does not exceed 10 
seconds. The volume of oxygen contained by the sample dictates the 
phosphorescence potency of the indicator dye (I-indicator). On the other hand, the 
fluorescence potency of the reference dye (I-reference) is not influenced by the volume 
of oxygen ratio IR, which indicates the concentration of oxygen.  Any fluorescence 
intensity reader which can scan from the base can be used to read the OxoPlate®. 
Due to the fact that the sensor consists of two distinct dyes, the reader can measure 
the dual kinetic mode by two different readings repeatedly taken from every well, 
which represents the measuring point, with the help of two different filter pairs.  The 
concentration of oxygen in the OxoPlate is measured with the use of two filter pairs. 
The first filter pair is 540 / 650 nm and the second filter pair is 540 / 590 nm. The 
first pair is designed to determine the indicator dye, I-indicator, whereas the second 
filter pair determines the reference dye, I-reference (Precision Sensing GmbH, 
2012). Kinetic parameters like enzyme or respiratory processes can be accurately 
detected resulting from the rapid response time and extensive wavelength of the 
OxoPlate indicator dye. 
1.8.1.1.Composition of the OxoPlate Sensor 
The OxoPlate sensor configuration is generally made up of luminescent dye with 
optical qualities susceptible to temporary alteration when exposed to molecular 
oxygen. Typically the dye is present in a polymeric matrix and placed on a solid 
support such as a microtiter plate. As numerous key metabolic activities of both 
prokaryotes and eukaryotes (e.g. respiration, biological oxidation, and 
photosynthesis) occur with the participation of porphyrins, the oxygen indicator is 
equipped with Pt(II)meso-tetra (pentafluorophenyl) porphyrine that affords the 
extensive assimilation and powerful emission properties in the visible area. 
Meanwhile, oxygen-permeable particles that display hydrophobicity also contain the 
reference dye sulphorhodamine B (chloride) (Fig.7). A hydrogel matrix contains the 
scatter of microspheres with oxygen sensitivity (Fig.8). The constancy of ratios and 
                                                                                    




internal referencing of the dyes’ fluorescence intensities are made possible by the 







Figure 7: Structure of two dyes that use in the oxygen sensor of the OxoPlate. Indicator dye 
Pt(II)meso-tetra(pentafluorophenyl) porphyrine and reference dye sulphorhodamine B (chloride) 
(Arain, 2006).   
                                     
Figure 8: Diagram of the optical sensors located at the bottom of the wells. ‘F1 is for excitation 
filter 540/650 nm F2 is for emission filter 540/590 nm, and Sensor layer’.  Oxygen-permeable 
particles that display hydrophobicity contain the indicator dye and reference dye embedded in a 
hydrogel matrix Adapted from Arain (2006).   
1.8.1.2.The principle of an optical oxygen sensor of the OxoPlate  
In terms of the operational processes, air pressure is measured on the basis of the 
OxoPlate optical oxygen sensing underpinned by phosphorescence measurements. 
The manner in which oxygen concentration and air pressure are correlated can be 
summarised as follows: since the rise in oxygen concentration is directly 
proportional to rise in oxygen partial pressure, painting of porphyrin on a solid 
surface causes a change in the surface oxygen concentration according to the 
alteration in air pressure and phosphorescence intensity reaction to alteration 










The image originally presented here cannot be made freely available via LJMU Digital Collections because of 
‘copyright’. The image was sourced from Arain (2000). 
 
                                                                                    




by the decrease in level of oxygen caused by the decline in partial pressure in the 
well solution, leaving the emission intensity of the second dye unchanged.  The 
decrease in the oxygen level has a negative impact on cell development, which stops 
completely when the oxygen partial pressure is at or near-zero. The sigmoidal curve 
of the fluorescence emission intensity proportion of the two dyes indicates this 
pattern of development. On the other hand, the oxygen level remains unaltered if the 
well contains medium that does not stimulate growth, reflected by the fluorescence 
emission intensity line (Becker, 2011). The fluorescence response of the sensor is 
transmitted by a polymer optical fibre to the instrument (PreSens) to be measured. 
The calculation of the oxygen partial pressure (pO2) can subsequently be undertaken. 
The obtained oxygen concentration is expressed as air saturation percentage (% air 
saturation), which represents a relative measure that indicates how much oxygen has 
been dissolved in a medium associated with ambient air oxygen concentration. A 
medium with full air saturation is considered to be 100% (Asakura and Okura, 
2009).   
 
The growth of microorganism is assessed based on the analysis of the amount of 
oxygen dissolved in the culture environment. The fluctuation exhibited by the 
concentration of dissolved oxygen over time is associated with bacterial growth and 
metabolic action. The dynamics of oxygen consumption are affected by the 
inhibitory action of the antibiotics on the metabolic performance. The use of the 
OxoPlate enabled the straightforward estimation of the minimum inhibitory 
concentration from the oxygen consumption curves, as well as the differentiation of 
bactericidal and bacteriostatic capacities. Bactericidal antibiotics show a decrease in 
the levels of oxygen in the cultures, followed by an increase when the cells had been 
destroyed (Fig.9a).  Bacteriostatic antibiotics, on the other hand, did not show any 
increase in the levels of oxygen after the initial growth phase (Fig. 9b) (Hutter and 
John, 2004). The use of the OxoPlate for the incipient assessment of antibacterial 
agents is highly advantageous. Temperature has a considerable impact on the optical 
oxygen sensors signal. As noted by Arain (2006), temperature influences the 
attributes of the sensor, as well as the degree of the oxygen solubility in the sample 
 
                                                                                    




   
 
 
Figure 9: Diagram of the differentiation between bactericidal (a), and bacteriostatic compounds 
(b), shown curves of the dissolved oxygen concentration in air saturation percentage against time.    
 
1.8.2. Antibiotic plate assay (agar well diffusion method) 
Microbial or microbiological assay represents a category of bioassay geared towards 
the examination of the chemical substances which bacteria are susceptible to. 
The microbiological assay aims to determine the antibiotic concentration or potency 
based on the measurement of the zone of inhibition generated by the test sample and 
its comparison to an accepted standard concentration. The microbiological assay is 
generally employed to determine the efficiency of antibiotics. As such, it is helpful 
in establishing optimal antibiotic concentrations necessary to effectively treat 
pathogenic infections (Hewitt, 2004). In order to determine the susceptibility of P. 
aeruginosa to antibiotics, an antibiotic plate assay has been conducted. This assay is 
generally considered as the “gold standard” method. 
 
 
                   Figure 10: Diagram of inhibition zone. Adapted from Dart (1996).  
 
(a) (b) 
                                                                                    




1.8.3. Epsilometer test (E-test) 
In 2007, Schwalbe reported that the E-test or Gradient Diffusion Method was 
introduced in 1988 at the Interscience Conference on Antimicrobial Agent and 
Chemotherapy (ICAAC) in Sweden. The principle of E-test is underpinned by both 
methods of disk diffusion and agar dilution, this method is the standard approach 
applied to assess quantitative antimicrobial susceptibility testing. It is preformed 
from the predefined antibiotic concentration gradient on a plastic-covered strip. The 
calibration of the continuous concentration gradient covers 15 two fold dilution, 
which included a wide range of MIC. After E-test strip is introduced on the surface 
of an inoculated agar plate, the antibiotic on the E-test strip undergoes immediate 
transfer to the agar. The MIC is determined after one day incubation, which can be 
read straight from the strip scale at a point where. The inhibition ellipse is observed 
on the top of the strip intersection with calibrated strip (Fig. 11). 
The E-test is similar to the disk diffusion technique, with the exception that the 
suitability time for the antibacterial gradient is extended. Furthermore, unlike the 
disk diffusion method which is appropriate solely for aerobic bacteria with fast 
growth, the E-test remains stable for between eighteen and twenty hours, thus 
spanning the growth intervals of various different pathogens with both rapid and 
slow growth. What is more, the stable gradient permits the application of a macro-
method with heavy inoculum in order to detect low-level resistance, hetero-
resistance and resistant subpopulations. In addition to susceptibility aims, the E-test 
is also applicable in the identification of hypermutable strains of P. aeruginosa 
which is often accompanied by the hypermutator phenotype and Resistant Mutant 
Subpopulations (RMS) which are typically present in CF patients with chronic 
colonisation (Waine et al., 2008).  
 
                                                                                    





Figure 11: The E-test strip. The E-test inhibition ellipse illustrates the MIC at the point where 















                                                                                    




1.9. Background of chemostat 
A microorganism culturing technique which involved maintaining a liquid medium 
at a constant volume to promote ongoing growth of the cells within it was developed 
by Jacques Monod in 1950. Concomitantly, this method was employed by Szilard 
and Novick to create a cell culturing device which has been since known as a 
chemostat (Novick and Szilard, 1950a,b). This device is a bioreactor characterised 
by a state of equilibrium that fosters the constancy of the chemical properties of pH, 
cell density and such equilibrium is reached by constantly adding medium with 
single growth-limiting nutrient and at the same rate removing culture. Under these 
circumstances, the rate of cell population growth and the rate of culture dilution are 
the same (Gresham and Hong, 2014). Although this steady state is generally reached 
following cell growth that spans 10-15 generations, this state can be occasionally 
achieved quicker if the physiological status of the microorganism allows it. Thus, the 
chemostat is advantageous because it offers a state of equilibrium in a stable 
environment and it enables regulation of the rate at which cells grow through control 
of the rate at which the culture is diluted. However, to be functional, a chemostat 
needs ample quantities of media in keeping with the fermenter size and rate of 
dilution. 
 
Due to their practical benefits, chemostats have been widely incorporated in the 
formulation of general ecological theories. The first benefit of chemostats is that they 
promote the proliferation of microorganisms in a physiologically steady state, thus 
facilitating the analysis of multiple generations in a short period of time. The second 
benefit is that chemostats permit the simulation of various environmental factors 
under closely regulated laboratory conditions. The third benefit is that chemostats 
provide the spatial uniformity needed for the assessment of a wide range of 
ecological models. Finally, chemostat experiments are so accurate that they afford 
unparalleled replication exactness (Huisman et al., 2002). As noted by the chemostat 
creators, these singular properties make the device particularly useful in cell growth 
research and analyses of evolution by mutation and selection. Six decades after its 
invention, the chemostat has attracted different attention due to the development of 
genome-scale experimental techniques and the resuscitation of a quantitative 
approach to biology (Bull, 2010, Hoskisson and Hobbs, 2005, Ziv N et al., 2013a). 
                                                                                    




Chemostats continue to be used mainly in research on cell growth and adaptive 
evolution which are essential study topics due to their significance in cell and 
evolutionary biology (Gresham and Hong, 2014).  
1.9.1. The environment of the chemostat and its uses for bacterial research 
Chemostats can have different configurations. Apart from chemostats intended for 
commercial purposes, a variety of chemostat were designed to be a suitable in 
research. It is very useful to use this technique to ensure that microorganisms grow 
in a physiologically steady state. There are some factors which need to be constantly 
maintained during growth, namely pH, oxygen, and the concentration of nutrient and 
metabolic products. The technique is considered to be a valuable research tool, 
because it offers the advantage of controlling the growth rate of cells, allowing the 
monitoring of dissolved O2, CO2 and biomass. The fermenter is the heart of the 
system, and a pump is used to feed the culture and probes are the monitoring 
devices. It has a straightforward process which allows the reservoir to enter a sterile 
medium into the culture vessel at the same rate as the efflux of a spent medium, 
ensuring that the growth rate becomes balanced and that new cell production is at the 
same rate as lost cells. In this system, a fresh sterile nutrient medium feeds cultures 
at a suitable rate to keep the growth of the bacterial population at a constant rate 
Fig.12 (Hoskisson and Hobbs, 2005). The volume of a fermenter determines the rate 
of medium flow rate, which is denoted by the dilution rate (D) with F and V 
representing the flow rate and culture volume, respectively.  
D=F/V (1) 
During stable growth, the biomass change (x) over time has the following 
expression:   
dx/dt=µx-Dx (2).  
The concentration of biomass remains the same during stable growth:   
dx/dt =0, thus µx-Dx= 0 or µ=D (3). 
 
                                                                                    





Figure 12: Schematic illustration of a simplified chemostat. The direction of the medium flow is 
shown by the arrows. To establish the dilution rate (D) and therefore to determine the rate at which 
the specific culture grows (µ), the medium flow rate (F) is regulated by the pump as a function of the 
working volume (V) of the vessel. Sr, x and s refer to the limiting nutrient concentration in the feed 
container, the biomass concentration in the fermenter, and the residual limiting nutrient concentration 
in the fermenter, respectively. Adapted from Hoskisson and Hobbs (2005).  
 
As such, under stable conditions, as long as the growth rate does not exceed the 
critical dilution rate Dc (i.e. the rate at which the steady-state biomass concentration 
is zero), it is possible to regulate the growth rate in relation to the dilution rate. More 
specifically, under the set conditions, Dc exceeds the maximum specific growth rate 
(µmax) of the organism and the culture is washed out.  The straightforward correlation 
between growth and substrate use was validated by Monod (1942). Therefore, the 
rate at which a growth limiting nutrient is supplied represents the limiting factor, 
since the dilution rate determines microorganism growth in steady state culture. 
Monod (1942) established that the biomass of a stable culture was related to the 
concentration of residual limiting substrate and the dilution rate based on the 
following equation: µ=µmax S/ (Ks+ S) (4)In which S and Ks represent the residual 
substrate concentration and the half-rate saturation constant that is equivalent to S 
when the rate of growth is 0.5 µmax. In the context of continuous culture, this is 
expressed as D=Dc S/(Ks+S) (5). 
The outcome of experimental observation of how growth rate and substrate 
concentration are correlated, the chemostat behaviour model proposed by Monod is 
not optimal. Thus, the model has been subjected to numerous amendments such as 
                                                                                    




Droop (1968, 1973, 1974), Fredrickson et al. (1970) and Goldman and McCarthy 
(1978). Nevertheless, due to its simplicity, the Monod model is still popular and is 
appropriate for use in the majority of kinetic studies. However, regardless of the 
chemostat design, the researcher has the same experimental options, as follows: 
 
(a) Organism-related options: the choice of strain is determined by the 
researcher’s objectives; however, there is a number of variables that can 
effect experiments course should be taken into account (Ferenci, 2008). The 
behaviour of bacterial strain is one of variables that influences when 
cultivation in continuous culture. A study was conducted by Mikkola and 
Kurland (1991) showed that a slow adaptive respond was seen in 70 strains 
of E. coli isolated from natural habitats and cultivation immediately in 
glucose-limited chemostat.  
 
(b) Options related to limiting nutrient: although the rate of growth in a 
chemostat is the same whether carbon, nitrogen or phosphorus sources are 
limited, there are clear discrepancies in the patterns of gene expression (Hua 
et al., 2004).  
(c) Options related to limiting nutrient concentration and medium choice: cell 
density in the continuous culture depends on the pump of the nutrient 
concentration into the chemostat. Culture density affects quorum sensing 
aspects, (Liu et al., 2000) and a high density can also reduce the amount of 
oxygen available or trace elements requirement. To prevent these secondary 
limitations of high density, cultures of approximately 108 cells/mL will be 
sufficient. 
(d) The dilution rate for chemostat functioning: the rate of growth in a 
continuous culture is determined by the dilution rate (D) (Monod, 1950).   
(e) Sampling times for gene expression or mutations: rather than being merely a 
shift between two states (batch and continuous), the time-course of activities 
in a chemostat is characterised by great complexity compared with a batch-
culture (Ferenci, 2008).  
Microbial growth is an essential factor in the study of bacteria physiology and 
biochemistry. The contribution of rate of growth to bacterial resistance to antibiotics 
has been highlighted by several chemostat studies (Brown et al., 1990). A key aspect 
                                                                                    




of fundamental microbiology knowledge, bacterial growth kinetics, representing the 
correlation between bacterial specific growth rate (µ) and substrate concentration (s), 
plays an important role the microbiology branches of physiology, genetics, ecology 
and biotechnology (Kova´Rova´-Kovar and Egli, 1998). It has been found that 
bacteria with a rapid growth rate are more susceptible to antibiotics than bacteria 
growing at slow rates of dilution (Brown et al., 1990). When bacteria grow slowly, 
the chance is that they become more resistant, and this is a big problem in microbial 
pathogens. However, this observation does not apply to every form of limitation. 
Notably, chlorhexidine susceptibility is influenced differently by distinct limitations, 
increasing and decreasing with carbon and phosphorus limitation, respectively 
(Brown et al., 1990). Similar to polymyxin susceptibility, this discrepancy in 
sensitivity has been attributed in certain cases to variation in the content of 
lipopolysaccharide at different rates of dilution (Wright and Gilbert, 1987). 
Furthermore, support also exists for the notion that antibiotic susceptibility through 
efflux is dependent on the rate of growth. At low dilution rate, there was elevated 
expression of the E. coli acrAB efflux system, which increased even more at low 
glucose levels (Rand et al., 2002), denoting a likely involvement in resistance at 
slow dilution rates. In addition, a direct correlation has been established between a 
greater population of persister cells and increased resistance to ciprofloxacin and 
tetracycline at slow growth rates (Sufya et al., 2003). Persister cells find themselves 
implicated in the human clinical setting due to their lower susceptibility to 
antibiotics compared to other bacterial cells (Balaban et al., 2004, Kussell et al., 
2005). The variables influencing the growth and distribution of persister cells within 
a bacterial population could be comprehensively investigated with the help of 
chemostats (Ferenci, 2008).  
1.9.2. The chemostat underlying principle 
There are some important distinctions between microorganism culturing in a 
chemostat and the batch- culture growth technique that microbiologists usually use 
to obtain continuous cultures. 
1.9.2.1.Bacterial growth in batch mode 
Bacteria undergo a distinctive series of transformations upon introduction in a 
nutrient medium and incubation at an appropriate temperature. Following a “lag 
                                                                                    




growth phase”, bacteria grow in mass and subsequently divide. During the process of 
growth, known as the exponential growth phase, bacteria assimilate nutrients from 
the medium and eliminate metabolic products into it. In general, metabolic activity 
determines a change in pH and, in the case of aerobic organism cultures, the rate of 
oxygen solution may not be enough to sustain appropriate aeration of the culture. 
Nutrient depletion occurs when the density of a population becomes relatively high, 
at which point the cells stop growing and a quiescent state is established. The culture 
reaches the stationary phase when the environment is modified to such an extent by 
the growth process that it becomes incapable of sustaining growth (Gresham and 
Hong, 2014, Novick and Szilard, 1950a).   
1.9.2.2.Bacterial growth in a continuous culture 
All continuous cultures are initially batch cultures, in which organisms are 
inoculated in the medium where they undergo growth and division as early 
explained. The difference is that, unlike in a batch culture, growth goes on 
continuously if the culture is fed with new medium during the exponential growth 
phase at a rate at which the density of the culture population can be preserved at a 
stable, less-than-maximum value. The process by which new medium is added and 
culture is removed on a constant basis is known as chemostat (Gresham and Hong, 
2014, Novick and Szilard, 1950a). However, if the culture is not constantly removed 
at the same rate as that of the addition of medium, there will be an exponential 
increase in the medium input rate and in the concentration of microorganisms. 
 
The researcher can choose any of the nutrients that play a crucial role in cell growth 
as the nutrient that will suppress growth. For instance, a chemostat in which glucose 
is the limiting nutrient is defined as ‘glucose-limited’. Based on experimental 
measurements of the growth rates of E. coli in various concentrations of glucose, 
Monod was the first to suggest this correlation between growth rate and nutrient 
concentration (Monod, 1949). Furthermore, the correlation has also been noted by 
Novick and Szilard (1950b) when varying tryptophan concentrations were used to 
grow a strain of E. coli.  
 
The concentration of microorganisms (x) and the concentration of the growth 
limiting nutrient (s) are the key dynamic variables in a chemostat, which influence 
                                                                                    




by dilution rate. Dilution rate variation affords a range of stable conditions 
characterised by the fact that the growth rate and dilution rate are identical, provided 
that the dilution rate  does not exceed the maximum rate of growth of the cells 
(Gresham and Hong, 2014). However, when dilution rate sets at or exceed µMax, the 
bacterial biomass will be increased rapidly resulting in depleting in the growth-
limiting nutrient concentration due to use by the cells within the chemostat culture. 
From this model, it can be inferred that, under stable conditions, the exponential 
growth rate constant, in other words, the specific growth rate (µ), and the rate of 
dilution (D) are directly equivalent. Therefore, the doubling time (td) of growing 
microorganism in exponential phase is basically calculated using 
                                               td=  ln (2)/D       (6) 
1.10. Biomass Monitoring System  
The BE2100 is a commercially distinguished technology directed at the provision of 
rapid and efficient biomass monitors of both microbial and animal cell cultures. The 
system offers the added advantage of being non-intrusive and is, thus, increasingly 
protected from contaminations in comparison to conventional immersive 
technologies. The method functions by means of attaching a sensor to the exterior of 
a bioreactor (various sizes and materials) and tracks the biomass in real time. 
Furthermore, the system is applicable to both laboratory and commercial research.  
In terms of the operational processes, this unique system is capable of generating 
constant and instantaneous biomass monitoring through the employment of a 
BE2100 Base Unit with an individual sensor in conjunction with BugLab software. 
Additionally, in contrast to previously employed optical biomass probes that are 
dependent on exclusive emission and detection combinations that are limited in 
biomass range, the BE2100 monitoring system measures a broader linear biomass 
OD unit range (≤ 0.1 to ≥ 300), eliminating the necessity for sample dilutions. Such 
a benefit is conferred through the utilisation of multiple infrared laser and detector 
combinations, the former of which encounters the bacterial cells in culture to 
generate light scatter patterns that are measured by the laser. Importantly, each of 
these combinations measure distinctive biomass alterations. The OD value is directly 
proportional to the concentration of the reflected light. As such, the Bug Lab 
software is able to generate increasingly reliable, broadly-ranging and linearised 
                                                                                    




biomass changes through the amalgamated evaluation of independent laser and 
detection readings (Applikon Biotechnolog, n.d). 
1.11. Aims of the investigation  
The aim of conducting this project is to consider the factors that influence the 
susceptibility and growth behaviour of the organism to antimicrobials and then to set 
the stage for developing an in vitro model to investigate the effects of long term 
exposure of P.aeruginosa to the antibiotics studied and to explore other contributory 
factors resulting in the evolution of antimicrobial resistance.   
1.12. Research objectives  
Several objectives have been established to attain the research aim, as follows: 
 To investigate the dynamics of P. aeruginosa growth suppression in the presence of 
stress factors using a novel fluorescence based assay (OxoPlate® system)  
 To determine antimicrobial activities of antibiotics against planktonic cells of 
P.aeruginosa using OxoPlate® system.  
 To analyse the growth behaviour of wild-type strain of P.aeruginosa to be able to 
determine the rate at which the cell population is growing.  
 To determine if over exposure to antibiotics at very low antibiotic concentrations 
below MIC can lead to phenotypic resistance, using a continuous culture (Chemostat 
system). 
 To evaluate whether prolonged exposure to antibiotics resulted in colony alterations.  
 To control the growth rate to see the effects of antibiotics at different growth rates 
and monitor dissolved O2 and biomass.  
 To sort cells to be able to identify subpopulation of “persister cells” from the whole 
population.  
 To measure how quickly antibiotics act on bacterial cell populations using 






Material and methods 
2.1. Bacterial strain 
A reference strain of Pseudomonas aeruginosa PA01 (ATCC 15692) was used 
throughout the study provided by Liverpool John Moores University (LJMU). 
2.2. Culture media 
Mueller Hinton agar, Nutrient agar, Nutrient broth, and Mueller Hinton broth were 
used throughout the study. Media were obtained from OXOID LTD, UK and 
preparation were carried out in accordance with the instructions provided by the 
manufacturer.   
2.2.1. Nutrient Agar (NA) 
The process entailed mixing 28g of NA with one litre of distilled water and the 
mixture was poured into Duran bottles and sterilised for 15 minutes at a temperature 
of 121°C.  Afterwards, the medium was poured into 90 mm sterile agar plates and 
left to solidify and then stored in a refrigerator at 4 °C. 
2.2.2. Mueller Hinton Agar (MHA) 
Mueller-Hinton Agar was prepared by weighing (38g) of MHA base powder and 
dissolved it in one litre of distilled water and the mixture was poured in Duran bottle 
and sterilised for 15 minutes at a temperature of 121°C. The medium was poured 
into 90 mm sterile agar plates and left to solidify and then stored in a refrigerator at 
4°C.  
2.2.3. Nutrient Broth (NB) and Mueller-Hinton Broth (MHB) 
Preparation of the Nutrient Broth and Mueller-Hinton Broth were conducted in the 
same way as the agar, the only difference being that only 13g of Nutrient Broth was 
dissolved in one litre of distilled water and 21g of Mueller-Hinton Broth was 
dissolved in one litre of distilled water. 




2.2.4. Evan’s defined synthetic medium 
The medium composition was NaH2PO4.2H2O (0.62g/l) (BDH, England), KCl 
(0.75g/l) (Fluka), NaNO3 (0.849g/l) (Sigma-Aldrich, United Kingdom (UK)), 
Na2SO4 (0.28g/l) (Sigma, Japan), citric acid (0.38g/l) 0.02% (v/v) (The British Drug 
Houses (BDH), England) and (1.8g/l) D-Glucose anhydrous (Fisher Scientific, UK), 
CaCl2.2H2O (0.037g/l) (BDH, England) and MgCl2 (0.11g/l) (Amresco, United 
States American (USA)) were added for defined medium used for testing and the pH 
was adjusted to 7.2 using1.5M NaOH (Fisher Scientific, UK) and autoclaved at 
121°C for 15 min. Furthermore, the autoclaving of glucose took place separately. 
Following autoclaving, for each litre of defined medium, one millilitre of trace 
elements was introduced in the sterile defined medium with the help of a disposable 
sterile syringe filter (0.2 µm, Corning) (Life Sciences, UK).   
2.2.5. Trace elements 
The trace elements solution had the following composition; ZnO (4.1 g/l), FeCl3  
(3.2 g/l) (Sigma-Aldrich, UK), MnCl2.4H2O (2.0g/l) (BDH, England), CuCl2 (1.4 
g/l) (BDH, England), CoCl2.6H2O (4.8 g/l) (BDH, England), Na2MoO4.2H2O 
(0.0048 g/l) (BDH, England), NOB4O7.10 H2O (3.82 g /l) (Sigma, Japan) and 80ml 
of concentrated HCl (Sigma-Aldrich, UK).  
2.3. Selection of antibiotics 
In vitro antibiotic susceptibility testing was conducted with P.aeruginosa by using 
these antibiotics, which were obtained from Sigma-Aldrich, UK (Table 1). 
 
              Table 1: The most common agents to treat P.aeruginosa 
Antibiotic  Potency  Molecular Weight 
Tobramycin sulphate salt 701µg/mg 467.51 
Amikacin disulphate salt 674-786µg/mg 781.76 








2.4. Broth methods 
2.4.1. The broth microdilution method (Standard) 
The broth microdilution method was one of the first methods used to test bacterial 
sensitivity to antibiotics. The process entails producing two-fold dilutions of 
antibiotics in Muller – Hinton Broth medium. For the preparation of a stock solution, 
20mg of amikacin and 32mg of tobramycin and colistin were dissolved in I ml of 
distilled water. Subsequently, the antibiotics were further diluted to obtain the final 
concentration ranges in the test medium. The preparation of the standardized 
bacterial suspension entailed the selection of a colony of P.aeruginosa with the use 
of a sterile plastic loop, followed by its suspension in 50 ml of MHB which was then 
left to incubate in an orbital shaking incubator (Sartorius, Germany) for 24 hours at a 
temperature of 37°C and a speed of 250 rpm. A sample of an overnight culture of P. 
aeruginosa was adjusted to equale the 0.5 MacFarland’s standard. The purpose of 
this experiment was to establish the MIC value of the antibiotics used, as well as to 
differentiate between bactericidal and bacteriostatic antibiotics. 
The wells were divided into samples and controls. The samples consisting of 180 µl 
of media amended with 10 µl of antibiotic to reach the required concentrations and 
then inoculated with 10 µl of an overnight culture. Replicates of each sample (3or 4 
each) were employed. The positive and negative controls consisted of 12 wells each, 
containing 180 µl of broth injected with 10 µl of water inoculated with 10 µl of an 
overnight culture. In addition, a 10 µl solution of sodium hypochlorite (reagent grad 
chlorine 10-15%), obtained from Sigma-Aldrich, UK, was added to the negative 
control wells. The microplate then left to incubate at a temperature of 37°C for 24 
hours. Subsequently, the wells were inspected for signs of bacterial development 
with sub-inhibitory concentrations, such as turbidity. However, with inhibitory 
concentrations, no growth is visually observed in the media because the growth of 
bacteria is inhibited by antibiotics used. 
2.4.2. OxoPlate®                                                         
Antibiotic susceptibility assay was prepared as previously mentioned in the broth 
microdilution method (see section 2.4.1). The OxoPlate OP96U (Precision Sensing 
GmbH, Germany) with a round bottom was used. The plate was covered with a 
polystyrene lid, the adhesive membrane of which permits gas to go through (Thermo 




Scientific AB-0718, UK). The time-resolved fluorescence measurement technique 
and the plate mode reading for slow dynamics were employed to carry out the test. 
The wells represented in the layout were read once every plate cycle, which 
amounted to 250 cycles in total. Prior to and after every cycle, the plate was agitated 
for 3 seconds. The optical sensors at the bottom of the OxoPlate wells were scanned 
with the FLUOstar OPTIMA fluorescent plate reader (BMG LABTECH GmbH, 
Germany). To identify the indicator dye and the reference dye, excitation filter 
540/650 nm and emission filter 540/590 nm were used respectively to measure the 
plate. 
 
The plate carrier was able to move from left to right across consecutive columns 
based on horizontal reading direction. The temperature was set at the desired 
temperature. The well with the untreated positive control sample was chosen to 
conduct the gain adjustment, as it had the highest intensity. Gain adjustment 
maximises signal intensification to enhance sensitivity and the dynamic range as 
much as possible. The reader measured the minimum times intervals. The test was 
carried out over a period of 48-72 hours and the results were recorded automatically 
in the MARS data analysis software version 2.20 and represented as curves. The data 
was analysed using Microsoft Excel, 2010 to calculate means, the fluorescence 
intensity ratio and the oxygen concentration. Then, data was presented graphically 
using Sigma Plot v.12.  
Calculation of oxygen concentration 
The equation used to calculate the fluorescence intensity ratio at the oxygen 
concentration was:  IR =I indicator/I reference    (7) 
The equation used to calculate the oxygen concentration as percentage air saturation 
in each well was: PO2 =100. (K0/IR-1) / (k0/k100-1)     (8) 
2.5. Diffusion methods 
2.5.1. Agar well diffusion method 
 A sample of an overnight culture of P. aeruginosa was adjusted to equal the 0.5 
MacFarland’s standard. The accepted absorbance range for 0.5 MacFarland’s 
standard at wavelength of 625nm is between 0.08 and 0.13 (corresponds to 




approximately 1.5 X 108 CFU/ml) and in all cases a spectrophotometer with a 1 cm 
light path was used and adjustments made by the addition of distilled water.  
The antimicrobial bioassay was performed in square agar plates obtained from 
Thermo Scientific (Nunc, UK). In this method, the standard dilution of antibiotic 
from stock solution was prepared to reach the final concentration required by using 
the twofold dilution method using sterile distilled water as diluent. The suspension 
(10ml) was poured over the entire surface of the square agar plate and rotated to 
completely cover the plate. The surplus liquid was disposed of. To expose the 
antibiotic on the plates, 10 mm diameter reservoirs were cut into the agar plates with 
a sterile cork borer. Standard antibiotic concentrations (100 µl) were introduced into 
the reservoirs. It is necessary for all doses of antibiotic to be introduced at the same 
time, particularly in the case of large plates with more reservoirs to avoid 
discrepancies in antibiotic diffusion between the first and last reservoirs. To this end, 
it is helpful to use a template sheet to create a pattern of sample distribution, which 
enables the pre-determined application of a high number of samples into a square 
agar plate. In order to permit the applied antibiotic to diffuse, the plates were 
incubated for 18 hours at a temperature of 4°C to minimize growth of bacteria. To 
increase the inhibition zone size and the dose response curve, the period of diffusion 
of the antibiotic should be extended. In addition, diffusion must occur at a 
temperature lower than the room temperature to prevent bacterial growth and an 
indeterminate zone. However, a low temperature slows down the process of 
diffusion and so it is necessary to assess the most suitable conditions by trial and 
error. It is considered that a period of  several  hours at 4°C is suitable for the 
process of diffusion to occur (Dart, 1996). Subsequently, the plates were incubated 
over a period of one day at a required temperature. Plug assays were carried out and 
evaluated based on the dimensions of the inhibition zones. Inhibition zone with 
diameter of 10mm was considered as having no antimicrobial activity. In order to 
determine the zones measurement, a ruler positioned underneath the inverted plate 
was used and had a standard error of ± 0.5 mm.  The area without any apparent 
growth visible with the unaided eye was established to be the zone edge. The  
European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines 
were consulted to define the inhibition zones sizes, being classified as susceptible, 
intermediate or resistant to the antibiotics used. The guidelines of the EUCAST were 
followed to carry out the tests. 




2.5.2. E-test  
E-Test gradient strips containing amikacin, colistin and tobramycin provided by 
manufacturer (Thermo Scientific, UK). The antimicrobial concentration ranges 
tested were 0.016 to 256 µg for amikacin, tobramycin and colistin. These strips were 
stored at a temperature of -20°C and, upon removal from the freezer, they were not 
immediately opened but kept for about half an hour at room temperature to allow for 
the complete evaporation of the condensed moisture on the external surface of the 
package containing the strips. The strips were used after the package reached room 
temperature. 
 
A molten MHA (25ml) was poured into 90mm diameter of sterile Petri dishes to 
give 4 mm ± 0.5 mm depth and left to solidify. The plates were left to reach ambient 
temperature and they were put into refrigerated storage at 2-8°C if they were not 
used in the same day. All plates were employed within a week after they were 
prepared. For purposes of sterility assessment, every plate before use was incubated 
to one day at a temperature of 37°C. 
 
To attain the turbidity of a 0.5 McFarland standard (corresponds to approximately 
1.5 X 108 CFU/ml), distilled water was used to dilute an overnight P. aeruginosa 
culture. Subsequently, the inoculum was spread out onto a MH agar plate using a 
serial cotton swab. Within 15 minutes following the adjustment of the inoculum 
suspension turbidity, a sterile cotton swab was dipped into the adjusted suspension. 
In order to eliminate excess inoculum, the swab was squeezed on the internal tube 
wall above the liquid level. The swab was then spread over the whole dried surface 
of the sterile Mueller-Hinton agar plate to inoculate it. The plate was rotated about 
60° to make sure that the inoculum was uniformly spread including the agar rim.  
Before the E-test strip was applied, the lid was left slightly open for a period of 
between three and five minutes for the absorption of any excess surface moisture. 
After drying, the plate had an E-test strip applied to it and was subjected to 
incubation at the required temperature.  
The guidelines specified by the manufacturer were followed to interpret the results. 
In the case of measuring MIC for wild-type susceptibility, the reading of the plates 
was done upon observation of enough growth after the one-day incubation period, 




while in the case of the subpopulation and resistance subpopulation, the plates were 
read after that period. 
2.6. The measurement of P. aeruginosa growth  
The SPECTRO star Nano (BMG LABTECH, Germany) was employed to monitor the 
growth/inhibition of P. aeruginosa. To monitor bacterial growth, the optical 
densities in every well are measured by the plate reader. Having a sophisticated 
photometrical technology in this plate reader was useful to conduct kinetic 
measurements of modifications in optical densities caused by bacterial growth or 
inhibition. In each experiment, the measurement of the optical densities was 
undertaken based on a wide-band filter associated with a spectrum range of between 
420 and 700nm.   
Threefold repetition of every growth curve was carried out, while the SPECTRO star 
Nano software automatically recorded at every hour the optical density values across 
48h. These values were then transferred to Microsoft Excel 2010 spreadsheet to 
calculate means and represented graphically using Sigma Plot v.12.  
2.7. The dynamics of growth inhibition in the presence of stress 
factors 
2.7.1. Temperature  
The antimicrobial activity of the antibiotics was determined under a range of 
temperatures (25, 30, 37, 42oC) using standard methods (E-test and Agar Well 
Diffusion method) and innovative method (OxoPlate). The assays were prepared as 
previously mentioned in the sections (2.4.2, 2.5.1& 2.5.2).   
2.7.2. Divalent cation  
The following procedure was undertaken to observe how the dynamics of P. 
aeruginosa growth suppression responded to the effect of Ca2+ and Mg2+ using 
OxoPlate. Different concentrations of Ca2+ and Mg2+ (1-5mM) were added to the 
medium both on their own and together, alongside bactericidal doses of the 
antibiotics employed. The 160 μl of media in every well contained 10 μl of antibiotic 
and 20μl ions to attain the necessary concentrations, to which 10 μl of an overnight 




culture was added. Each sample was associated with three replicates. Incubation 
lasted for 72h, at a temperature of 30°C.  
2.7.3. Inoculum size  
To assess the effect of three antibiotics used on the bacterium at different inoculum 
densities, experiments were run using OxoPlate method inoculated with high and 
low inoculum sizes. The test bacterium was used at various inoculum sizes from 
6x108 cfu/ml to 1.2x105 cfu/ml. The rest of the assay was prepared as previously 
mentioned in section (2.4.2).   
2.8. Determination of limiting nutrient 
Growth was regulated by the medium through limitation of one constituent element, 
which allows growth of P.aeruginosa to be limited.  In the case of synthetic medium 
with just one vital nutrient in a concentration less than that usually employed in 
batch culture, the chemostat is referred to as a nutrient-limited chemostat because 
growth is limited by depleting a specific concentration of nutrient, whilst the rest of 
the nutrients exist in excess concentration.  
2.8.1. Glucose-limited growth 
Different concentrations of D-Glucose anhydrous (Fisher Scientific, UK) were 
prepared to determine the concentration that gave carbon limitation in continuous 
culture. The concentrations were 5, 10, 15, 20, 25, 30, 35, 40, 45 and 50mM. In 
shake flasks, each concentration was added into Evans’ defined synthetic medium 
containing (10 mM sodium nitrate as sole nitrogen source). The defined synthetic 
medium (100ml) was inoculated with 10% (V/V) solution (10 ml) of cell culture in 
the exponential growth phase of P.aeruginosa PA01 1.5 X 108 CFU/ml. It was then 
left to incubate in an orbital shaking incubator for 24 hours at a temperature of 30°C 
and a speed of 250 rpm. The measurement of the Optical Density (OD) after 24h 
incubation was conducted at A625 using the SPECTRO star Nano.  
2.8.2. Nitrate- Limited growth 
 The initial sodium nitrate concentration was also determined in order to use only 
one nutrient limitation in the glucose limited chemostat culture. Different 
concentrations of NaNO3 were prepared to determine the nitrogen limited 
concentration, which ranged from 1 to 20mM. In shaking flask each concentration 




was added into Evans’ defined synthetic medium supplemented with 1.8g/l of 
glucose. The rest of the preparation as mentioned in glucose limited.   
2.9. Setting up the chemostat 
The confirmation of chemostat is illustrated in Fig.13. The components of chemostat 
are shown in Fig. 14.  
2.10. Cell culture preparation and conditions of chemostat 
A new applikon chemostat from Holland was used in this study. The bacterial 
growth was undertaken in a vessel with a capacity of 2.8L and a working volume of 
2L and airflow rate was 1.75 l/h. The system was initially run as a batch mode at 
different stirring speeds 150, 250 and 350 rpm in order to gain a homogenous culture 
and ensure that the continuous culture was running under optimum conditions. 
Dissolved oxygen concentrations were monitored using a poloragraphic dissolved 
oxygen probe (Applikon, Holland) (Fig.14B). CO2 and biomass were also monitored 
using a CO2 gas analyser (Electrolab, UK) and BagLab system (BE/2100) 
(Applikon, Holland) respectively (Fig.14 G and H). The pH was controlled at 7.2 
using solutions of 2.5M NaOH and 2.5M H2SO4. The temperature was controlled at 
30ºC using a chiller and heating jacket (Applikon, Holland). An anti-grow back tube 
(Applikon, Holland) was used to minimise the growth of cells into the medium feed 
line (Fig. 14 D). Silicone antifoam (1g/l) (BDH, England) was prepared to control 
excessive foaming by injecting 1ml of diluted antifoam into the culture every 6h 
using timed addition.   
The 2L volume of chemostat Evans’ defined synthetic medium was inoculated with 
a 10% (V/V) solution (200 ml) of cell culture. The bacterial inoculation was 
prepared as follows: a pure colony of P.aeruginosa PA01 (ATCC 15692) was 
selected using a sterile plastic loop, followed by its suspension into separate flasks 
containing 100 ml of defined medium and 100µl of filtrated trace elements solution 
which was then left to incubate in an orbital shaking incubator for 24 hours at a 
temperature of 30°C and a speed of 250 rpm. The OD was measured after 24h 
incubation using The SPECTRO star Nano. Then, the overnight culture of P. 
aeruginosa was adjusted to equal the 0.5 MacFarland’s standard. When the 
exponential growth phase was entered after 20-24 h, the pump-323 (Watson Marlow 
Fluid Technology Group, UK) was activated to permit a steady stead culture to 




begin. Different dilution rates were set up (from the slowest to the fastest) as 
following 0.025h-1, 0.06 h-1, 0.099 h-1 and 0.12 h-1. In order to obtain the growth of 
the bacterial population at a constant rate, fresh sterile nutrient medium was fed at an 
appropriate flow rate. When the reactor volume reached or exceeded the 2L volume, 
effluent was eliminated via the weir. After growth was stabilized, amikacin at sub 
inhibitory concentration was then introduced into a 10L or 20L bottle and fed to the 
culture. The results were automatically recorded in Bioexpert software and 
represented as data plots. The data was statistically analysed using Microsoft Excel 
2010 and SPSS v.21. Data was presented graphically using Sigma Plot v.12.  
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Figure13: Photograph of chemostat system 






Figure 14: The components of the chemostat. Polarizer (Applikon, Holland) (A), dO2 probe (B), An 
aluminum blocks (24 x 1.5ml) (Appleton wood HE1513/000205, UK) (C), Anti-growth back tube 
(D), Weir (E), Heating jacket (F), CO2 gas analyser (G), BagLab system (H), Filter with blue stone (I) 
and Feeding tube made from peroxide-cured silicone with masterflex (96400-14) (J).




2.11. Analytical methods 
 A 10-20ml of sample was collected during the steady state culture for each 
experiment to not only determine the cell viability, glucose concentration, antibiotic 
susceptibility testing and bacterial optical density but also to analysis the cell 
population and morphology of colony and to check the purity of culture.  
2.11.1. The cell viability assessment 
A sample was taken both before and after treating with antibiotic to determine the 
cell viability, using the Miles and Misra assay and LIVE/DEAD® BacLightTM strain.  
2.11.1.1. The Miles and Misra method 
 For the viable bacterial cell count, the culture sample was diluted in a series of 
tenfold dilutions using sterile distilled water. The values were represented a mean of 
3 repetitions. The mean number of Colony Forming Units (CFUs) was calculated 
using the following formula:    
Number of CFU/ml = average of colony counts x 50 x dilution factor.    (9) 
The results were represented graphically as the time of exposure against the log of 
surviving’ colonies.  
2.11.1.2. Fluorescence microscopy 
The live/dead cells were also assessed using the BacLightTM stain (Life Technology 
L7007, USA). The BacLight stain is a mixture of two coloured fluorescent dyes the 
green fluorescent nucleic acid stain is SYTO 9 to stain cells with undamaged 
membranes (live cells) and the red fluorescent nucleic acid stain is propidium iodide 
to stain cells with damaged membranes. The dyes are assessed with the use of two 
filter pairs. The first filter pair of excitation/emission is 480/500 nm and the second 
filter pair is 490/635 nm. The first pair is designed for SYTO 9, and the second filter 
pair for propidium iodide. The sample and staining optimization were prepared 
according to the instructions provided by the manufacturer. Then the stained sample 
was observed under 100x lens using fluorescence microscope (Olympus, UK). The 
images were observed in an image analysis program Volocity software version 6.3. 




2.11.2. Glucose concentration assay 
The glucose concentration was measured using enzymatic colourimeteric method 
(Gulcose oxidase /PAP) from Randox, UK. The measurement of glucose 
concentration of each steady stead experiment was conducted as following: 
In a cuvette of 1cm light path, bacterial culture (10µl) was diluted into 1ml of 
reagent blank.  The preparation of glucose standard was conducted by diluting 10 µl 
into 1ml of reagent blank. The blank consisting of 1ml of reagent with 10 µl of 
dH2O. The sample and glucose standard were mixed well and incubated at 37
oC for 
20minutes. After this period, the absorbance of sample and glucose standard were 
measured at 500nm and the concentration of glucose was determined by applying the 
following equation:   
                                                                                                  ∆A Sample 
   Concentration of glucose = Standard concentration ×   --------------   (g/l)    (10) 
                                                                                                 ∆A Standard  
2.11.3. Determination of Ks 
The nutrient is considered to an essential factor to limit the growth of the organisms.  
The correlation between the initial glucose concentration and specific growth rate 
were determined. From this correlation, the maximum specific growth rate µmax can 
be also determined. Based on the values of specific growth rate and initial 
concentration of glucose, Ks for glucose was also measured using the following 
equation:  
                                         1          Ks               1 
------ = ----------- + ------                (11) 
                                          µ        s. µmax              µ 
 
Where Ks is the substrate affinity constant (g/l), µ is the specific growth rate (h-1), s is the initial 
concentration of glucose (g/l) and µmax is the maximum specific growth rate (h-1).  
 
The inverse of the initial concentration of glucose (1/ s) was plotted against the 
inverse specific growth rate (1/µ) to determined Ks. Based on the values obtained, 
the straight line will crossed the X axis and the intercept gives the value -1/Ks .




2.11.4. Colony morphology 
In order to detect any phenotypic switch, the bacterial cells were grown on nutrient 
agar plates (antibiotic free). The plates inoculated with 10µl of bacterial cells from a 
steady state cultures and incubation between 24 h and 72h at 30°C. Any colony 
morphology changes were observed and evaluated based on the antibiotic 
susceptibility testing using OxoPlate method.  
2.11.5. Cells sorting 
The cells of 3 and 6 days age were taken from the centre and the edge of any mutant 
colonies and re-suspended in filter sterilized dH2O to reach the final concentration of 
1x108 CFU/ml (~0.03 OD670). In an Eppendorf tube, 1 ml of the bacterial suspension 
was stained with 3µl of the staining reagent mixture of the LIVE/DEAD BacLight 
dye. The samples were covered with foil then vortexed and incubated between 10-15 
minutes at room temperature in a dark place. After this period, the BD Accuri® C6 
Flow Cytometer (Biosciences, UK) was used to sort the cells. In order to analyse the 
cells, the appropriate threshold value was set up at 10,000 and the sample was run 
with a limit of 90,000 cells at a slow flow rate. The results were recorded 
automatically in the BD Accuri® C6 software version 1.0.264.21 and represented as 
data plots.  
2.11.6. Antibiotic susceptibility testing 
The susceptibility of P.aeruginosa cultures that prolonged exposure to sub-inhibitory 
concentrations of amikacin in the glucose limited chemostat was determined in MHB 
by using OxoPlate method. Antibiotic susceptibility assay was prepared as 
previously mentioned in section (2.4.2).  The susceptibility of P.aeruginosa was 
classified as susceptible, intermediate or resistant to the antibiotics use by referring 
to the EUCAST guidelines.  
2.11.7. Scanning electron microscopy (SEM) 
Following 3days incubation in absence of amikacin, bacterial cells presented in the 
centre of colony of culture exposed to amikacin in the chemostat grown at 0.125h-1 
were harvested and fixed with 2.5% glutaraldehyde (Agar Scientific Ltd, UK) at 4°C




 overnight. An overnight culture was re-suspended in 1.5 ml micro-centrifuge tube 
and centrifuged at 4000xg for 5 minutes. The supernatant was discarded and the 
pellet was washed three times with dH2O. A loop of fixed bacterial cells was placed 
on a circular coverslip and gold-coated (15nm thickness) for 25 minutes at 25mA 
using K550X Sutter Coater (EMITECH, UK).  
 
The colony of treated P.aeruginosa had been cultured for 3days and the centre was 
cut and fixed by freezing in liquid nitrogen (BDH, England). A liquid N2-cooled 
brass metal holder was used to place the sample into a cold trap and allowed to dry 
overnight before examined under Inspect S Electron Scanning Microscope (FEI, 
USA). The images were observed in an image analysis program FEI software 
version 4-1.10.2127. 
2.12. Bacterial DNA extraction for 16S ribosomal RNA 
The identification of species of bacteria and the formation of taxonomic 
classifications have relied on the sequence analysis of the 16S ribosomal RNA gene. 
Chakravorty et al. (2007) explained that the 16S rRNA genes of bacteria consist of 
nine ‘hypervariable regions’, which can be employed to distinguish between species 
as their sequence varies significantly among the wide range of species of bacteria.  
2.12.1. Extraction of genomic DNA 
Genomic DNA was extracted from cells using E.Z.N.A. Bacterial DNA Kit obtained 
from Omega, USA and instructions were followed according to the manufacturer.   
NB medium (100ml) in a 250ml shaking flask was inoculated with P.aeruginosa and 
incubated in an orbital shaking incubator for 24 hours at a temperature of 30°C at a 
speed of 250 rpm. An overnight culture (1.5 ml) was re-suspended in 1.5 ml micro-
centrifuge tube and centrifuged at 4000xg for 10 minutes using centrifuge 5418, 
Germany. The media was discarded and the pellet retained. Lysozyme (10µl) was 
added to the pellets in the tubes and following vortexing the tubes were incubated at 
37ºC for 10 minutes. BTL buffer (100µl) and proteinase (20µl) were added and the 
tubes vortexed to mix thoroughly. The samples were incubated at 55ºC in a shaking 
water bath for 1 hour. RNase (5µl) was added and the samples inverted up and down 
in order to mix the samples were then incubated at room temperature for 5 minutes.




The samples were centrifuged for 2 minutes at 10,000xg to pellet any undigested 
material. The supernatant of each tube was transferred to a new 1.5 ml micro-
centrifuge tube without disturbing the pellet. BDL buffer (220µl) was added and 
samples were vortexed to mix. The samples were then incubated at 65°C for 10 
minutes. Ethanol (96-100%) (220 µl) was added in each tube and vortexed for 20 
seconds at a high speed. The samples were then transferred into HiBind®DNA Min 
columns and centrifuged at 10,000xg for 1 minute. The filtrate in the collection tube 
was discarded. The column was then inserted into a new 2ml collection tube. DNA 
wash buffer (700µl) was added then the tubes centrifuged at 10,000xg for 1 minute. 
The filtrate was discarded and the collection tube was reused.  A second DNA wash 
buffer was also applied. The empty HiBind®DNA Min column was then centrifuged 
at maximum speed >10,000xg for 2 minutes to dry the column. HiBind®DNA Min 
column was then inserted into a new 1.5 ml micro-centrifuge tube. Preheated Elution 
buffer (65C°) (50 µl) was added to the HiBind®DNA Min column. The 
HiBind®DNA Min columns were incubated at room temperature for 3 to 5 minutes. 
The samples were then centrifuged at 10,000xg for 1 minute to elute the DNA. A 
second elution step was repeated. Eluted DNA was stored at -20C°.  
2.12.2. 16S rRNA gene amplification and detection of PCR products  
The 50µl PCR reaction mixtures contained 45µl of MasterMix (1.5 mM MgCl2) 
(Qiagen), 2µl of DMSO, 1µl of genomic DNA, 1µl of sterile dH2O and 0.5 of each 
primer (forward and reverse) (Table 2). Amplification of the 16S rRNA sequences 
was performed using thermal cycler 2720 (Applied Biosystems, UK). The 35 cycles 
of the amplification conditions was conducted including a denaturing step at 95°C 
for 1 min followed by an annealing step at 52°C for 1 min, and the final elongation 
step was performed at 72°C for 2 min. 
 
Table 2: Eubacterial universal primers were used to amplify the 16S rRNA gene. 
Primer name Sequence (5’to 3’) Positions 
27f AGA GTT TGA TCM TGG CTC AG 8-27 
1492r TAC GGY TAC CTT GTT ACG ACT T 1510-1492 
 




2.12.3. Purification  
In accordance with the guidelines provided by the manufacturer, a QIAquick kit 
(QIAGEN, UK) was used to purify the PCR products. pH indicator (4µl) was added 
into 1000µl of buffer PB. Buffer PB (100µl) was added into 20µl of PCR products. 
3M sodium acetate pH 5.5 obtained from Ambion the RNA Company (10µl) was 
added to each sample. The colour of the mixture turned yellow. Samples were 
applied to the QlAquick column and centrifuged at 13, 000 rpm for 30-60 seconds. 
The flow through was discarded and the QlAquick column was placed back in the 
same tube. Buffer PE (750µl) was added into the QlAquick column and centrifuged 
at 13,000 rpm for 30-60 seconds. The flow through was discarded again and the 
QlAquick column placed back in the same tube. The QlAquick columns were 
centrifuged once more in 2 ml collection tubes for 1 minute to remove residual wash 
buffer. Each of the QlAquick columns was placed in a 1.5 ml micro centrifuge tube. 
Elution buffer (30µl) was added to the centre of the QlAquick membrane and the 
column was allowed to stand for 1 minute and then centrifuged at 13,000 rpm for 30-
60 seconds. The presence of PCR products was confirmed by agarose gel 
electrophoresis.  
2.12.4. Agarose gel electrophoresis 
EDTA (0.5M): Distilled water (88 ml) was used to dissolve 18.6g of 0.5M EDTA 
(Sigma, USA) and sterile distilled water was added to increase the volume to 100ml, 
whilst the pH was adjusted to 8.0 using 1.0 M NaOH (Fisher Scientific, UK). 
TAE: Distilled water (750 ml) was used to dissolve 242g of Tris base (Severn 
Biotech ltd, England). Furthermore, the mixture contained 57.1ml of glacial acetic 
acid (20mM) (BDH, England) and 100ml of 0.5 M EDTA. Sterile distilled water was 
added to increase the volume to 1L, and the pH was adjusted at 8.5 using 1.0 M 
NaOH (Fisher Scientific, UK). 
Electrophoresis running buffer: TAE (6 ml) was used to dissolve 0.6g of Agarose 
(Molecular Grand) obtained from Bioline, UK and distilled water was added to 
increase the volume to 60 ml. Upon attaining a hazy appearance, the solution was 
introduced in the microwave and heated for no more than 3 minutes on medium heat. 
Afterwards it was gently mixed to avoid the formation of bubbles and when it 




became clear it was mixed with a solution of 3 µl of ethidium bromide obtained from 
Sigma, Germany. The solution was introduced into a horizontal tank containing 10 
ml of 50x TAE and distilled water was added to increase the volume to 500 ml. 
2.12.5. Analysis of the purified DNA on the gel 
DNA loading buffer (2 µl) (Bioline, UK) was added into 5 µl of purified DNA and 
mixed well by pipetting up and down before loading it into the gel. HyperLadder TM 
I is a molecular weight marker obtained from Bioline was loaded into gel. The gel 
was then run at 80 mV until the dye extended through the gel using runVIEW-B 
(Geneflow, UK). Then, the gel was visualised under gel imaging system (Gel DocTm 






3.1. Antimicrobial susceptibility testing      
                                                                  
The tests were carried out to assess in vitro the extent of the effect of antibiotics on 
planktonic cells of the wild-type of P.aeruginosa. A number of standard methods 
such as Broth Micro-Dilution, Agar Well Diffusion and innovative method 
(OxoPlate) were applied to evaluate the effect of the antibiotics tobramycin, 
amikacin and colistin against P. aeruginosa. Clinically, aminoglycoside antibiotics 
are considered to be an important group of antimicrobial agents. However, due to the 
limited therapeutic options, the use of colistin has received greatest attention in 
treating multidrug-resistant gram-negative bacteria (Lee et al., 2016). 
Aminoglycoside antibiotics are still used clinically in spite of their well-known 
toxicity due to their limited resistance development during treatment of infections 
(Loffhagen et al., 2004). The recent study showed that only 5.7%  of P.aeruginosa 
strains exhibited resistance against amikacin in the health care setting (Özyürek and 
Bilkay, 2015).  
3.1.1. Determination of MIC and MBC 
The OxoPlate reader was employed to determine MIC and MBC based on the 
oxygen depletion levels. The MIC represents the lowest concentration which exhibits 
visual discrepancies from the untreated positive control sample at any given point in 
the first 10 hours following drug treatment. This visual discrepancy is an increase in 
the oxygen curve which lasts longer than 15 minutes in contrast to the untreated 
control sample (Fig.9b). 
This is in sharp contrast to the MBC, whose equivalent to the lowest concentration 
induces an increase in the oxygen concentration as a result of the diffusion of 
atmospheric oxygen into the wells following cell death which indicates that the cells 
are no longer respiring and hence this represents the MBC (Fig.9a). Oxygen 
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depletion curves were generated for all the samples of bacterial culture treated with 
antibiotics. A connection between the MIC value and MBC that influences oxygen 
depletion in the OxoPlate was noticed in the case of all the antibiotics used. By 
plotting the oxygen concentration in relation to time, it is possible to obtain the 
lowest concentration of antibiotic that gave a MIC and MBC.  
In addition, a comparison was carried out between the MIC values obtained in the 
test and the established guidelines of the EUCAST, in order to verify the resistance 
or susceptibility of the organism. The lowest concentration of antibiotic that 
inhibited the visible growth of P.aeruginosa after 24h incubation at 37C˚ for 
amikacin was 1.25µg/ml (Fig.15A). The MIC value obtained, however was twofold 
lower than the conventional method (2.5 µg/ml) (Fig.16). According to the EUCAST 
guidelines, P.aeruginosa was considered a sensitive strain to the antibiotic tested. In 
the case of tobramycin and colistin, the MIC values were 0.25µg/ml and 0.5µg/ml 
respectively (Fig.15 B-C). The MIC value obtained was similar to traditional MIC 
values for colistin, whereas, tobramycin was twofold lower than the conventional 
method (0.5 µg/ml) (Fig.16).  
The lowest bactericidal concentration of tobramycin and colistin was >1μg/ml. both 
antibiotics proved to have highest activity against to P.aeruginosa, in contrast to the 
MBC of the antibiotic amikacin was found to be four folds higher than the MIC. 
This was clearly observed in the Fig.15 at concentration of 5 μg/ml, which did not 
reveal any indications of bacterial development after being left incubated for 72h at 
37ºC. It was thus possible to conclude that these concentrations inhibited the growth 
of P. aeruginosa during the exponential and stationary stages of the growth curve.  
Observations revealed that tobramycin and colistin displayed nearly identical 
spectrums of activity and had a considerable effect against P. aeruginosa, which 
indicated it to be more susceptible to tobramycin and colistin at a low concentration 
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3.1.2. Kinetics of growth inhibition  
The oxygen depletion curves provide information not only with regard to the MIC 
and MBC values, but also for the kinetics of bacterial growth inhibition. The 
antibiotics used have been proven to be particularly effective against the test strain. 
Figure15A shows that the presence of amikacin at 1.25-2.5 µg/ml resulted in a delay 
in oxygen depletion followed by a gradual decrease in the oxygen level in the wells 
to 0%. On the other hand, amikacin efficiently prevented bacterial development at ≥ 
5 µg/ml during the period of experiment. Tobramycin had a bactericidal effect on the 
wild-type, which showed a decrease in the amounts of oxygen at the beginning of the 
run, followed by a steady state of 100% pO2 when the cells had died at the 
concentrations of ≥1μg/ml. However, it showed a bacteriostatic effect at a 
concentration of 0.25-0.5μg/ml (Fig.15B). Based on the level of oxygen, colistin had 
a bacteriostatic effect on the strain at a concentration of 0.5µg/ml. However, no 
oxygen consumption was observed to occur when colistin was applied to 





















Figure 15: MIC and MBC of planktonic cells of P.aeruginosa treated with (A) amikacin; (B) 
tobramycin and (C) colistin at 37°C for 48h. It was assessed using a fluorescent plate reader, the 
lines represent the means of three replicates. Antibiotic concentrations have been indicated. The 
positive control presents an overnight culture of P.aeruginosa (untreated). The negative control 









Figure 16: Conventional assay of the MIC for colistin, tobramycin and amikacin against “wild 
type” P.aeruginosa at 37°C for 24h.  P.aeruginosa was tested for susceptibility at different 
concentrations ranges from 10-0.3µg/ml for amikacin and 8-0.25µg/ml for both colistin and 
tobramycin. The positive control represents an overnight culture of P.aeruginosa (untreated). The 
negative control represents an overnight culture injected with solution of sodium hypochlorite.  
 
3.1.3. Measurement of antimicrobial activity using agar well diffusion method 
A conventional bioassay method was employed in-vitro to ascertain the antibacterial 
activities of all three antibiotics on the bacterium P.aeruginosa. The results indicated 
that all three antibiotics had a pronounced effect on P.aeruginosa, generating 
extensive average zones of inhibition. These were identified by taking measurements 
of the zone diameter. For every antibiotic at each concentration, the test was carried 
out four times and the average values were recorded. According to the breakpoint 
interpretation by the EUCAST, P.aeruginosa was found to be active against three 
antibiotics.   
 
Figure 17, shows that P. aeruginosa was particularly susceptible to tobramycin and 
colistin, as indicated by the inhibition zone size.  Tobramycin at the concentration of 
10µg/ml showed a zone of inhibition of 19.25 mm and the zone size of inhibition 
exhibited by colistin was 20.25 mm at the concentration of 25µg/ml. However, 
amikacin at 30µg/ml showed intermediate performance since the size of the 
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Figure 17: Growth inhibition zones of the planktonic cells of P.aeruginosa using the agar well 
diffusion method. (A) Agar size of plugs for amikacin at 30μg/ml; (B) Agar size of plugs for colistin 
at 25μg/ml; (C) Agar size of plugs for tobramycin at 10μg/ml.  The Plates were incubated for 24 h at 
4°C, followed by incubation at 37°C for another 24h. The clear zones around the well are the degree 
of the activity of antibiotics to inhibit growth of bacterium. (D) The means of four replications of 

















C H A P T E R  3 .  R e s u l t s                                       74                                        
 
 
3.2. Effect of selected antibiotics on P.aeruginosa growth dynamics  
An automated plate reader called the SPECTRO star Nano was used in order to assess 
the growth response of wild-type of P.aeruginosa to a selection of antibiotics. The 
process of the automated cultivation based assay is a high throughput method and 
allows for on-line analysis of the bacteria that develop. Observing the OD during 
antibiotic treatment helps to obtain more detail in how bacterial cell populations 
behaved, the overall productivity of bacterial density during time of the experiment 
and the growth rate of the cell population. This method is important to perform 
because the activity of antimicrobial agents known to be influenced by the growth 
rate of microorganisms, which displayed diverse susceptibility to antibiotics 
depending on the different growth phases.  
 
The results of this analysis help to determine which antibiotic concentrations impact 
on the extent to which P.aeruginosa grows. The control culture that has not been 
exposed to an antibiotic indicates the natural development of P.aeruginosa. It is 
apparent that after a 4-hour cultivation period (lag phase) this control culture 
demonstrated a significant increase in the OD. The remaining cultivation period 
showed a subsequent decline in the OD levels. However, the concentration of the 
antibiotic was directly influenced the lag phase period. For example, colistin 
(concentration 0.5 μg/ mL) treated P.aeruginosa experienced a lag phase duration of 
11 h, whilst amikacin (1.25μg/mL) exposed to bacterial cells experienced a lag of 20 
hours. For the higher amikacin concentration 2.5 μg/mL, there was a delayed up to 
34 hours before the P.aeruginosa commenced growth. Thus the higher the 
concentration, the greater the lag phase. Furthermore, the duration of the lag phase in 
the culture exposed to tobramycin at a concentration of 0.25μg/mL was 10 hours 
whereas, a longer lag phase was observed of 26 hours in the presence of 0.5 μg/ mL 
of tobramycin. These findings are illustrated in Figure18. Based on these results, the 
detection of the bacterial growth inhibition treated with aminoglycoside antibiotics 
using the SPECTRO star Nano was not as high in terms of temporal resolution as the 
OxoPlate outputs.  
 
During the exponential phase, however, the final OD values of the P.aeruginosa 
treated with amikacin and colistin (inhibitory concentrations) were comparable with 
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that of the control culture which was devoid of any antibiotics (Fig. 18A&C). The 
remaining antibiotic, culture had significantly lower OD values than those of the 
control culture when cultures exposed to inhibitory concentrations (Fig.18 B). 
Within the logarithmic phase, the OD values of P.aeruginosa treated with colistin at 
sub-inhibitory concentrations was noticeably higher than that of the control 
antibiotic free culture. This indicates that colistin is capable of acting as a growth 
stimulant when administered at sub-inhibitory concentrations such as  
0.125-0.25 μg/mL (Fig.18C). After 18h, however, the OD values showed a gradual 
decreased in the colistin-exposed culture (sub-inhibitory concentrations) compared 
with control culture, which showed an extended period of the stationary phase. 
Furthermore, when the concentration of colistin was increased ≥1μg/mL, the treated 
culture becomes under stress and thus prevents the growth of P.aeruginosa entirely. 
For the remaining antibiotics that were tested, it is clear that treating P.aeruginosa 
with a high concentration affected the growth dynamic of cells.  
 
This finding brings in to question which factors can be meaningful in predicting how 
an antibiotic will affect microbial growth. The final OD value, the lag phase duration 
and the growth of P.aeruginosa were all affected through concentration of 
antibiotics either sub- inhibitory or inhibitory during the course of treatment. 
 
 




             
Figure 18: Effects of selected antibiotics on the growth dynamics of P.aeruginosa at 37°C. The 
individual data points represented in the above figure, over a 48 h period, reflect the progress of each 
of the cultures, which have been subsequently normalized by the control culture that was devoid of 
any antibiotic. In conjunction with a negative control culture represents growth medium- lacking 
bacterial cells. A range of antibacterial concentrations were tested to determine P.aeruginosa’s 
susceptibility. These concentrations ranged from 10-0.3µg/ml for amikacin (A) and 8-0.25µg/ml for 
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3.3. Environmental Factors  
 
A range of environmental cues can affect the outcome of susceptibility testing, 
including the size of the bacterial inoculum, the chosen culture media and their pH, 
as well as incubation length and temperature (Gilbert et al., 1971).  
 
3.3.1. The effect of temperature on the antimicrobial susceptibility of PA01  
 
The classical antimicrobial techniques have been usually used to determine the 
activity of antibiotics by observing the growth inhibition of the test organisms. Thus, 
the in vitro susceptibility testing has to be reliable in order for the antibiotics to be 
used rationally. In this study, the antimicrobial activity of the antibiotics was 
determined under a range of temperatures using standard and innovative methods. 
The OxoPlate method was used in order to assess the antimicrobial action based on 
the oxygen depletion levels. The growth inhibition was also determined in 
conjunction with the MIC. To determine the inhibition that the antibiotics caused to 
the growth of P.aeruginosa, the treated cultures were compared against the untreated 
culture (control). The MIC and MBC values obtained by method of OxoPate for the 
three antibiotics against the strain PA01 is shown Fig.19, 20 &21. Figures 15 and19 
show that, a considerable difference in the susceptibility to amikacin was observed at 
the different incubation temperatures 42°C, 37°C and 30°C. At 42°C, PA01 became 
more sensitive to amikacin, which exhibited a 4- fold decreased in the MIC value 
compared with those obtained at 25°C or 30°C. A similar result for the MIC value 
(2.5g/ml) was obtained at both temperatures 25°C and 30°C, in spite of the 
different incubation temperatures of amikacin. However, when the bacterial culture 
was incubated for another 24h the activity of amikacin at 10 g/ml switched from 
bactericidal to bacteriostatic when incubation temperature was decreased from 30°C 
to 25°C. Through the use of the E-test (Fig. 22), the presence of surviving colonies 
was indicated in association with an amikacin at 25°C.  It has been suggested that the 
surviving colonies may represent persistent bacterial cells that respond 
heterogeneously to the action of the antimicrobial agent.  
 
The activity of tobramycin remained the same (no change in the MIC value) when 
incubated at the temperature of 42°C compared with control sample. Tobramycin 
however, had the ability to inhibit the growth of PA01 for a long period when 
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incubated at 42°C compared with control sample at optimum temperature Fig.15B 
and 20. The length of the antibiotic action was diminished from11h to 6h when the 
temperature decreased from 42°C to 37°C in which bacteria were treated with 
0.25µg/ml of tobramycin. From this analysis (Fig.21), the OxoPlate results showed 
that at a temperature of 25°C and 30oC there was no observable change in the MIC 
value of colistin to PA01 compared to control culture at optimum incubation 
temperature (37°C). At these temperatures, however the activity of colistin was 
determined through detecting the time taken to observe the initial decrease in oxygen 
(time to detect). For colistin the time to detect was delayed for 19h at 37°C while at 
25 °C and 30 °C the time to detect was shortened to 8h and 14h respectively. 
 
The MBC value for amikacin showed a decrease when the temperature was 
increased from 20 µg/ml at 25 °C to 2.5 µg/ml at 42oC. Decreasing the temperature 
to 25oC during incubation with colistin led to an increase in the MBC value to 
2µg/ml compared with the control sample at 37°C. However, the reduction of the 
MBC value (0.5 µg/ml) was enhanced at 42°C for colistin. The result showed that a 
notable difference was exhibited by the action of tobramycin; at the low incubation 
temperatures (25°C and 30°C). Tobramycin exhibited the same MBC (2µg/ml) and 
there was no observable change. In addition, at the high temperatures (37°C and 
42°C), tobramycin also displayed identical MBC values (1µg/ml) for both 
temperatures. It was observed that, in comparison to the MBC of colistin and 
tobramycin, amikacin MBC values were more affected by temperature.  
 
 

















Figure 19: Effect of temperatures on the susceptibility of amikacin against PA01. It was assessed 
based on the depletion of the oxygen using the OxoPlate OP96U.  The lines represent the means of 
three replicates. Antibiotic concentrations have been indicated. The positive control presents an 
overnight culture of P.aeruginosa (untreated). The negative control represents an overnight culture 
injected with solution of sodium hypochlorite (10% v/v). The MIC represents the lowest 
concentration that exhibits visual discrepancies from the untreated positive control sample at any 
given point in the first 10 hours following drug treatment. The MBC, which is the equivalent to the 













Figure 20: Effect of temperatures on the susceptibility of tobramycin against PA01. It was 
assessed based on the depletion of the oxygen using the OxoPlate OP96U.  The lines represent the 
means of three replicates. Antibiotic concentrations have been indicated. The positive control presents 
an overnight culture of P.aeruginosa (untreated). The negative control represents an overnight culture 
injected with solution of sodium hypochlorite (10% v/v). The MIC represents the lowest 
concentration that exhibits visual discrepancies from the untreated positive control sample at any 
given point in the first 10 hours following drug treatment. The MBC, which is the equivalent to the 













Figure 21: Effect of temperatures on the susceptibility of colistin against PA01. It was assessed 
based on the depletion of the oxygen using the OxoPlate OP96U.  The lines represent the means of 
three replicates. Antibiotic concentrations have been indicated. The positive control presents an 
overnight culture of P.aeruginosa (untreated). The negative control represents an overnight culture 
injected with solution of sodium hypochlorite (10% v/v). The MIC represents the lowest 
concentration that exhibits visual discrepancies from the untreated positive control sample at any 
given point in the first 10 hours following drug treatment. The MBC, which is the equivalent to the 
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The distribution of the MICs by the Agar Well Diffusion and the E-test of the three 
antibiotics for PA01 is shown in Table 3. The MIC values obtained by the E-test and 
Agar Well Diffusion were higher than the OxoPlate’s MICs except the MIC obtained 
by E-test at 42°C. However, the E-test showed that test organism was strongly 
influenced by temperature. The MIC values of colistin declined as the temperature 
increased, from 1g at 25°C to 0.01g at 42°C (Fig.22). Yet again, the E-test MIC 
values for amikacin increased with a decrease in the incubation temperature, from 
0.12g at 42°C to 4g at 25°C (Fig.22). The results obtained from the Agar Well 
Diffusion method showed that at a temperature of 30°C and 37oC there was no 
observable change in the MIC value for all antibiotics tested (Table 3). However, 
when the temperature was increased from 25°C to 42°C, the MIC of colistin showed 
a decrease from 8 µg/ml to 2 µg/ml. The activity of tobramycin became less when 
temperature decreased to 25oC.  
 
Table 3: The MICs values of antibiotics over a rage of temperatures against P.aeruginosa using 
the Agar Well Diffusion and the E-test  












               MIC (g) MIC (g/ml) 
37°C 
Con. 
25°C 30°C 42°C 37°C 
Con. 
25°C 30°C 42°C 
AM 1 4 2 0.12 10 10 10 5 
TM 0.38 1 0.5 0.32 2 8 2 2 
CO 0.5 1 0.75 0.01 4 8 4 2 
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Figure 22: The MIC of amikacin (AK), colistin (CO) and tobramycin (TM) generated by E-test. 
The MIC determined after 24h at different incubation temperature. It was measured based on a point 
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3.3.2. The relationship between the growth rate of P.aeruginosa and incubation 
temperature 
 
An automated 96-well microtiter plate assay (SPECTRO star Nano) was used to 
monitor the effect of temperature on the growth dynamics of P.aeruginosa. The 
growth rate curves of P.aeruginosa versus temperature are shown in Fig. 23. The 
temperature was in the range from 25°C to 42°C. The impact of the temperature on 
the rate of bacterial growth over 24-h incubation became evident, when the growth 
dynamics was examined in real time using the automated assay. Figure 23 shows 
that cultures exposed to low temperature exhibited a longer lag phase compared with 
other cultures.  The growth rate was measured using the following equation  
                                              µ=In Nt-In N0/t   (12).  
µ: represents the specific growth rate, Nt: represents the final optical density value during the log phase, N0: 
represents the initial value of bacterial density and t: represents time.   
The growth rate of bacterial cells was increased as the temperature increased 
(Fig.23). At 25oC, bacterial population exhibited lower overall productivity 
compared to the other cultures. Thus, temperture had a significant effect in the final 
OD value, lag phase duration and specific growth rate of P.aeruginosa.   
 
Figure 23: Effect of incubation temperature on the growth of P.aeruginosa using the SPECTRO 
star Nano. (A) The growth rate of tested bacterium. It was assessed based on ΔOD at 600 nm. The 
lines represent the mean of three replicates. The growth rate of P.aeruginosa at different incubation 
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3.3.3. The effect of divalent cations in a defined synthetic medium on the 
antimicrobial susceptibility of PA01  
 
Divalent cations are known to influence the measurement of MBC values when 
studying the effects of aminoglycoside antibiotics and colistin on gram negative 
bacteria. In this study we have used a defined synthetic medium and investigated the 
effect of the levels of Ca2+ and Mg2+ on the metabolism of P.aeruginosa in the 
presence of bactericidal concentrations using an OxoPlate system. 
3.3.3.1.Deducing the MBC from OxoPlate measurements 
The MBC was determined using the OxoPlate reader on the basis of levels of oxygen 
depletion. The minimum antibiotic concentration reflecting the MBC was attained by 
plotting the oxygen concentration alongside time. The MBC was determined based 
on the re-introduction of atmospheric oxygen into the well once the cells had died, 
which caused the MBC correspondent to the minimum concentration to trigger a rise 
in the oxygen concentration. Every bacterial culture sample that antibiotics were 
applied to was characterised by an oxygen depletion curve. Figure 24 indicates the 
MBCs of the strain that was tested. Amikacin had an MBC of 2.5µg/ ml, whereas 
tobramycin had an MBC of 0.5µg/ ml. Colistin had a bactericidal effect on PA01 at a 













           
Figure 24:  The MBC of classes of antimicrobial agents in a defined synthetic medium against 
P.aeruginosa. The oxygen consumption of an overnight culture of planktonic cells of P.aeruginosa 
treated with amikacin, tobramycin and colistins using a fluorescent plate reader incubated at 30°C for 
72 h. Antibiotic concentrations have been indicated. The MBC represents the lowest concentration 
that induces an increase in the oxygen concentration as a result of oxygen diffusion back into the 
wells following cell death. In contrast to the untreated positive control sample, the negative control 
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3.3.3.2.Effect of different divalent cation individually on the susceptibility of P. 
aeruginosa to antibiotics 
The effect of the various concentrations of Mg2+or Ca2+ on the susceptibility of 
P.aeruginosa to lethal doses of the antibiotics is shown in Figures 25 and 26. The 
level of kinetics of bacterial growth suppression is represented by the oxygen curves. 
A decline in these curves over a short time indicated accelerated cell growth, 
promoted by the higher concentration of ions. P.aeruginosa showed a change in the 
growth inhibition when the concentration of Ca2+ or Mg2+ was increased. The 
consumption of oxygen was observed immediately at a high cation concentration 
whereas; oxygen consumption occurred at a slower rate at low cation concentrations. 
 
No oxygen consumption was observed to occur when a bactericidal dose of 
aminoglycoside and colistin was applied to P.aeruginosa in the absence of divalent 
cations. The study results corroborate that, in comparison to tobramycin and colistin, 
amikacin had a weaker effect on P. aeruginosa when Mg2+were individually added 
in defined medium. The action of amikacin was gradually obliterated, shown by a 
decline in the duration of oxygen depletion as the concentration of Ca2+ or Mg2+ 
were increased from 2 to 5mM. For tobramycin at concentration of Mg2+ up to 3mM 
no oxygen consumption was detected. The susceptibility of P. aeruginosa to the 
action of colistin was low in medium that contained Ca2+ ranging from 1mM to 
5mM, which showed a large change in the period of growth inhibition. Even at a low 
concentration of Ca2+, the level of the oxygen was reduced following a period of 
incubation of 56 h in the presence of colistin (Fig. 26). Ca2+ was found to provide 
greater protection to bacterial cells over that provided by Mg2+.  





Figure 25: The effect of various concentrations of Mg2+ on PA01 treated with amikacin at 2.5µg/ 
ml, tobramycin at 0.5µg/ ml and colistin at 2µg/ ml. The amount of dissolved oxygen was followed 
over 72h. The time represents the initial decrease of oxygen level “time to detect”. The values shown 
are the means of three replicates. Note: Where time to detect values is shown as 72 h this indicates 
that no oxygen consumption was detected in the duration of the experiment. 
 
Figure 26: The effect of various concentrations of Ca2+ on PA01 treated with amikacin at 2.5µg/ 
ml, tobramycin at 0.5µg/ ml and colistin at 2µg/ ml. The amount of dissolved oxygen was followed 
over 72h. The time represents the initial decrease of oxygen level “time to detect”. The values shown 
are the means of three replicates. Note: Where time to detect values is shown as 72 h this indicates 
that no oxygen consumption was detected in the duration of the experiment. 
C H A P T E R  3 .  R e s u l t s                                       90                                        
 
 
3.3.3.3.Effect of Mg2+ in combination with Ca2+ on the in-vitro susceptibility of 
P. aeruginosa to antibiotics 
 
The impact of combining Mg2+ and Ca2+ on the in vitro action of amikacin, 
tobramycin and colistin on P. aeruginosa was also investigated using the OxoPlate 
reader, which was based on the depletion of dissolved oxygen (see Fig. 27, 28 and 
29). It was observed that the combined concentrations of Mg2+ and Ca2+ had greater 
influence on the effect of amikacin than that of tobramycin. The development of P. 
aeruginosa was suppressed by tobramycin for a long period time when 1mM of Ca2+ 
was added in the defined medium in the presence of increasing concentrations of 
Mg2+. The duration of dissolved oxygen declined when the Mg2+ concentration was 
increased, from 72 h at 1mM to 21 h at 5mM (see Figure 28). In contrast, the in vitro 
efficacy of amikacin against PA01 was reduced by the combined effects of Ca2+ and 
Mg2+supplementation. Figure 27 shows that the period of growth inhibition declined 
when it was in the presence of a bactericidal concentration of amikacin at increasing 
concentrations of Mg2+ combined with a constant concentration of Ca2+ (1mM), from 
34 h at 1mM to 12 h at 5mM. The bacterial cells treated with colistin showed that the 
addition of ≤ 3mM Mg2+ in the presence of low concentrations of Ca2+ (1-2mM) 
resulted in a short period of the growth inhibition (Figure 29).    
The protection of bacterial cells against the action of antibiotics, provided by 
divalent cations, was evident. High concentrations of Ca2+ provided a greater level of 
protection when it was combined with Mg2+. The bactericidal activity of colistin was 
sharply reduced when 5mM of Ca2+ were combined with Mg2+ (5mM) (Figure 29). 
The oxygen consumption was detected following a period of incubation of 5 h. 
Figure 25 shows that when the medium was treated with tobramycin in the presence 
of Mg2+ concentrations, ranging from 1 to 3mM, no oxygen consumption occurred. 
This effect was seen in the medium where calcium was absent. The results show that 
the effects of Mg2+ were removed when combined with Ca2+ (5mM) in the presence 
of tobramycin. P. aeruginosa’s susceptibility to tobramycin was constantly 
responded to by the addition of 5mM of Ca2+ combined with Mg2+concentrations of 
between 1 and 5mM. The oxygen consumption was detected following a period of 
incubation of 14 h (see Figure 28). The bactericidal activity of amikacin was 
progressively reduced when concentrations of 4 or 5mM of Ca2+ were added 
alongside increased concentrations of Mg2+ (see Figure 27).  




Figure 27: Effect of combinations of Mg2+ and Ca2+ on the rate of dissolved oxygen depletion in 
culture medium treated with amikacin at 2.5µg/ ml . The time represents the “time to detect” the 
start of oxygen depletion. The values shown are the means of two replicates and the vertical bars 













Figure 28: Effect of combinations of Mg2+ and Ca2+ on the rate of dissolved oxygen depletion in 
culture medium treated with tobramycin at 0.5µg/ ml. The time represents the “time to detect” the 
start of oxygen depletion. The values shown are the means of two replicates and the vertical bars 
represent the standard errors of the values. 
 
 




Figure 29: Effect of combinations of Mg2+ and Ca2+ on the rate of dissolved oxygen depletion in 
culture medium treated with colistin at 2µg/ ml. The time represents the “time to detect” the start 
of oxygen depletion. The values shown are the means of two replicates and the vertical bars represent 
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3.3.4. Influence of divalent cations on the growth of P.aeruginosa 
 
Divalent cations are well known ions that influence a number of fundamental 
processes in bacteria. In this study a defined synthetic medium was used to 
investigate the effect of Ca
2+
and Mg
2+ in the presence of antibiotics on the growth 
kinetics of P. aeruginosa using the SPECTRO star Nano system.   
3.3.4.1.Response of P.aeruginosa to Ca2+ and Mg2+ when individually added into 
defined medium containing antibiotics 
 
Effects of Ca2+ concentrations: Based on the growth of P.aeruginosa, the activity 
of all antibiotics used was clearly affected by the concentrations of Ca2+ (Fig. 30).  
Based on ΔOD at 600 nm during the time of the experiment, growth was clearly 
inhibited when Ca2+ (1-5 mM) was individually added in the cultures lacking 
antibiotic (Fig.30.A). The growth curves show that in comparison to colistin, 
aminoglycoside agents had a higher OD values when Ca
2+ was individually added in 
the defined medium. The bacterial density reached 0.72, 0.69 and 0.56 when the 
cultures were treated with amikacin supplemented with Ca2+ at a concentration of 3, 
4 and 5mM respectively (Fig.30 B). In the case of colistin, however the OD of the 
cells was reduced when the Ca2+ concentration was increased, from 0.51 at 3mM to 
0.39 at 5mM (Fig.30.D). The study indicated that as Ca2+ concentration increased, 
bacterial densities were decreased. Within the logarithmic phase, the growth 
dynamic of P.aeruginosa treated with colistin in the presence of 1mM of Ca2+ had 
higher OD values than culture exposed to ≥ 2mM of Ca2+.  
 
To investigate the effect of divalent cations on the growth rate of P.aeruginosa, Eq. 
12 was taken into account. The results of the influence of Ca2+ on the growth (µ) of 
P.aeruginosa presents in Table 4. The data indicated that the presence of Ca2+ ions 
in the antibiotic free medium caused a gradual decreased in the growth rates.  The 
addition of increasing concentrations of Ca2+ from 3 to 5mM showed a large 
difference on the growth rates of bacterial cultures exposed to antibiotics compared 
with the control cultures. The growth rates show that in comparison to colistin and 
tobramycin, amikacin had a faster growth rates when Ca2+ was individually added in 
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the defined medium. Based on the growth rate of P.aeruginosa, the culture treated 
with amikacin in the presence of 3mM of Ca2+exhibited an increase in the growth 







Effects of Mg2+ concentrations: Based on the growth curves (Fig.30), Mg2+ had a 
strong effect on the cells of P.aeruginosa when it was individually added in the 
antibiotic free medium, which resulted in a 6-fold increase in the OD values 
compared with Ca2+.  Observations revealed that the addition of divalent cations 
inhibited the activity of antibiotics used but the inhibition potency of Ca2+ was 
higher than that of Mg2+. With Mg2+ as the concentration was increased final 
bacterial densities also increased. This was observed in all stages of growth when the 
bacterial culture treated with amikacin in the presence of different concentrations of 
Mg2+ (Fig. 30.B). For the remaining two antibiotics, cultures had lower final OD 
values when cultures were exposed to high concentrations of Mg2+ compared with 
amikacin.  For tobramycin, the culture of bacterial cells reached a lower OD value 
when 5mM of Mg2+ was added individually into defined synthetic medium 
compared with lower concentrations (Fig.30. C).  However, a lowering of Mg2+ 
concentration to 2mM resulted in an increase in the cell density when the culture was 
treated with colistin (Fig.30. D).  
The effect of Mg2+ concentrations on the growth rate of P.aeruginosa is shown in 
Table 5. The presence of Mg2+ ions in the synthetic medium treated with colistin 
caused a decrease in the specific growth rates as the concentrations of Mg2+ 
increased from 0.12h-1 at 3mM to 0.08h-1 at 5mM. However, addition of Mg2+ 
(2mM) resulted in an increase in the growth of P.aeruginosa when the bacterial 
Table 4: Effect of Ca2+ concentrations on the growth rate of P.aeruginosa  
Antibiotic concentration ug/ml shown in parenthesis and growth rate (u) h-1 
 
Ca2+ 
Control Amikacin  
    (2.5) 
Tobramycin  
      (0.5) 
Colistin 
 (2) 
0mM 0.02 _ _ _ 
1mM 0.06 _ _ 0.07 
2mM 0.06 _ _ 0.06 
3mM 0.03 0.14 0.11 0.07 
4mM 0.03 0.09 0.06 0.07 
5mM 0.02 0.09 0.04 0.03 
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culture was treated with colistin. The addition of increasing concentrations of Mg2+ 
did not show a significant difference on the growth rate of bacterial cultures exposed 




























Table 5: Effect of Mg2+ concentrations on the growth rate of P.aeruginosa  









0mM 0.021 _ _ _ 
1mM 0.13 _ _ _ 
2mM 0.14 0.11 _ 0.17 
3mM 0.14 0.11 _ 0.12 
4mM 0.14 0.14 0.15 0.09 
5mM 0.13 0.11 0.15 0.08 
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Figure 30: Effect of Mg2+ and Ca2+ when individually added into defined medium on the growth 
of PA01. The concentrations of Mg2+ and Ca2+ supplemented were from 1mM to 5mM. The bacterial 
cultures incubated at 30ºC for 72h without antibiotics (control) (A), with bactericidal concentrations 
of 2.5ug/ml of amikacin (B), 0.5ug/ml of tobramycin (C), and 2ug/ml of colistin (D). The values 
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3.3.4.2.Influence of combinations of Ca2+ and Mg2+on the response of 
P.aeruginosa  
Our early study confirmed that the bacterial densities were dramatically inhibited by 
increasing concentrations of Ca2+ compared with Mg2+ (Fig.30 A). Those densities 
however; had significantly increased when Mg2+ was added into the defined synthetic 
medium with supplementation of Ca2+. This result was observed in the medium 
lacking antibiotic (Fig.31). The impact of combining Mg2+ and Ca2+ on the behaviour 
of P.aeruginosa in the presence of antibiotics was also investigated using the 
SPECTRO star Nano system (Fig. 32). As a result of this experiment, the growth of 
P.aeruginosa exhibited an increase in the final cell densities when the Mg2+ added 
into defined synthetic medium treated with aminoglycoside agents and colistin in the 
presence of Ca2+. The result indicates that the final optical densities had significantly 
increased to double the value when Mg2+ was added into the defined synthetic 
medium with supplementation of low concentration of Ca2+ (1mM) when the cells 
were treated with colistin. What does appear from this result is that increasing 
concentrations of Mg 2+ resulted in higher final optical densities suggesting growth 
stimulation by this ion in the presence of 1mM of Ca2+. The combination of 1mM of 
Ca2+ with low concentrations of Mg2+ (1mM) resulted in an increase in the cells 
density to the highest value (from 0.6 to1.09) when cells were treated with amikacin.  
Yet again the final densities of bacterial cells treated with tobramycin or amikacin 
showed that the addition of ≥ 2mM Mg2+ in the presence of low concentrations of 
Ca2+ (1-2mM) slightly increased in the optical density values compared with the 
control cultures (Fig.31 & 32). However, the combination of 5 mM of Ca2+ and ≥ 
1mM of Mg2+ gradually exhibited a reduction of the final bacterial density from 0.8 
to 0.6. What does appear from these results is that increasing concentrations of Ca 2+ 
resulted in lower final optical densities suggesting growth inhibition by this ion in 
the presence of Mg2+. This result was observed when the medium treated with 










   
 
 
Figure 31: Control cultures of the effect of various concentration of Ca2+ combined with a 
constant concentration of Mg2+ A. 1mM, B. 2mM, C. 3mM, D. 4mM and E. 5mM on the growth 
of PA01 at 600nm. The bacterial cultures incubated at 30Co for 72h in the absence of antibiotics.The 



















Figure 32: Effect of various concentration of Ca2+ combined with a constant concentration of 
Mg2+ A. 1mM, B. 2mM, C. 3mM, D. 4mM and E. 5mM on the growth of PA01 at 600nm. The 
bacterial cultures incubated at 30Co for 72h with 2.5 ug/ml of amikacin, 0.5 ug/ml of tobramycin, and 
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3.3.5. Effect of inoculum size on the susceptibility of antibiotics against 
P.aeruginosa 
 
To assess the effect of three antibiotics used on the bacterium at different inoculum 
sizes, experiments were run using 96-well microtiter plate (OxoPlate) inoculated 
with high and low inoculum sizes. The effect of inoculum size on the activity of 
tobramycin is shown in Fig. 33. The results indicate that at the high inoculated size 
(6x108 cfu/ml); the ability of tobramycin to suppress the growth of P. aeruginosa 
was considerably reduced. The oxygen concentration decreased in the presence of 
tobramycin at 8μg/ml, due to the high metabolic activity of the high inoculum size of 
P.aeruginosa. The MIC and MBC value of the high inoculum (6x108 cfu/ml) was 
4μg/ml and 8μg/ml respectively. P.aeruginosa displayed similar MIC and MBC 
value when initial inoculum size was diluted two-fold. Based on the MIC value, 
tobramycin was more active against P.aeruginosa when the culture was inoculated 
with 1.5x108 cfm/ml, but the MBC value had no further effect at this inoculum size, 
when compared with the inocula of 6x108 and 3x108 cfu/ml. The activity of 
tobramycin to suppress the growth of P.aeruginosa gradually increased when the 
inoculum size was further diluted. This result was observed when inoculum size was 
decreased to1.9x106 cfu/ml and the bacterial growth was inhibited at a lower 
concentration of tobramycin (1μg/ml). However, tobramycin efficiently inhibited 
bacterial development at the low inoculum sizes of 2.3x105 and 1.2x105 cfu/ml. As a 
result of this the MIC value was reduced eightfold (0.25μg/ml) and MBC value also 
reduced 4-fold (2μg/ml). 




Figure 33: Inoculum effect on MIC and MBC of tobramycin. Planktonic cells of P.aeruginosa 
were treated with tobramycin at different concentrations from 16-0.25µg/ml and incubated at 30°C 
for 48 h using Oxo Plate reader. The test bacterium was used at various inoculum sizes from 6x108 
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The effect of inoculum sizes on the antimicrobial activity of amikacin was also 
determined.  The data given in the Figure 34 revealed that when the inoculum size 
increased from 1.5x108 cfu/ml to 6x108 cfu/ml, the activity of amikacin exhibited an 
increase in the MIC to 5µg/ml and the MBC to >10µg/ml. Based on the MIC results, 
the activity of amikacin was the same at the inoculum of 1.5x108 cfu/ml and 7.5x107 
cfu/ml. As shown in Fig. 34, amikacin exhibited greater activity against 
P.aeruginosa, which inhibited the bacterial growth at 2.5µg/ml compared with initial 
inoculum size. Cultures treated with amikacin inoculated with (3.8x106 cfu/ml-
9.4x105 cfu/ml), resulted in significantly decreased in the MIC and MBC to 0.6 and 
2.5µg/ml respectively. This reduction was further observed in the low inoculum 
sizes (4.7x105, 2.3x105 and 1.2x105cfu/ml.), where the sensitivity of P.aeruginosa to 
amikacin was strongly increased (MIC 0.3µg/ml and MBC 1.25µg/ml) compared 
with high inoculum size.  
 
Figure 34: Inoculum effect on MIC and MBC of amikacin. Planktonic cells of P.aeruginosa were 
treated with amikacin at different concentrations from 10-0.31µg/ml and incubated at 30°C for 48 h 
using OxoPlate reader. The test bacterium was used at various inoculum sizes from 6x108 cfu/ml to 
1.2x105 cfu/ml .  
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In the high inoculum size ≥ 1.5x108 cfu/ml, there was no marked difference in the 
MIC values (0.5µg/ml) and this was observed when cultures were treated with 
colistin. For those inocula, however the MBC values showed a gradual decrease as 
the inoculum size was lowered from 4µg/ml at 6x108 cfu/ml to 1 µg/ml at 1.5x108 
cfu/ml (Fig. 35). Decreasing inoculum size ranging between (7.5x107 cfu/ml – 
1.9x106 cfu/ml) and (9.4x105 cfu/ml-1.2x105cfu/ml) resulted in identical MBCs, in 
spite of difference in MICs. At ≤ 2.3x105 cfu/ml, the MIC and MBC of this 
experiment were 0.03 and 0.5µg/ml respectively. Based on the susceptibility test, the 
antibacterial activity of colistin was significantly higher (Fig.35) than 
aminoglycoside agents (Fig.33 and 34) against P.aeruginosa. As can be seen in the 
Fig. 33, 34 and 35, the novel assay based on the OxoPlate system indicates that 
suppression of growth following treatment with three antibiotics was found to be less 
marked with high inoculum of P. aeruginosa.  
 
Figure 35: Inoculum effect on MIC and MBC of colistin. Planktonic cells of P.aeruginosa culture 
treated with colistin at different concentrations ranges from 16-0.031µg/ml incubated at 30°C for 48 h 
using OxoPlate reader. The test bacterium was used at various inoculum sizes from 6x108 cfu/ml to 
1.2x105 cfu/ml .  
. 
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3.3.6. Impact of inoculum size on the duration of lag phase of P.aeruginosa  
To assess the effect of different inocula on the duration of lag phase, experiments 
were conducted using the SPECTRO star Nano system. Based on the OD obtained by 
this method, the duration of lag phase was influenced by the inocula. Figure 36 
shows the effect of inoculum sizes on the duration of the lag phase. The results 
demonstrated that the duration of lag phase was gradually increased as the size of 
inoculum was decreased. Decreasing the inoculum size from 6x108 cfu/ml to 1.2x105 
cfu/ml resulted in an extended lag phase from 2 to 8h. 
 
Figure 36: Effect of inoculum size on the duration of lag phase of P.aeruginosa. Planktonic cells 
of P.aeruginosa culture incubated at 30°C for 20 h using the SPECTRO star Nano. The test bacterium 
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3.4. The influence of prolonged exposure of sub-inhibitory 
concentrations of amikacin in glucose limited chemostat 
cultures of P.aeruginosa  
3.4.1. Determination of nutrient limited growth 
The limiting nutrient can be determined, once the final density of the bacterial cell is 
a linear function of the initial concentration of selected the nutrient. A chemostat in 
which glucose is the limiting nutrient is defined as ‘glucose-limited’ Glucose and 
sodium nitrate were used as a carbon and a nitrogen source respectively in this 
experiment. From statistically analysis (SPPS, v.21), there was a significant 
correlation between the concentration of glucose and the bacterial cells density over 
the range 5-20mM (P <0.01) (see appx. Table E.1). This correlation is considered to 
be a positive. Similarly, based on the R2 value obtained, the values were linear. As 
shown in Fig. 37, the optical density of bacteria was dependent on the concentration 
of glucose at these ranges, which showed a straight proportionality. At a 
concentration of 25mM of glucose there was a slight increase in the optical density. 
However, increased concentration of glucose from 30-50mM resulted on the growth 
of bacterial cells was significantly inhibited over the time of experiment. The half-
sturation constant (Ks) for glucose uptake was 0.5g/l (see appx. Fig.E.1)  
 
 In the nitrate limitation study, at a low concentration of nitrate, there was a 
significant relationship between optical density and concentration of nitrate (P 
<0.01). The concentration of nitrate ranged from 1-5mM showed a well-fitting 
regression line (R2=0.96) (Appx. Table E.2). When the concentration of nitrate was 
increased above 5mM, the final bacterial cells density steadily decreased, 
demonstrating that bacterial growth was inhibited by such high concentrations (Fig. 
38).  




Figure 37: Determination of glucose-limited growth. Different concentrations of glucose were 
prepared in a series of cultures ranging from 5 to 50mM. The concentration of sodium nitrate was 
initially used in the medium at 10mM. The values shown are the means of two replicates and the 
vertical bars represent the standard errors of the values.  
 
Figure 38: Determination of nitrate-limited growth. Different concentrations of sodium nitrate 
were prepared in a series of cultures ranging from 1 to 20 mM. The concentration of glucose was 
initially used in the medium at 10mM. The values shown are the means of two replicates and the 
vertical bars represent the standard errors of the values.  
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3.4.2. The growth behaviour of P.aeruginosa in the batch culture:  
The P.aeruginosa culture was initially grown as a batch culture and the results of the 
fermentation profile of bacterial cell growth and oxygen consumption are illustrated 
in Fig. 39. During the batch culture, P.aeruginosa entered a logarithmic phase after 
4h cultivation. During this phase, the concentration of biomass gradually increased 
along with a decrease in the dissolved oxygen concentration over the period (4-9h). 
Based on these results, oxygen was completely depleted at 9h when bacterial 
biomass reached 0.5 Buglab units. Interestingly the majority of the biomass accretion 
occurred over periods (9-15h) where the dissolved oxygen level was at 0%. During 
this period, a sharp slope was observed during a second biomass accretion phase.  
From cell mass data obtained, two growth rates were observed when bacteria were 
growing exponentially. For cells grown in the presence of oxygen, the growth rate 
was found to be 0.26h-1. However, the rate of bacterial growth of the second biomass 
phase of which was associated with oxygen limitation; was increased to 0.36h-1. This 
was followed by a stationary phase, where the concentration of dissolved oxygen 
gradually increased to 100% and bacterial mass remained fairly constant (15-19h).   
 
Figure 39: Batch culture of P.aeruginosa. During the process of growth, dissolved oxygen and 
biomass showed a significant change in its levels. The values shown are the means of two 
independent experiments and the vertical bars represent the standard errors of the values. pH of the 
fermentation was controlled throughout at pH 7.2. 
Time(h) 
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3.4.3. A glucose-limited chemostat culture of P.aeruginosa 
After the exponential growth phase was entered, the feed pump was activated to 
permit a constant flow of fresh medium into the vessel. For all subsequent 
experiments, the growth rate of the organism in the chemostat was regulated by the 
flow rate of the incoming medium. A steady state was deemed to be reached when 
the biomass levels stayed constant as evidenced from the Buglab output. Different 
dilution rates (D) were controlled (from the slowest to the fastest) as following 
0.025h-1, 0.06 h-1, 0.099 h-1 and 0.125 h-1 under a glucose limited chemostat culture 
(Fig.40 and 42). Glucose was measured off-line and found to be zero during the 
steady state (Appx. F. Table F.1).  During initial feeding, the viability of bacterial 
cells grown in the absence of amikacin exhibited 100% of live cells (Fig.41A).   
 
After 5 to 10 generations, cultures were exposed to amikacin by introducing the 
antibiotic into the feed reservoir at the concentrations indicated. The growth rate of 
P.aeruginosa was initially controlled using slow dilution rates D= 0.025h-1 and 
0.06h-1. The bacterial cultures were maintained over 72 generations; introducing sub-
MIC concentrations of antibiotic at day 7. The MIC of amikacin against 
P.aeruginosa was previously measured during batch fermentation using MHB  
(1.25 ug/ml) (Appx. Fig.E.3). The MIC of bacterial cells in chemostat medium 
before antibiotic introduced was 5ug/ml (Appx. Fig.F.1). In the culture grown at 
0.025h-1, the level of biomass was slightly decreased for nearly10 h after initial 
exposed to amikacin (0.625µg/ml) as evidenced from the BugLab output (Fig.40-
arrow A). It was immediately linked to a decrease in the bacterial cells number from 
4.9 to 4.5 log10 cfu/ml. After 24h treatment, the bacterial mass stopped decreasing 
and remained constant at this level as evidenced from the BugLab monitor. Over the 
first 4 days of treatment, the cell population started to became less susceptibility to 
amikacin as evidenced from OxoPlate data output, which showed an increase in the 
MBC value. After 4 days exposure, the MIC value was increased 4-fold (Appx.F.2). 
After this point, the MIC values remained constant.  
 
When the dilution rate increased to 0.06h-1, the culture appeared to be more sensitive 
to antibiotic action compared with culture exposed to the same concentration (0.625 
µg/ml) at low dilution rate (0.025h-1) (Fig.40 arrow B). This was evident from the 
BugLab data and viability of cells, which showed a decrease in the biomass level 
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(Fig.40 arrow B) and the cells viability (Fig. 41C) following a recovery (816h) (Fig. 
41D).  At this concentration of antibiotic, it took 4 days for the culture to adapt to the 
antibiotic. However, during the length of treatment, both cultures grown at 0.025h-1 
and 0.06h-1 exhibited slower and smaller increases in the MIC value (as measured 
using the OxoPlate method). For both cultures exposure to the antibiotic resulted in 
an increase in the MIC 4-fold. The final MIC value after prolonged exposure to sub-
inhibitory concentrations of amikacin was 5µg/ml (Appx. F.4). For both cultures 
exposure, adaptive resistance to amikacin conferred low-level resistance to other 
aminoglycosides such as tobramycin and antibiotics with different modes of action 
such as colistin (Appx.F.3 &5). 
 
An analysis of the stability of the adapted cultures to amikacin were carried out 
following passaging of the cultures every 24h through drug-free medium (Nutrient 
agar) and testing the MIC using OxoPlate technique. The MIC of bacterial cells 
grown at 0.025h-1 was stable for the first nine subcultures. However, over the next 
one subculture, the MIC was decreased from 5 to 1.25µg/ml. The MIC value of 
P.aeruginosa grown at 0.025h-1 under limiting nutrient did return to its original 
sensitivity level after ten subcultures. In the case of the MIC of the bacterial 
population grown in the chemostat at 0.06h-1 it took 8 subcultures before the 













Figure 40: A glucose-limited chemostat culture of P.aeruginosa under stress of amikacin. The 
conditions of the steady-state experiments were as following: T (30◦C), pH (7.2), agitation rate (150 
rpm), glucose (1.8 g/l) and air flow rate (1.75 l/h). Dilution rates have been indicated in the above 

















Figure 41: Fluorescent microscopy images at 100X showed the viability of P.aeruginosa culture 
grown in chemostat at 0.06h-1 stained with BacLight dye. Viability of bacterial cells that grown 
during initial feeding in the absence of antibiotic stress (control) (A).Viability of bacterial cells after 
three-day exposure to amikacin at 0.3µg/ml (B). Viability of bacterial cells after increased the 
concentration of amikacin to 0.625 µg/m, the cells examined after two-day treatment (C) and 
recovered culture (4days after exposure) at 816h cultivation time (D). The green fluorescent nucleic 
acid dye stains live cells and the red fluorescent nucleic acid dye stains dead cells. Scale bar =0.5-
2µm.  
 
Cells were grown at “rapid” dilution rates (D=0.099 and 0.125h-1) were maintained 
over 50 generations (Fig.42). Cell death was faster as evidenced by cell counts and 
the BugLab data in these fermentations when the culture was exposed to 0.625µg/ml 
amikacin compared with cells grown at the slower growth rates.  Following an initial 
4-h amikacin exposure at a concentration of 0.625µg/ml to a culture grown at 
0.099h-1, a decrease in the viability cells from 4.45 to 3.73 log10 cfu/ml was 
observed. After 24-h exposure to the antibiotic, bacterial cells showed a further 
decrease to 3.25 log10 cfu/ml. Based on the viability test, the number of viable cells 
increasing to 3.74 log10 cfu/ml. The cell viability then remained constant.   
At  D=0.125 h-1 when the culture was exposed to 0.625 µg/ml amikacin, there was a 
decrease in biomass level from 3.5 to 1.8 biomass units over the initial 4- days 
followed by a recovery in biomass levels after 300h cultivation time (Fig.42). Using 
A B 
C D 
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the BacLight stain on the cultures it was evident that the number of viable cells 
decreased immediately after exposure to the antibiotic (Fig.43) and that the culture 
then regained viability with prolonged exposure to the antibiotic after 300h.   
 
 
Figure 42: A glucose-limited chemostat culture of P.aeruginosa exposed to  amikacin. The 
conditions of the steady-state experiments were as following: T (30◦C), pH (7.2), agitation rate (150 
rpm), glucose (1.8 g/l) and air flow rate (1.75 l/h). Dilution rates have been indicated in the above 










Figure 43: Fluorescent microscopy images at 100x showed the viability of P.aeruginosa culture 
grown in chemostat at 0.125h-1 stained with BacLight dye. Viability of bacterial cells after 2-h 
exposure to amikacin at 0.625 µg/ml (A). The cells examined after 24-h treatment (B). A decrease in 
cells number within 4- days treatment (C). The green fluorescent nucleic acid dye stains live cells and 
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The OxoPlate was used to test the susceptibility of faster-growing cells during the 
treatment period. Based on the susceptibility test, the continued presence of amikacin 
at a sub-inhibitory concentration in cultures grown at high dilution rates showed no 
change in MIC value in the both cultures during the period of treatment. However, 
an increase was observed in the MBC value from 10 to 40µg/ml in both cultures 
compared with the untreated control culture (Fig.44& appx.E.3). The increase in the 
MBC was transient and the MBC returned to control levels after three subcultures in 
amikacin-free nutrient agar. It has been suggested that the surviving cells up to a 
concentration of 20µg/ml may represent persister bacterial cells that respond 
heterogeneously to the action of the antimicrobial agent. 
    
This observation was confirmed by E-test. As illustrated in Fig.45, survival colonies 
were clearly observed after 72h incubation time in treated culture (Fig.45-A). 
Survival colonies were tested for its susceptibility to amikacin using the E-test. The 
MIC value of surviving colonies obtained from the E-test was 64µg for the treated 
culture (Fig.45-B). This result was further investigated by analysing the bacterial cell 
size distribution during the incubation time of 24 and 72h using flow-cytometry after 
staining with the Baclight dye. After bacterial cells were sorted as live and dead, the 
flow-cytometry analysis demonstrated that a small subpopulation showed a reduction 
in bacterial cell size see (Fig.45-D). This distinct in the size could potentially 













Figure 44: MIC and MBC of of P.aeruginosa after prolonged exposure to amikacin at 0.099 and 
0.125h-1. It was assessed using a fluorescent plate reader, the lines represent the means of three 
replicates. Antibiotic concentrations have been indicated. The positive control presents an overnight 
culture of P.aeruginosa (untreated). The negative control represents an overnight culture injected with 
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Figure 45: E-test represents survival colonies after 3days incubation (A) and the MIC of survival 
colonies (B). Flowcytometry analysis of treated culture grown at the highest dilution rate.  Histograms 
show FSC-A, which represent the size distribution of live cells. Analysis of treated culture after 24h 
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3.4.4. Effects of dilution rate on the colony morphology of the population 
 
 During the first few days of the chemostat culture samples were taken and plated out 
onto nutrient agar without antibiotic. After 24 h the resultant colonies were 
homogeneous and identical to the wild type. With further cultivation in the fermenter 
in the presence of antibiotic in the feed the colonies became distinctly different 
taking on shapes that had irregular margins. To establish that these colonies were not 
contaminants random colonies were sub-cultured into nutrient broth with no 
antibiotic and the DNA was extracted, and the 16S rRNA was sequenced, the result 
indicated that the culture remained pure and indeed was still P. aeruginosa.  
The results indicated that the colony morphology of P. aeruginosa was clearly 
affected by controlling the dilution rate under antibiotic stress (Fig.46). Each 
morphology described in this study was apparent in a minimum of three of the four 
replicates. It was observed that colonies of planktonic P. aeruginosa that were not 
subjected to antibiotics exhibited a circular form, smooth texture, flat elevation, 
entire margin, and large size (Fig. 46-A). However, distant colonies of treated cells 
at growth rate of 0.125 and 0.099 h-1 exhibited irregular form, lobate margin (Fig. 
46-B1- 2), wrinkled texture and convex elevation (Fig.46-B3). When grown at a 
lower growth rate of 0.025 and 0.06h-1, colonies displayed an irregular form and 
















Figure 46: The diverse of colony morphology of P.aeruginosa exposed to amikacin in chemostat 
at different dilution rates. The morphological change was observed on NA media after 6days 
incubation at 30°C. (A). Control colony morphology of P.aerugionsa was not treated. Row B 
represents  the colony morphology changed of culture at dilution rate 0.125and 0.099h-1. Row C 
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3.4.5. The effects of colony age on colony morphological characteristics and on 
the susceptibility to antibiotic 
 
In order to detect any colony alterations, samples were taken from the chemostat at 
high dilution rates during the treatment period and plated out onto antibiotic-free 
medium (Nutrient agar) and incubated over the period of 6 days. During this process, 
colonies were analysed at different stages of colony growth (one, three and six days). 
As illustrated in Fig. 47, a morphological change was noted, such as the size and 
texture of colonies after the first day of growth on the agar plate. As shown in 
Fig.48, morphological differences were observed in the colonies incubated for 3 and 
6 days growth on the ager plates compared with the control colony (Fig.48-A). 
 
      
Figure 47: Colony morphology of planktonic cells of P.aeruginosa observed in amikacin-free 
nutrient agar after 24h incubation at 30°C.  The colony morphology development of the control 
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      3 days                                       6 days 
Figure 48: Evolution of morphology change of P.aeruginosa colonies observed in NA media after 3 and 6 days 
incubation at 30°C. A) Represents the development of colony morphology of untreated cells (control). B and C 
represent the colony morphology variation during incubation time detected on bacterial cells subjected to amikacin 
in continues culture at dilution rate 0.099 and 0.125h-1. 
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To assess the susceptibility of these colonies at different incubation times, a loop of 
culture was removed from different positions in the colony (centre and edge) see 
Figure 49. Based on the susceptibility testing, no difference was observed in the MIC 
values (1.25 µg/ml) of cells located at the centre and the edge of colony after 3 days 
growth, although the MBC value of cells at the centre of colony was increased from 
10 to 20 µg/ml (Fig.49). The increase in the MBC value was due to development of a 
small subpopulation as confirmed by Flowcytometry analysis (Fig. 49 (FL1-A)).  
The flow-cytometry analysis also showed that cells size was distinctly different in 
the two colonial positions (Fig.49 (FSC-A)). The size of bacterial cells located at the 
edge of colony was greater than the cells size located at the center of the colony.  
Scanning electronic microscopy confirmed the ability of the P.aeruginosa cells that 
were located in the centre of colony to form fibers (Fig.50) and cells become 
encapsulated with membranous extracellular matrix components after 3-days 
incubation (Fig.51).  
 
With colonies that had been cultured for 6 days, visible differences were observed in 
P. aeruginosa colonies compared with earlier time points (3days) (Fig.48), and 
greater resistance to amikacin was also noted. The data presented in Fig. 49 indicates 
that, when colony incubation time was increased to 6 days, the susceptibility of 
bacterial cells located at centre of colony showed a mark increased in MIC value to 
40 µg/ml. At this point, the level of the changes in the susceptibility test was 
dependent on the results obtained from FL1-A, which showed an increase in the 
formation of the subpopulation and the cell size remained constant at this stage 
compared with younger colonies.  No change in the MIC value was observed for the 
cells located at the edge of colony but the MBC was increased to >40 µg/ml.  This 
observation was further examined by sorting the bacterial cells population using 
flow-cytometry. The results showed that increasing the incubation time to 6 days led 
to decrease in the cell size located at the edge of colony and the formation of two 
populations was also noted compared with early period (3days).














                                 
Figure 49: Effects of growth time of adapted colonies of P.aeruginosa that grown at high dilution rate in chemostat on the susceptibility to amikacin. It had been 
isolated from chemostat in the presence of amikacin at 0.125h-1and incubated at 30oC in amikacin-free nutrient agar. Oxoplate output represents the MIC and MBC of 
colonies incubated for 3 and 6 days. Flowcytometry analysis of different stages of colony growth at centre (1) represents a red curve and at edge (2) represents a black curve.  
Histograms show FL1-A and FSC-A which represent the fluorescent parameter of live cells and cells size respectively. The analysis of the bacterial cell size distribution 
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Figure 50: SEM image showing a great number of extracellular polymeric fibrils in the cells 
derived from the centre of colony of  P.aeruginosa. It had been isolated from chemostat in the 
presence of amikacin at 0.125h-1and incubated at 30oC for 3 days in amikacin-free nutrient agar. The 
arrow represents the cells linking with fibrils.  
    
 
Figure 51: SEM image showing the P.aeruginosa cells encapsulated with the extracellular 
polymeric components. A) The clonal populations of P.aeruginosa located at the centre after 
exposed to amikacin in chemostat at 0.125h-1and incubated at 30oC for 3 days in amikacin-free 
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3.5. Confirmation that the cells exhibiting increased resistance 
following prolonged antibiotic exposure were not contaminants 
 
One possible scenario with the experiments involving continuous culture is that 
during this process we may have inadvertently introduced a contaminating 
bacterium. This contaminant could then be maintained on subculture and could in 
part explain our phenotypic resistance. To eliminate this scenario, on a routine basis 
samples were taken from the chemostat to determine that the culture remained pure. 
DNA for 16S ribosomal RNA was extracted (Fig. 52). The strands of the PCR 
product were sent to be sequenced by Source Bioscience LifeSciences Company. 
DNA sequence traces were conducted using the windows software program called 
Geospiza’s FinchTV, version 1.4, which is a chromatogram viewer capable of 
exhibiting a complete trace in a multi-pane view with scale options. In addition, the 
program is able to communicate with BLAST searching in the NCBI website for 
correlating sequences and traces.  A comparison was conducted between the 16S 
rRNA gene sequence of P. aeruginosa and with those in the NCBI nucleotide 
sequence database. The result of the 16S rRNA gene sequence analysis revealed that 
the strain used is, indeed, P. aeruginosa, a type of bacterium of the genus 
Pseudomonas and exhibited maximum similarity with the 16S rRNA sequence of  
P. aeruginosa (99% sequence similarity).  
 
Figure 52: P.aeruginosa template DNA for 16S rDNA PCR assay, PCR amplification products 
targeting the 16S rRNA gene using 27f and 1492r primers. Lane 1 represents the negative control 
(a sterile distilled water,  Lane2 represents the positive control (purified P.aeruginosa DNA), lanes 3-
6 represent P.aeruginosa grown under a glucose limited chemostat culture and lane 7 represents 




4.1. Susceptibility of P.aeruginosa to antibiotics 
In this study, a number of antimicrobial susceptibility test methods were employed to 
assess the in vitro sensitivity of culture of P. aeruginosa to antibiotics. Susceptibility 
testing was carried out with the use of the conventional technique geared towards 
estimating the MIC and MBC as well as a novel technique OxoPlate. This study 
made use of three of the most commonly used anti- Pseudomonal drugs to treat P. 
aeruginosa infections, namely, tobramycin, amikacin and colistin. Determination of 
MIC and MBC values were carried out. The results of the present study revealed that 
P.aeruginosa was highly sensitive to the effect of the antibiotics selected.  Our data 
shows in general that, tobramycin and colistin had the most extensive effect on the 
wild type (PA01) of P. aeruginosa, followed by amikacin. This result supports data 
previously reported by others and suggest that amikacin has a more reduced 
bactericidal effect compared with tobramycin (Burton et al., 2006). It has also been 
reported that among seven of the antibiotics, ceftazidime, aztreonam, amikacin, 
ticarcillin, gentamicin, ciprofloxacin, and tobramycin. It was tobramycin that had the 
most efficient bactericidal effect against isolated strains of P. aeruginosa found in 
individuals suffering from cystic fibrosis (Shawar et al., 1999).   
 
The effect of antimicrobial agents on bacterial development, as well as the dynamics 
of this process, can be inferred from the oxygen concentration. The measurement of 
oxygen concentration is considered to be a central to numerous research areas since 
this substance is inevitable fundamental to behaviour and growth of aerobic cells. In 
antibacterial research, the use of the OxoPlate could prove particularly advantageous 
as it can readily determine the MIC value by measuring the rate oxygen depletion. 
The measurement of oxygen depletion indirectly indicates the level of bacterial 
development, which alongside bacterial metabolic activity, alters the oxygen 
concentration with time. This study has evaluated the use of a fluorescence-based 
assay to determine the oxygen concentration in the growth environment. The
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OxoPlate method has proven to be an accurate, real time method to test the 
susceptibility of P.aeruginosa to antimicrobial agents.  In the case of aminoglycoside 
antibiotics used, the OxoPlate technique has been observed to show a higher 
sensitivity to the antibiotics than the broth dilution technique, the broth dilution 
method led to a two-fold higher MIC (Fig.15 A&B and 16). The MIC values 
obtained by way of this method were more accurate to those obtained through the 
standard methods because these methods rely on measurements at specific time 
points normally between 18 and 24h. The accuracy of the OxoPlate is related to 
analysing samples with two fluorescent dyes, one being receptive to oxygen and the 
other emitting a regular signal. Any alterations in the otherwise constant ratio 
between these two dyes are recorded in real time with high temporal resolution. 
 
The reliability of the susceptibility tests used to evaluate the antimicrobial activities 
of antibiotics against bacteria is considered an important parameter of the sustainable 
use of antimicrobials. At present, bacterial development, in the presence or absence 
of antibiotics, can be examined through a number of methods. Conventional 
susceptibility tests (endpoint or off-line measurement) are usually used to assess the 
activity of antibiotics, including microscopy, turbidity measurements, indirect 
staining methods, a viable count and a agar well diffusion method based on 
inhibition zone measurements (Jorgensen and Ferraro, 2009). In addition, standard 
methods (known as ‘applied methods’) include broth micro-dilution, which is geared 
towards the determination of MIC, disc diffusion and the E-test, are used on a 
regular basis as per the recommendations of CLSI (2013) and EUCAST (2014). One 
major drawback of these methods is that they cannot be automated, which means 
that it is difficult to apply them to higher throughput applications. By using the 
above methods, the kinetic of microbial growth in the presence of antibiotics cannot 
be monitored with high temporal resolution because it is only reliant upon the 
discrete intervals. Cultivation-dependent analyses are still fundamental for routine 
examinations despite the increasing use of molecular methods in research.  
Thus, an alternative assay able to detect or quantify the growth inhibition of bacterial 
cells when exposed to antibiotics is the OxoPlate. This method is advantageous as it 
does not need calibration, it is not difficult to use and the process can be automated. 
The OxoPlate represents a viable, flexible and straightforward option for undertaking                 
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bacterial susceptibility assessment in broth.  Despite the fact that there have been 
previous studies that have analysed oxygen depletion with the use of OxoPlates, no 
studies prior to this have investigated the ability of such a system to distinguish 
between bactericidal and bacteriostatic antibiotics. The OxoPlate system can be 
adjusted to suit the development pattern of a certain bacterium (Hutter and John, 
2004). The microbiological assay system is highly sensitive and has a wide dynamic 
range. 
4.2. P.aeruginosa growth dynamics in the presence of antibiotics  
In this study, an automated cultivation based assay (the SPECTRO star Nano) was 
used in order to assess the growth response of a wild-type P.aeruginosa to a 
selection of antibiotics. The results of this analysis indicate which antibiotic 
concentrations affect the extent to which P.aeruginosa grows.  Based on these 
findings, the growth rate in the culture exposed to colistin exceeded the final OD 
values of the control culture (absence of antibiotic) during log phase. This indicates 
that colistin is capable of acting as a growth stimulant when administered at sub-
inhibitory concentrations such as 0.125-0.25 μg/ml. If a phenomenon does in vivo, it 
is difficult to achieve antibiotic action. It is also difficult to ensure that the antibiotic 
level is above the threshold during long-term treatment. During chronic infection, the 
antibiotic concentration may decrease to sub-inhibitory levels in some parts of the 
body. The consequences of this over the course of treatment could enhance the 
protection of microorganism from the action of antibiotics and lead to selection 
mechanisms including SOS response, direct mutagenic effects, presister cells and 
hypermutation (Rodriguez-Rojas et al., 2013). In our study, growth promotion 
occurred as a result of treating P.aeruginosa at sub-inhibitory concentration of 
colistin, which may go along with or be enhancing by other mechanisms. In addition, 
the effect of sulfate salt present in the colistin components might have induced the 
growth promotion of P.aeruginosa by colistin.  
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4.3. Effect of inoculum size on susceptibility test 
 
A number of reports have described that bacterial inoculum size is a critical factor in 
determining the level of activity of antimicrobial agents (Brook, 1989, Soriano et al., 
1990, Reguera et al., 1991, Reguera et al., 1988). The activity of antimicrobial 
agents can be assessed based on the MIC value. The MIC of bacterial populations in 
infections tends to rise when bacterial loads increase. This issue may explain why 
such infection is not successfully treated when more cells are present, because the 
MIC value obtained from the classic laboratory tests use the standard bacterial 
inoculum size is lower than the actual MIC of those treated in vivo (Soriano et al., 
1990).  
The impact of bacterial inoculum size has been primarily considered in microbes 
producing enzymes that inactivate antimicrobial agents, including the staphylococci 
species. Almost every class of antibiotics is influenced by the microbial inoculum 
size, particularly β-lactam antibiotics. Therefore, it is believed that the primary cause 
of the inoculum effect is the loss of antibiotic activity that occurs as a result of β-
lactamase enzyme production. This causes a high antibiotic degradation rate when a 
large number of bacterial cells are treated with the β-lactam antibiotics (Eliopoulos 
and Moellering, 1996, Reguera et al., 1988, Reguera et al., 1991). However, the 
correlation between this effect and bacteria (where resistance mechanisms do not 
involve the degradation of antibiotics) is less apparent (Corona and Martinez, 2013). 
Aminoglycosides (for example, tobramycin) do not usually trigger the inoculum 
effect when treating the Pseudomonas species (Brown et al., 1990).  
It is well- documented that the MIC value can be affected by the size of bacterial 
inoculum, and this effect has been extensively examined using only the survival-time 
method (Bulitta et al., 2015, Chan et al., 2006). This research has employed 
alternative evaluation techniques from those used in the studies mentioned above, 
particularly in terms of the range of inoculum sizes used and the types of 
microbiological tests performed. This study uses the OxoPlate system to carry out an 
in vitro study of P. aeruginosa (a reference strain PA01), in order to derive a new 
understanding of the inoculum effect. No previous studies have documented the use 
of the Oxoplate system to determine the impact of inoculum size. However, this
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analysis showed not only excellent replication but also precision, sensitivity and 
accuracy.  
In our study, the novel assay based on the OxoPlate system indications that 
suppression of growth following treatment with tobramycin, amikacin and colistin 
was found to be less marked when the size of inoculum of P. aeruginosa was 
increased. The fact that colistin exhibits an inoculum effect has been well reported. 
However, previous studies have concluded that the phenomenon is not typically 
associated with aminoglycosides, meaning that our findings contradict the existing 
literature. It is important to note that, our results are in agreement with only one 
recent study has linking aminoglycosides, such as tobramycin with an inoculum 
effect when multiple inocula was used (Bulitta et al., 2015)  and another study also 
showed this effect only when amikacin was combined with piperacillin (Chan et al., 
2006). The results showed that minor changes in the total initial cell of P.aeruginosa 
treated with tobramycin and amikacin can account for the increase in the MIC values 
recorded, as explained in the results section (Fig. 33-34).  
 
One possible explanation for the detected inoculum effect might be that our work 
used a wide range of inoculum sizes (above and below standard inoculum) in order 
to perform a full and broad evaluation of this effect, yet earlier work only focused on 
single inoculum size (above standard inoculum). In light of this investigation, as 
other situations can be associated with inoculum dependent antibiotic including 
mathematical modelling and experimental approaches, other processes are also 
possible to effect this phenomenon (Udekwu et al., 2009). It is suggested that when 
the bacterial cell is loaded in large numbers, the commensurate reduction of its 
capacity to bind to cell envelopes and debris from live and dead cells may cause it to 
become less vulnerable to the effects of aminoglycoside. The reduced accumulation 
of antibiotic molecules in each cell at high bacterial cellular mass may provide an 
alternative explanation for the occurrence of the inoculum effect with both 
tobramycin and amikacin. The fact that high bacterial cell loades are able to activate 
the response of QS, together with the suggestion that QS might have an impact on 
the susceptibility of bacteria to antimicrobial agents, may indicate that QS is 
significant in controlling the susceptibility of inoculum-dependent
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antibiotics to the populations of microorganism. So far, no examination of this 
theory has been recorded (Corona and Martinez, 2013).  
The anti-endotoxin action of colistin in counteracting bacterial lipopolysaccharide 
(LPS) was tentatively identified as a possible cause for the inoculum effect of 
colistin. In conjunction with phospholipids, colistin creates combined monolayers 
encompassed in micelles in vitro. (Mestres et al. 1998 cited in Bulitta et al., 2010). 
The inoculum effect may be brought about through the attachment of colistin to the 
LPS fragments of destroyed bacteria which can determine the reduction of the 
concentration of unattached colistin in vitro (Bulitta et al., 2010). The reduced effect 
of colistin on bacterial development may be due to a decrease in the negative charge 
of LPS as well as by transformations in the hydrophobic side chain located in the 
external membrane of the bacterial cell induced by the cells sensing as they react to 
their medium (Bulitta et al., 2010). 
4.4. Phenotypic variation in P.aeruginosa isolated from continuous 
culture  
4.4.1. Adaptive phenotypes  
In the current study, which explored the prolonged exposure of amikacin in glucose-
limited chemostat cultures, it was revealed that P. aeruginosa survived and 
subsequently developed temporary adaptive resistance to amikacin. When growth 
without antibiotic presence, however, this phenomenon was not observed. Adaptive 
resistance to amikacin conferred low-level resistance to other aminoglycosides such 
as tobramycin and antibiotics with different modes of action such as colistin when 
cultures grown at 0.025h-1 and 0.06h-1. This finding is supported by the recent work 
carried out by Amabile-Cuevas (2016)  where resistant strains of P.aeruginosa 
exposed to graded concentrations of amikacin resulted in a rise in the MIC and this 
resistance was not associated with genetic resistance. Altered susceptibility of 
P.aeruginosa to other antibiotics is also occurring.  
Gilleland et al. (1989) reported that adaptive resistance has been shown to be 
associated with the prolonged administration of aminoglycoside antibiotics. It is 
common to observe aminoglycoside-resistant bacteria instability in adaptively 
  
                                                                                                                                                                          




resistant bacteria. This results in a return to the initial susceptibility level, upon 
several passes through a drug-free medium (Poole, 2005).  
 
It has been previously demonstrated that the concentration of aminoglycoside and 
the length of exposure of aminoglycoside therapy are the main factors that impact 
the level of adaptive resistance (Daikos et al., 1990). Our results suggest that another 
factor that affects this phenomenon is the growth rate of bacteria, which showed that 
the time it took for the culture to become adaptive to amikacin was longer with 
culture exposed to amikacin at fast dilution rate (Fig. 40&42). Resistant 
subpopulations that normally developed as a result of continued aminoglycoside 
therapy in hospitalised patients became undetectable in the absence of antibiotics, as 
reported by epidemiological surveys. On the other hand, since the phenotype may 
immediately revert to its original state during the initial isolation (Daikos et al., 
1990), it may be difficult to detect aminoglycoside adaptive resistance in 
immunocompetent patients and clinical microbiological laboratories (Price et al., 
1981, Weinstein et al., 1980) . The presence of resistant subpopulations during 
infection may be linked to the failure to treat chronic infections, including 
endocarditis, cystic fibrosis or other immunity issues in patients who were subjected 
to a continued dose of aminoglycoside (Gilbert, 1995).  
 
Adaptive resistance has been well associated with P.aeruginosa because it is one of 
the most important pathogens in nosocomial infections and fails to respond to 
standard treatment (Korvick and Yu, 1991). Due to continuing use of 
aminoglycoside therapy during chronical infections caused by P.aeruginosa, it is 
clinically essential that the nature of adaptive resistance of P. aeruginosa to 
aminoglycoside antibiotics is understood to improve the usage of these antibiotics.  
4.4.2. Colony morphotypes 
 The observations of morphological changes in bacterial colony are becoming 
increasingly significant as these are believed to be caused by adaptation to survive 
the stressful challenge of a new environmental condition, which become an obstacle 
issue in clinical diagnosis to identify pathogens because it adds variation to 
morphological trials. The accuracy of diagnoses may be compromised by the 
  
                                                                                                                                                                          




occurrence of alteration in colony morphotypes. This observation has been 
previously reported in cystic fibrosis patients infected by P.aeruginosa, which 
regularly converts the structure of the cell surface from a non-mucoid to a mucoid 
phenotype (Ogle et al., 1987).   The effects of experimental conditions under which 
results were obtained, resulting in alteration of colony morphology and are 
considered to be an important factor to exam the phenomena of bacterial adaptation. 
By way of example, the characterisation of P. aeruginosa colonies has been 
accomplished using various agar growth media types and with a number of 
supplements, each conducted within different time scales (Hay et al., 2009, Starkey 
et al., 2009). The following species have been similarly examined for their colony 
morphologies:  Staphylococcus aureus, (Norstrom et al., 2007, Schneider et al., 
2008), Streptococcus pneumoniae (Allegrucci and Sauer, 2007) and Enterococcus 
faecalis (Wellinghausen et al., 2009, Qamer et al., 2003).  
 
Under all growth conditions used, different colony morphological types were clearly 
detected in a single sample isolated from chemostat. The results of the in vitro study 
of P.aeruginosa exposed to amikacin in chemostat at different dilution rates showed 
that morphological alterations were clearly observed in the colony growth on 
amikacin-free nutrient agar compared with the untreated-control colony (Fig.46). 
Visible differences were also observed in P. aeruginosa colonies that had been 
cultured for 6 days, which leads to the introduction of subpopulation, resulting in 
development of drug resistance compared with earlier time points (3days) (Fig.49).  
Since the effect of experimental factors into colony morphology trials is as yet 
unquantified, the validity of apparent positive outcomes in respect of research into 
bacterial adaptation such as bacterial persistence and phenotypic switching may be 
affected. Additionally, changes in characteristic morphologies of colonies may be 
suggested to be a change arising as a result of phenotypic switching. The binary 
alternation between phenotypic states in response to situational challenges is the 
same as ON/Off mechanism that do not engender a permanent mutation that may 
result in bacteria becoming more virulent, less vulnerable to microbial effects or 
exhibiting of bacterial persistence phenotype (Massey et al., 2001, Sousa et al., 
2011). The phenotypic switching phenomenon has been considered in respect of 
  
                                                                                                                                                                          




colony morphology (Be'er et al., 2011, Sousa et al., 2013). Colony morphology is 
considered an important tool to identify bacterial type; nowadays this tool should be 
used with caution because of increasing observation of a phenotypic change in 
bacteria involved in cystic fibrosis and other chronic lung infections.  
4.5. Is the behavioural response of bacterial cells within colonies 
grown on an agar plate equal to that of a biofilm? 
 
The relationships between planktonic cells and biofilms have been extensively 
investigated, with significant differences being noted between the growth modes of 
the two states. However, few of these investigations have analysed the growth of 
colonies on agar plates. In this study, colonies were grown on an agar plate over six 
days to obtain a clear overview of the development of bacterial colonies over the 
time period as well as their susceptibility to antibiotics. Our results showed that the 
comparison of P. aeruginosa colonies grown on agar plates (isolated chemostat) for 
three days and six days presented visible differences with respect to morphology and 
susceptibility (Fig.48). P.aeruginosa colonies that had been cultured for six days 
exhibited higher amikacin resistance than cells derived from early agar-grown 
colonies (three days old).  In our study, an important indicator of colony morphology 
was colony age. This finding is in agreement with the study conducted by Pipe 
(2014) who found that colony growth resulted in differentiation.  In addition, SEM 
analysis revealed that cells derived from a colony that was isolated from chemostat 
incubation for 3 days led to the development of an extracellular matrix, unlike with 
control (untreated) sample. Thus, a direct effect on the ability of amikacin to form a 
biofilm in agar when antibiotic was removed. This phenomenon may explain the 
alteration that was observed in bacterial susceptibility. It has been indicated that 
biofilm formation can directly be influenced by manipulating cell morphology via 
exposure of planktonic cells to antibiotics at a concentration below the lethal level  
(Song et al., 2016). It has been found that film formation occurs in bacterial cells of 
E.coli when treated by either piperacillin or a pipercillin-tazobactam at a sub- 
inhibitory concentration (De Andrade et al., 2016).  The recent study conducted by 
Amabile-Cuevas (2016) demonstrated the ability of P.aeruginosa to generate a 
biofilm when amikacin was applied as a graded exposure to resistant strains of 
  
                                                                                                                                                                          




P.aeruginosa .  
It has been shown that the bacterial cell growth in colonies in agar plates possess 
similar features to that of biofilms. This includes the development of communities 
with high cell densities, encapsulated with a polysaccharide matrix and coordinating 
cellular behaviour. Therefore, the behavioural responses of both models are expected 
to be the same (Shapiro, 1998). Bacterial populations prefer to organise an extensive 
communication between bacterial cells, as they provide defence against stressors 
such as biotic, chemical and physical factors (John et al., 2003). Kolter and 
Greenberg (2006) likened P. aeruginosa colonies to air-exposed biofilms, and both 
structures showed bacterial cells entrapped within an exopolymer matrix (Asakura 
and Okura, 2009). In addition, both biofilms and cells within colonies created 
heterogeneously-temporary environments (e.g. gradients of nutrients, oxygen, ionic 
strength, pH, redox potential, and waste products) (Shapiro, 1998). However, 
mutagenesis was extensively increased in both structures. Thus, the growth of 
colonies on agar plates is associated with genetic or morpohotype change (Be'er et 
al., 2011) 
4.6. Interaction of bacterial cells within colony grown an ager 
plate  
 
The ways by which cells interact within colonies are extremely coordinated and 
complex. Detailed study has revealed that cells in colonies have developed 
differential morphological and physiological characteristics, which are location-
specific.  
The length of individual microbe cell within a colony differs depending on their 
position. Thus, the length of bacterial cells grows in the internal colony area maybe 
shorter compared with those located in the edge of colony. For this reason, the 
ability of microbial cells to build up a tolerance to the deadly effect of antimicrobial 
agents is increasingly being seen in the cells located at the heart of the colony.  This 
theory may explain our finding in which cells derived from the central colony area 
gained higher resistance to amikacin than those located in the peripheral area. An 
increase in MIC value (40µg/ml) was observed at the centre of the colony compared 
  
                                                                                                                                                                          




with cells at the colony margin (1.25µg/ml) (Fig.49). The reduction in the cell size 
was also observed in the cells located on the interior structure of colony. In this 
stage, the formation of subpopulation was also increased.  It is possible that their 
drug targets were inactivated due to the physiological state rather than genetic 
mutations in a subpopulation of bacteria.   
Another possible reason may be due to an increase of nutrient limitation in the centre 
when the colony becomes large, resulting in successfully adaptation to a new 
condition. The physiological status of P. aeruginosa would be negatively impacted 
by depleted nutrient supply, especially intracellular energy metabolism. Then, 
utilization of nutrients would have to be improved and the growth rate of bacterial 
cells within colony would be reduced (Terry et al., 1991). Therefore, the colony has 
protected itself by evolving; stationary-phase cells are located in the centre of the 
community, while the cells at the edge have developed the ability to divide and grow 
outwards to reach nutrient sources far away from the core of the structure (Lovitt and 
Wright, 2014). 
Other factors that influence the physiological response of cells within colony 
including enzyme composition (Saier, 2000) and the gene expression. (Lovitt and 
Wright, 2014). The variations of both enzyme composition and the gene expression 
within the colony are responsible to control their role depending on their site inside 
the colony. Hence, the complexity of construction of a colony during growth relies 
on the interaction with external influences, such as diffusion of nutrients and gases 
across the structure, and innate factors such as size and shape of bacterial cell, 
method of reproduction, bacterial motility, and the ability to produce extracellular 
molecules (Lovitt and Wright, 2014). Colonies are an excellent model system for 
understanding the complexity that is emerged at the dawn of life of microorganisms. 
The use of bacterial colonies as models for understanding the emergence and 
evolution of complex life forms from bio-complex micro-organisms is gradually 
being appreciated.   
  
                                                                                                                                                                          




4.7. Effect of growth rates on the susceptibility to antibiotic   
Based on the MIC values, the continued presence of amikacin in cultures grown at 
slow dilution rates showed less susceptible to amikacin compared with those grown 
at high dilution rates (Fig.44, appx. F 2&4). The reason they persist being thought to 
be growth rate related. There is a well-documented relationship between growth rate 
and antibiotic resistance. Work carried out using chemostat cultures by Wu and 
Lfrettnore (1990) where the growth rate of the bacteria was regulated by the nutrient 
feed rate showed that at low growth rates the organisms were less susceptible to the 
antibiotics than at faster growth rates. This study was conducted to exam the effect 
of several antibiotics – ceftazidime, imipenem, piperacillin and meropenem – against 
different growth rate of P. aeruginosa developed in a chemostat. Thus, a slower rate 
of development enables bacteria to acquire resistance against antibiotics, which 
represents a significant issue in microbial pathogens. The resistance can be acquired 
as a result of transformation, conjugation and transduction (Tenover, 2006).  
 
A small fraction of less-susceptible cells was observed after 72h incubation time in 
the P. aeruginosa exposed to amikacin in  the chemostat at high dilution rates using 
the OxoPlate (Fig.44), which demonstrated that exposure to amikacin resulted in 
some surviving bacterial cells that escaped the lethal action of the antibiotic. These 
surviving cells may well be the so called “persister” cells described in the literature 
(Gefen and Balaban, 2009). Persister cells are often considered to be slow growing 
variants within a population and respond heterogeneously to the action of the 
antimicrobial agent. 
 
4.8. Effect of glucose concentration on the growth of P.aeruginosa 
An increase in the concentration of glucose from 30-50mM resulted on the growth of 
bacterial cells was significantly inhibited over the time of experiment (Fig.37). This 
finding indicated that increasing glucose above 25mM had no further increase on the 
density of P.aeruginosa, which indicating that bacterial densities  were noticeably 
independent on presence of theses concentrations of glucose. Based on the study 
published previously on the growth rate of E.coli in the presence of different 
  
                                                                                                                                                                          




concentration of glucose, the reason for inhibition of bacterial growth was due to 
acetate production (Vemuri, et al., 2006).  
 
4.9. Response of P.aeruginosa to the availability of O2 
concentration during fermentation process 
 
The results presented in this study reveal that P. aeruginosa exhibited significant 
physiological responses to oxygen level upon its growth rate during batch mode. 
During batch culture, P.aeruginosa showed a strong preference for a microaerophilic 
growth environment, achieving its fastest growth rate (0.36h-1) when the 
concentration of O2 was low. However, a high pO2 value in the growth medium 
caused a dropped in growth rate to 0.26h-1 (Fig.40). This finding was also observed 
during continuous cultures, where a reduction in the concentration of oxygen was 
exhibited when dilution rates were increased to 0.099 and 0.125h-1 (Fig.42). This 
finding is supported by the previous work carried out by Sabra et al. (2002), where 
the pO2 value was controlled to 1% air saturation, revealing a greater increase in the 
growth rate of P. aeruginosa (PA01) under low oxygen concentration than under a 
high concentration of oxygen. Oxygen limitation was only observed in the cultures at 
fast dilution rates (Fig.42) and not with slow cell growth (Fig.40). As a result of 
reducing the oxygen concentration at high dilution rates, the cells adapted a mucoid 
phenotype when colonies were grown in an agar plates for 3 days. Thus, oxidative 
stress observed during continuous cultures may explain the extraordinary 
physiological reaction of P.aeruginosa.  
The formation of reactive oxygen and nitrogen intermediates is a typical 
immunological response against pathogenic bacteria that attacks the host cells. 
Consequently, pathogenic bacteria such as P. aeruginosa protect themselves against 
these poisonous reactive intermediates by developing defence mechanisms.  One of 
the defence mechanisms in which pathogenic bacteria use against oxidants is that the 
transportation of oxygen to the culture media is reduced by blocking the formation of 
the oxygen reactive intermediate. Other pathogens have evolved with a number of 
different responses, not only enzymic and non-enzymic but also the  polysaccharide 
coat that serves to eliminate these intermediates from their environment (Bogdan et 
al., 2000). Oxidant inactivation in P. aeruginosa has been identified through specific 
  
                                                                                                                                                                          




enzymic pathways such as enzymes catalysed by peroxidase, catalase and superoxide 
dismutase.  (Sabra et al., 2002).  
4.10. Effect of ions on the susceptibility to antibiotic 
To evaluate the correlation between the experimental results and studies published 
previously, the dissolved oxygen curves revealed that the extent to which P. 
aeruginosa was susceptible to antibiotics depends on the concentration of divalent 
cations in the test medium.  Similar results have been published previously based on 
the susceptibility of P. aeruginosa to both aminoglycosides and colistin in the 
presence of the cations in broth as well as agar (Jeffrey et al., 1982). Posing a major 
issue in aminoglycoside therapy, aminoglycoside antagonism by divalent cations has 
been comprehensively explored in the case of P. aeruginosa (Medeiros et al., 1971, 
Zimelis and Jackson, 1973, D’Amato et al., 1975). As confirmed by many studies, 
this antagonism is caused by the fact that aminoglycoside assimilation at sites on the 
external and internal membrane is disrupted by cations (Bryan and Van De Elzen, 
1977, Campbell and Kadner, 1980, Zimelis and Jackson, 1973). Additional evidence 
in support of the fact that the internal membrane is a site for cation antagonism was 
provided by Mao et al. (2001), who demonstrated that aminoglycoside assimilation 
in Staphylococcus aureus and in spheroplasts of Escherichia coli seemed to be 
suppressed by cations. Furthermore, according to the findings of Mao et al. (2001), a 
direct correlation exists between the functionality of the MexXY-OprM efflux pump 
and antagonism of aminoglycoside by divalent cations. 
Based on the oxygen depletion curves, Mg2+ was not as effective as Ca2+ in 
suppressing the effect of aminoglycoside agents against P.aeruginosa. Similar 
results were found in resent study for gram negative bacteria (Sahalan et al., 2013), 
where the activity of Polymyxin B was significantly inhibited in the present of Ca2+ 
in defined medium, which lead to survival bacteria. The experimental findings 
suggest that the greater efficiency of calcium can be explained in terms of specific 
cations adapted to particular functions. In fact, calcium is rather an element of the 
cell structural components, and less frequently a co-factor of active proteins as 
magnesium in E-coli (Verkhovskaya et al., 2011). The reliability of the observation 
of growth inhibitors is enhanced by the oxygen consumption measurements. 
  
                                                                                                                                                                          




4.11. Effect of temperature in the growth rate and antibiotic 
susceptibility of P.aeruginosa 
 
Temperature is one of the most important environmental factors that influence the 
growth behaviour of microorganisms and  their susceptibility to antibiotics (Estrela 
et al., 1995, Segun, 2004). Only a small number of research papers reveal the way in 
which P. aeruginosa responds to growth temperature. In addition, very little 
evidence exists in the literature for the behavior of P. aeruginosa at temperatures 
below and above the optimal level despite a high number of studies having 
investigated the way in which P. aeruginosa behaves at 37°C (optimal).  
 
A study on P. aeruginosa strain PAO1 revealed that temperature-based adaptation 
occurred in its outer membrane protein, lipopolysaccharide and phospholipid 
(Kropinski et al., 1987).  Research also reveals that temperature changes in the 
environment cause the channel size of P. aeruginosa porin (OprF) to fluctuate, with 
suboptimal temperatures resulting in a small pore size (Jaouen et al., 2004). It is 
probable that these adaptations protect the bacterium by helping it to hold essential 
metabolites. This also likely protects the bacterial cell from the invasion of toxic 
substances. A study conducted by Jaouen et al. (2004) showed that temperature 
regulation has also been found in gene PA0011 in P.aeruginosa PAO1.  Here, it was 
found that temperature impacts the bacterium’s resistance to carbapenem, with a 
temperature of 21oC resulting in a higher PA0011 expression than a temperature of 
37oC (body temperature). It is proposed that in order for P. aeruginosa to grow or 
survive at suboptimal temperatures, up-regulated PA0011 is essential. It is probable 
that growth temperature fluctuations have an impact given the likelihood that 
phospholipids and other lipids within the cell wall protect the cell from toxic 
substances (Farrell and Rose, 1967).  
 
In light of thermal adaptation, P.aeruginosa is able to thrive in many different 
environmental conditions due to its complexity and large genome size. Metabolic 
flexibility and strong adaptation to new environments are the two abilities for which 
the ubiquitous environmental bacterium P.aeruginosa is most known. Given this, the 
  
                                                                                                                                                                          




opportunistic behaviour of the pathogen is likely prompted by the facilitation of 
these very factors.  
In the study of pathogenic bacteria, the determination of microbial growth rates is 
essential, particularly in relation to temperature. The effect of temperature on the 
growth rate of bacteria and on its susceptibility to antibiotics has been investigated in 
this study. Three independent methods were used in this study to evaluate 
temperature-based fluctuations of P. aeruginosa susceptibility. The OxoPlate 
revealed that susceptibility to aminoglycosides fluctuated significantly between 30°C 
and 37°C, where in susceptibility doubled at 37°C compared to 30°C. When exposed 
to colistin at these temperatures, however, the same MIC was shown and no change 
was noted. However, no difference in the MIC breakpoints was observed in all 
antibiotics when the agar well diffusion method was used at these temperatures. This 
finding is in agreement with a study conducted in 1985, exists regarding the way in 
which P.aeruginosa reacts to aminoglycoside at certain temperatures. In this study, 
the disk diffusion method was used to test the behaviour of P. aeruginosa with 
aminoglycoside antibiotics at two different temperatures: 30oC and 37oC. The study 
revealed that neither temperature altered the susceptibility of P. aeruginosa strains 
(Wheat et al., 1985). On the other hand, Pseudomonas maltophilia was found to 
exhibit significantly varied susceptibility to aminoglycosides, as well as to other 
antibiotics. Furthermore, Stenotrophomonas (Xanthomonas) maltophilia strains were 
exposed to polymixin B and aminoglycosides and found to exhibit susceptibility to 
these antibiotics at a temperature of 37°C but resistance at 30°C  (Wheat et al., 1985, 
Rahmati-Bahram et al., 1995).  
At 25oC, P.aeruginosa became less sensitive to aminoglycoside because the growth 
rate of bacterial cells was lower.  In most cases, phospholipid composition appears to 
vary at lower temperatures, whilst lipids also show a higher level of unsaturated fatty 
acid residues at the lower end of the growth temperature range. This effect was 
reported in some Pseduomonas species such as P.putida (Loffhagen et al., 2004). 
However, the susceptibility of P.aeruginosa to colistin and amikacin was also tested 
at 42oC (above optimal) and the result indicated that, bacterial cells became more 
sensitive to antibiotics. Based on the measurement of the growth rate, this study 
  
                                                                                                                                                                          




found that temperature was influenced the growth of cells, resulting in a fast growth 
rate when the temperature was increased. Worthy of note is the fact that many 
researchers have found that as temperature rises, various antimicrobial agents 
become more active against both gram-negative bacteria and gram-positive cocci 
(Mackowiak et al., 1982).  
The susceptibility of P.aeruginosa to all antibiotics tested at 25, 30, 37 and 42oC, 
showed a significant variation in its MICs when an E-test was used. It is important to 
note that E-test (diffusion technique) has observed to show a higher sensitivity to the 
antibiotics at 42oC. Due to the fact that the agar diffusion technique depends on 
several factors, including agar depth, antibiotic dispersal rate, bacterial growth rate, 
the temperature and period of incubation (Mesaros et al., 2007). These factors can 
affect the outcome of the results. Moreover, the broth dilution method relies on the 
manual preparation of antibiotic dilutions; the accuracy of the method was reported 
to be +/- a two-fold concentration compared with E-test that has a precise known 
gradient of antibiotic concentrations. Apart from the manual preparation of the 
antibiotic solution, this can result in errors (Jorgensen and Ferraro, 2009). 
 
Chapter 5 
Conclusion and future work 
 
While antimicrobial medicine has been in existence for almost one hundred years, it 
is now necessary to review its usage in light of the widespread antibiotic resistance. 
Nowadays, antibiotics are regularly prescribed to remedy infectious conditions in 
both human and animal species, along with additional areas such as in farm-related 
activities. Notwithstanding this, an entire body of research attests that in reality a 
paradoxical reaction may occur as a result of its usage, thus contributing to the 
development of antibiotic resistance. 
Infections caused by P. aeruginosa are becoming increasingly difficult to treat as the 
bacterium is becoming more and more resistant to a significant range of commonly 
used antibiotics. With the extensive use of antibiotics, P. aeruginosa is responsible 
for the greatest number of gram negative bacterial infections, particularly in the case 
of patients subjected to prolong antibiotic treatment. By developing and growing 
bacteria in the presence of antibacterial agents, bacteria acquire/develop resistance to 
them and seem to have a ‘life of their own’. This study has aimed to develop an in 
vitro model to examine the effect of continual expose of P.aeruginosa PA01 to 
amikacin as a model antibiotic. Experiments were initially conducted to consider the 
factors that having a significant influence on the susceptibility and growth behaviors 
of the cells population using an automated cultivation based assay (the SPECTRO star 
Nano and OxoPlate system). To the best of our knowledge, the development of 
antibiotics resistance in planktonic cells has not been studied as extensively as that in 
biofilms. Planktonic cells use in this thesis as stepping stones to understand the 
complexity that is emerged at the dawn of life of microorganisms. This point is to 
the potential to substantially increasing the likelihood of development of phenotypic 
resistance in the case of planktonic cells of P. aeruginosa.   
The results of the in vitro analysis showed that, from among the three antibiotics 
used in this study, amikacin posed a more serious risk to develop resistance in P. 
aeruginosa , which was a more effect by selecting stress including: 




I.  The least effective antibiotic against P.aeruginosa compared with other 
antibiotics used was amikacin as evidenced from OxoPlate output. 
II. P.aeruginosa displayed intermediate susceptibility to amikacin as observed 
in the agar well diffusion method.  
III. Activity was influenced by temperature, which resulted in cultures that 
showed from the MIC and MBC data, less susceptibility to amikacin when 
temperature was decreased from 42 to 25oC.  
IV. The presence of surviving colonies was indicated in association with 
amikacin at low tempertures 25 and 30°C.  
V. In comparison to colistin and tobramycin, amikacin had a weaker effect on P. 
aeruginosa when Mg2+were individually added in defined medium.   
VI. The highest optical density (OD600nm) values were detected when Mg2+ or 
Ca+2 was individually added in the defined medium in the presence of lethal 
concentration of amikacin that means the action of amikacin was obliterated 
and provided a greater level of protection to the cells.   
VII. The efficacy of amikacin against PA01 was reduced markedly by the 
combined effects of Ca2+ and Mg2+supplementation compared with 
tobramycin.  
VIII. It was investigated that amikacin with an inoculum effect when multiple 
inocula were used, this finding contradict the existing literature. 
IX. Bacterial cells had faster growth rates when Ca2+ was added individual into 
defined medium in the presence of amikacin.  
 
Consequences of these, chemostat studies were designed to examine prolonged 
exposure of the antibiotic to the planktonic cells. The issue of adaptive resistance 
may emerge in a clinical context, culminating in a lack of response to treatment. In 
addition, it may arise in situations where an insufficient quantity of medication was 
administered or where the recipient did not comply with the recommended treatment 
plan. Sub-inhibitory concentrations of medication may occur in every one of these 
conditions.  The consequences of this over the course of treatment could enhance the 
protection of microorganism from the action of antibiotics and lead to developing 
resistance. Sub-lethal concentrations may play an important role in developing 
resistance in patients who requiring prolonged therapy. 
   




 Thus, in vitro studies were designed using chemostat systems to examine the effect 
of prolonged exposure of antibiotic at sub leathal concentrations at different growth 
rates. By regulating the growth rates it will be possible to also investigate whether or 
not a continuous prescription of antibiotics for a human will be a greater threat than 
the environment, where antibiotics at sub-inhibitory concentrations are routinely 
used as additives in food for animal husbandry.  Based on the results, P. aeruginosa 
exhibited low-level resistance to more recently developed antibiotics with broader 
spectra of antibacterial activity such as amikacin, tobramycin and colistin. The 
results of the tests conducted during this study revealed that the phenotypic 
transformations exhibited by the resistant strains of P. aeruginosa are temporary; 
returning to normal after the strain was left to develop over a number of days in a 
medium that does not contain antibiotics, thus becoming once again susceptible to 
the effect of antibiotics. These findings indicate a clear phenotypic variation during 
long term therapy to the most common antibiotics used to treat P.aeruginosa. Low 
oxygen availability was seen in the cultures grown at 0.099 h-1 and 0.125 h-1, which 
leading to the development of the so called “persister” phenotype that showed a 
reduction in bacterial cell size and resistance to the action of antibiotics. The 
P.aeruginosa cells encapsulated with the extracellular polymeric components in the 
cells derived after 72h incubation time when antibiotic was removed. In all cases, 
continual exposure resulted in phenotypically distinct mucoid or non- mucoid colony 
morphotypes, which were clearly observed on absence of antibiotics. Some of these 
selected morphotypes showed from the MIC and MBC data a high-level resistance to 
the antibiotic in spite of media lacking antibiotics.  
 
Based on the results obtained, the major response to the action of amikacin was 
attributed to persisters cells. This increases the challenge of distinguishing a direct 
relationship between antibiotic use and development of resistance. Clearly antibiotic 
resistance can be induced in situations where an organism is exposed continually to 
an antibiotic, as may be the case in some clinical settings, for example cystic fibrosis 
patients. Based on the results of this study, it can be concurred with that failure to 
eradicate P. aeruginosa in patients suffering from cystic fibrosis can be attributed to 
temporary bacterial resistance to an antimicrobial agent used to treat the patients. 
The biological responses resulting from these studies offer valuable clues underlying 
unsuccessful treatment and this will contribute to the development of viable 




treatment options and help to reduce of the emergence of high antibiotic resistance.  
The response of P.aeruginosa to fast growth rates (expected in human) showed a 
greater threat when left without antibiotic (stress was removed) than cultures grown 
at slow growth rates (expected in environment). This means misuse of antibiotics 
leads to the development of much more aggressive strains of P.aeruginosa. Based on 
the results obtained from divalent cation experiments, one of the most important 
factors that contributed to increase in growth rates of P.aeruginosa when treated 
with amikacin was the presence of  ≥ 3mM of Ca2+.  
As far as conclusions based on the research conducted on the planktonic cells of the 
bacterium P. aeruginosa, using an in vitro procedure treated with a single antibiotic, 
it was found that amikacin typically performed a crucial function in the development 
of resistant variants. This project indicates the way in which the extensive utilisation 
of antimicrobial medicines resulted in alterations occurring in bacterial cells, 
resulting in a reduction in the effectiveness of these antibiotics. Furthermore, it 
demonstrates the manner in which bacteria may become less receptive to medicine, 
in particular circumstances or physical conditions. It is worth to note that, the more 
bacteria are exposed to antibiotics, the more reduced the number of susceptible 
bacteria will become and the higher the probability of selecting resistant bacteria. It 
would be advantageous if research examining the change process of antibiotic 
resistance would focus more closely on the part limiting nutrient and growth rates 
can play on the consequences and selection of adapted strains. 
In summary, the phenomenon of adaptive drug resistance needs to be cognisant of 
advances in new antimicrobial agents, as well as the analysis and correction of any 
difficulties arising from this process. Therefore, in introducing new pharmaceutical 
products to the market, clearly not only must their capability to destroy bacteria and 
toxicity be examined, but also how they stimulate adaptive resistance must take into 
account. Gaining a more in-depth knowledge of the processes by which adaptive 
resistance to antibiotics occurs will assist in devising more successful interventions.  
In addition, it will support the introduction of new drugs, with a reduced likelihood 
of them becoming resistant to disease, but producing equally beneficial medical 
outcomes. These approaches should be established at the initial drug development 
phase, so as to modify the therapeutic intervention (for example, quantity of 




medication) and reduce the persistence of resistance variables at low levels, as they 
often occur by choosing concentrations at specific levels.  
Furthermore, greater emphasis should be placed on the slight rise in drug resistance 
emerging from ongoing clinical reviews. This could be suggestive of adaptive 
resistance occurring throughout an illness, and could also determine indicators of 
high resistance in the future. At the same time, the reliability of the susceptibility 
tests used to detect low-level resistance is considered an important parameter of the 
sustainable use of antimicrobials and prevents the development of high level 
resistance. Thus, use of OxoPlate system as an alternative method to existing 
techniques (conventional methods) would allow monitoring the metabolic activity of 
microorganism in the presence of antibiotics with high temporal resolution. The 
study results underscore that the reliability of the observation of growth inhibition is 
enhanced by the oxygen consumption measurement. With respect to standard 
methods, the OxoPlate method has proven to be an accurate method to detect 
survival subpopulations that resist the action of antibiotics and to test the factors that 
influence the susceptibility of P. aeruginosa to antimicrobials.  
It is imperative that we remain alert to the significant directional changes 
microorganisms are undergoing. In this context, it is necessary to gain a more 
comprehensive understanding of living organisms, as well as an awareness of the 
incidence and management of low levels of antibacterial resistance. A number of 
measures must be taken in an effort to ensure that antibiotics are utilised in a more 
appropriate manner, and to reduce environmental pollution by the drug industry. 
These include providing advice and training, in addition to circulating details on the 
correct enactment and imposition of the law, in relation to the use and discarding of 
medication. Sub-inhibitory antimicrobial levels will play one key function in the 
coming years by comprehensively outlining how these agents can produce 
antibacterial properties, from a molecular biological perspective. 
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